
<html lang="en"     class="pb-page"  data-request-id="93ea18b3-d690-4553-88cc-53faa6591dc3"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/jm301626p;website:website:acspubs;issue:issue:10.1021/jmcmar.2013.56.issue-1;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design and Synthesis of Diazatricyclodecane Agonists of the G-Protein-Coupled Receptor 119" /></meta><meta name="dc.Creator" content="Etzer  Darout" /></meta><meta name="dc.Creator" content="Ralph P.  Robinson" /></meta><meta name="dc.Creator" content="Kim F.  McClure" /></meta><meta name="dc.Creator" content="Matthew  Corbett" /></meta><meta name="dc.Creator" content="Bryan  Li" /></meta><meta name="dc.Creator" content="Andrei  Shavnya" /></meta><meta name="dc.Creator" content="Melissa P.  Andrews" /></meta><meta name="dc.Creator" content="Christopher S.  Jones" /></meta><meta name="dc.Creator" content="Qifang,  Li" /></meta><meta name="dc.Creator" content="Martha L.  Minich" /></meta><meta name="dc.Creator" content="Vincent  Mascitti" /></meta><meta name="dc.Creator" content="Cristiano R. W.  Guimarães" /></meta><meta name="dc.Creator" content="Michael J.  Munchhof" /></meta><meta name="dc.Creator" content="Kevin B.  Bahnck" /></meta><meta name="dc.Creator" content="Cuiman  Cai" /></meta><meta name="dc.Creator" content="David A.  Price" /></meta><meta name="dc.Creator" content="Spiros  Liras" /></meta><meta name="dc.Creator" content="Paul D.  Bonin" /></meta><meta name="dc.Creator" content="Peter  Cornelius" /></meta><meta name="dc.Creator" content="Ruduan  Wang" /></meta><meta name="dc.Creator" content="Victoria  Bagdasarian" /></meta><meta name="dc.Creator" content="Colleen P.  Sobota" /></meta><meta name="dc.Creator" content="Sam  Hornby" /></meta><meta name="dc.Creator" content="Victoria M.  Masterson" /></meta><meta name="dc.Creator" content="Reena M.  Joseph" /></meta><meta name="dc.Creator" content="Amit S.  Kalgutkar" /></meta><meta name="dc.Creator" content="Yue  Chen" /></meta><meta name="dc.Description" content="A series of GPR119 agonists based on a 2,6-diazatricyclo[3.3.1.1∼3,7∼]decane ring system is described. Also provided is a detailed account of the development of a multigram scale synthesis of the d..." /></meta><meta name="Description" content="A series of GPR119 agonists based on a 2,6-diazatricyclo[3.3.1.1∼3,7∼]decane ring system is described. Also provided is a detailed account of the development of a multigram scale synthesis of the d..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 31, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm301626p" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm301626p" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm301626p" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm301626p" /></link>
        
    
    

<title>Design and Synthesis of Diazatricyclodecane Agonists of the G-Protein-Coupled Receptor 119 | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm301626p" /></meta><meta property="og:title" content="Design and Synthesis of Diazatricyclodecane Agonists of the G-Protein-Coupled Receptor 119" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0017.jpeg" /></meta><meta property="og:description" content="A series of GPR119 agonists based on a 2,6-diazatricyclo[3.3.1.1∼3,7∼]decane ring system is described. Also provided is a detailed account of the development of a multigram scale synthesis of the diazatricyclic ring system, which was achieved using a Hofmann–Löffler–Freytag reaction as the key step. The basis for the use of this complex framework lies in an attempt to constrain one end of the molecule in the “agonist conformation” as was previously described for 3-oxa-7-aza-bicyclo[3.3.1]nonanes. Optimization of carbamate analogues of the diazatricylic compounds led to the identification of 32i as a potent agonist of the GPR119 receptor with low unbound human liver microsomal clearance. The use of an agonist response weighted ligand lipophilic efficiency (LLE) termed AgLLE is discussed along with the issues of applying efficiency measures to agonist programs. Ultimately, solubility limited absorption and poor exposure reduced further interest in these molecules." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm301626p"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm301626p">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm301626p&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm301626p&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm301626p&amp;href=/doi/10.1021/jm301626p" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2013</span><span class="cit-fg-volume">, 56</span><span class="cit-fg-issue">, 1</span><span class="cit-fg-pageRange">, 301-319</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/56/1" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm301625s" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm3016393" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design and Synthesis of Diazatricyclodecane Agonists of the G-Protein-Coupled Receptor 119</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Etzer++Darout">Etzer Darout</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ralph+P.++Robinson">Ralph P. Robinson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kim+F.++McClure">Kim F. McClure</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthew++Corbett">Matthew Corbett</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bryan++Li">Bryan Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrei++Shavnya">Andrei Shavnya</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Melissa+P.++Andrews">Melissa P. Andrews</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+S.++Jones">Christopher S. Jones</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Qifang%2C++Li">Qifang, Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Martha+L.++Minich">Martha L. Minich</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vincent++Mascitti">Vincent Mascitti</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cristiano+R.+W.++Guimar%C3%A3es">Cristiano R. W. Guimarães</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+J.++Munchhof">Michael J. Munchhof</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kevin+B.++Bahnck">Kevin B. Bahnck</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cuiman++Cai">Cuiman Cai</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+A.++Price">David A. Price</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Spiros++Liras">Spiros Liras</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul+D.++Bonin">Paul D. Bonin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter++Cornelius">Peter Cornelius</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ruduan++Wang">Ruduan Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Victoria++Bagdasarian">Victoria Bagdasarian</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Colleen+P.++Sobota">Colleen P. Sobota</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sam++Hornby">Sam Hornby</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Victoria+M.++Masterson">Victoria M. Masterson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Reena+M.++Joseph">Reena M. Joseph</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Amit+S.++Kalgutkar">Amit S. Kalgutkar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yue++Chen">Yue Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Departments of Medicinal Chemistry, Discovery Biology, Drug Metabolism, and Pharmaceutical Sciences, Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Departments of Medicinal Chemistry, Discovery Biology, Drug Metabolism, and Pharmaceutical Sciences, Pfizer Worldwide Research and Development, 620 Memorial Drive, Cambridge, Massachusetts 02139, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: +1-617-551-3516. Fax: +1-617-551-3082. E-mail: <a href="/cdn-cgi/l/email-protection#d6bdbfbbf8b0f8bbb5b5baa3a4b396a6b0bfacb3a4f8b5b9bb"><span class="__cf_email__" data-cfemail="412a282c6f276f2c22222d343324013127283b24336f222e2c">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm301626p&amp;href=/doi/10.1021%2Fjm301626p" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2013</span></span><span class="cit-volume">, 56</span><span class="cit-issue">, 1</span><span class="cit-pageRange">, 301–319</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 12, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>3 November 2012</li><li><span class="item_label"><b>Published</b> online</span>31 December 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 January 2013</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm301626p" title="DOI URL">https://doi.org/10.1021/jm301626p</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D301%26pageCount%3D19%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DEtzer%2BDarout%252C%2BRalph%2BP.%2BRobinson%252C%2BKim%2BF.%2BMcClure%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D56%26issueNum%3D1%26contentID%3Djm301626p%26title%3DDesign%2Band%2BSynthesis%2Bof%2BDiazatricyclodecane%2BAgonists%2Bof%2Bthe%2BG-Protein-Coupled%2BReceptor%2B119%26numPages%3D19%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D319%26publicationDate%3DJanuary%2B2013">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm301626p"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2863</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">27</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm301626p" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design and Synthesis of Diazatricyclodecane Agonists of the G-Protein-Coupled Receptor 119&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Etzer&quot;,&quot;last_name&quot;:&quot;Darout&quot;},{&quot;first_name&quot;:&quot;Ralph&quot;,&quot;last_name&quot;:&quot;P. Robinson&quot;},{&quot;first_name&quot;:&quot;Kim&quot;,&quot;last_name&quot;:&quot;F. McClure&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;Corbett&quot;},{&quot;first_name&quot;:&quot;Bryan&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Andrei&quot;,&quot;last_name&quot;:&quot;Shavnya&quot;},{&quot;first_name&quot;:&quot;Melissa&quot;,&quot;last_name&quot;:&quot;P. Andrews&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;S. Jones&quot;},{&quot;first_name&quot;:&quot;Qifang,&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Martha&quot;,&quot;last_name&quot;:&quot;L. Minich&quot;},{&quot;first_name&quot;:&quot;Vincent&quot;,&quot;last_name&quot;:&quot;Mascitti&quot;},{&quot;first_name&quot;:&quot;Cristiano&quot;,&quot;last_name&quot;:&quot;R. W. Guimarães&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;J. Munchhof&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;B. Bahnck&quot;},{&quot;first_name&quot;:&quot;Cuiman&quot;,&quot;last_name&quot;:&quot;Cai&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;A. Price&quot;},{&quot;first_name&quot;:&quot;Spiros&quot;,&quot;last_name&quot;:&quot;Liras&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;D. Bonin&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;Cornelius&quot;},{&quot;first_name&quot;:&quot;Ruduan&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Victoria&quot;,&quot;last_name&quot;:&quot;Bagdasarian&quot;},{&quot;first_name&quot;:&quot;Colleen&quot;,&quot;last_name&quot;:&quot;P. Sobota&quot;},{&quot;first_name&quot;:&quot;Sam&quot;,&quot;last_name&quot;:&quot;Hornby&quot;},{&quot;first_name&quot;:&quot;Victoria&quot;,&quot;last_name&quot;:&quot;M. Masterson&quot;},{&quot;first_name&quot;:&quot;Reena&quot;,&quot;last_name&quot;:&quot;M. Joseph&quot;},{&quot;first_name&quot;:&quot;Amit&quot;,&quot;last_name&quot;:&quot;S. Kalgutkar&quot;},{&quot;first_name&quot;:&quot;Yue&quot;,&quot;last_name&quot;:&quot;Chen&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;31&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;volume&quot;:&quot;56&quot;,&quot;pages&quot;:&quot;301-319&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm301626p&quot;},&quot;abstract&quot;:&quot;A series of GPR119 agonists based on a 2,6-diazatricyclo[3.3.1.1∼3,7∼]decane ring system is described. Also provided is a detailed account of the development of a multigram scale synthesis of the diazatricyclic ring system, which was achieved using a Hofmann–Löffler–Freytag reaction as the key step. The basis for the use of this complex framework lies in an attempt to constrain one end of the molecule in the “agonist conformation” as was previously described for 3-oxa-7-aza-bicyclo[3.3.1]nonanes. Optimization of carbamate analogues of the diazatricylic compounds led to the identification of 32i as a potent agonist of the GPR119 receptor with low unbound human liver microsomal clearance. The use of an agonist response weighted ligand lipophilic efficiency (LLE) termed AgLLE is discussed along with the issues of applying efficiency measures to agonist programs. Ultimately, solubility limited absorption and poor exposure reduced further interest in these molecules.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm301626p&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm301626p" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm301626p&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm301626p" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm301626p&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm301626p" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm301626p&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm301626p&amp;href=/doi/10.1021/jm301626p" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm301626p" /></input><a href="/doi/pdf/10.1021/jm301626p" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (975 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm301626p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm301626p%26sid%3Dliteratum%253Aachs%26pmid%3D23234271%26genre%3Darticle%26aulast%3DDarout%26date%3D2013%26atitle%3DDesign%2Band%2BSynthesis%2Bof%2BDiazatricyclodecane%2BAgonists%2Bof%2Bthe%2BG-Protein-Coupled%2BReceptor%2B119%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D56%26issue%3D1%26spage%3D301%26epage%3D319%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292039" title="Pharmacology">Pharmacology</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=290888" title="Liquid liquid equilibrium">Liquid liquid equilibrium</a>,</li><li><a href="/action/doSearch?ConceptID=291454" title="Solubility">Solubility</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/56/1" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jmcmar.2013.56.issue-1/production/jmcmar.2013.56.issue-1.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/medium/jm-2012-01626p_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301626p&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A series of GPR119 agonists based on a 2,6-diazatricyclo[3.3.1.1∼3,7∼]decane ring system is described. Also provided is a detailed account of the development of a multigram scale synthesis of the diazatricyclic ring system, which was achieved using a Hofmann–Löffler–Freytag reaction as the key step. The basis for the use of this complex framework lies in an attempt to constrain one end of the molecule in the “agonist conformation” as was previously described for 3-oxa-7-aza-bicyclo[3.3.1]nonanes. Optimization of carbamate analogues of the diazatricylic compounds led to the identification of <b>32i</b> as a potent agonist of the GPR119 receptor with low unbound human liver microsomal clearance. The use of an agonist response weighted ligand lipophilic efficiency (LLE) termed AgLLE is discussed along with the issues of applying efficiency measures to agonist programs. Ultimately, solubility limited absorption and poor exposure reduced further interest in these molecules.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52177" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52177" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The incidence of diabetes continues to grow globally with recent estimates of 384 million cases worldwide.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Generally diagnosis is determined by measurement of fasting plasma glucose (FPG), but recently an international recommendation has been made for the use of glycosylated hemoglobin (HbA<sub>1c</sub>) as a time integrated marker of glucose levels.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Current pharmacologic treatment of diabetes is largely characterized by modulation of the pathway for the endogenous hormone insulin either by increasing its secretion or by sensitizing the target tissues to its action.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a> Although an orthogonal mechanism that addresses glucose directly by increasing its disposal in urine is currently in development,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> the insulin pathway continues to receive attention, particularly with respect to achieving glycemic control with reduced risk of hypoglycemia or for exhausting the ability of the pancreas to secrete insulin.</div><div class="NLM_p">Interest in the non-peptide G-protein-coupled receptor 119 (GPR119) can be traced to the success of glucagon-like peptide 1 (GLP-1) injectable drugs such as exenatide<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> and the oral small molecule inhibitors that act by increasing the circulating levels of active GLP-1 by blocking its enzymatic degradation by dipetidyl dipeptidase IV (DPPIV).<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Theoretically a GPR119 agonist could provide the benefits of the former in an oral agent through the stimulation of GPR119 receptors in the gastrointestinal tract.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> In addition, stimulation of GPR119 receptors in the islet is proposed to have beneficial effects on the health of islets.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> These theoretical attributes have thus far been a challenge to demonstrate clinically, and the potential of GPR119 agonists remains unanswered.<a onclick="showRef(event, 'ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13">(11-13)</a></div><div class="NLM_p last">Although early GPR119 structures showed a high prevalence of a piperidine carbamate on one end of the molecule (the “head”) and a sulfone on the other (the “tail”), it is now apparent that other structural motifs are tolerated.<a onclick="showRef(event, 'ref14 ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16 ref17 ref18">(14-18)</a> Interestingly, synthetic agonist ligands are structurally distinct from the growing number of “endogenous” ligands of the receptor.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a>Accompanying the evolution of GPR119 agonist structures has been an increasing understanding of the structural features that drive an agonist response. Previously we described a conformational hypothesis to explain the differences in human agonist pharmacology for oxaazabicyclo[3.3.1]nonane head pieces.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Herein we describe the extension of this hypothesis to a novel series of bridged cyclic structures.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58211" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58211" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Design and Synthesis of the “Cage”</h3><div class="NLM_p">As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>, the approach was to constrain the piperidine head piece as in the oxoazabicyclo[3.2.1]octanes <b>1</b> and <b>2</b>.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> At the same time the aim was to ensure that the preferred conformation locks this part of the molecule into the “agonist conformation”. The ring system we planned to use for achieving this was a 2,6-diazatricyclo[3.3.1.1∼3,7∼]decane, informally referred to as the “cage”.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> While the carbamate placement would closely match that of compound <b>1</b> and provide a level of confidence in achieving an agonist profile, the switch to a nitrogen linkage between the headgroup and the “core” central pyrimidine ring would have less predictable consequences. One of the concerns with the change centered on the added carbons near the pyrimidine ring and the impact they may have on the torsion to the central pyrimidine, particularly one bearing a methyl group as in <b>3a</b>. From a calculated physicochemical perspective, the diazatricyclo[3.3.1.1∼3,7∼]decane system has a similar ClogP to the oxoazabicyclo[3.2.1]octane in the context of structures <b>1</b>–<b>3</b> (ClogP(<b>3a</b>) = ClogP(<b>1</b>) = 3.3). By far the biggest concern with the proposal, however, was how to address the synthesis challenge presented by the complex cage structure.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/medium/jm-2012-01626p_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Functional profile for bridged cyclic vs unbridged structures.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301626p&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To fully test how well the cage structures fit our conformational hypothesis, we needed to enable an efficient and scalable synthesis of a versatile intermediate such as <b>5</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) to access bridged-cyclic structures such as <b>3a</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). Several synthetic strategies for the synthesis of the requisite cage intermediate were explored. Our first attempt is outlined retrosynthetically in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. In this scheme the cage template <b>5</b> would ultimately result from a hydrodechlorination of intermediate <b>6b</b>.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> In turn, this intermediate would arise from chlorination of the corresponding aminal <b>6a</b>. An oxidation of the hydroxyl group in <b>7</b> and reductive amination with hydride delivery from the convex face would be required to produce <b>6a</b>. Bicyclic <b>7</b> would then be accessed via a double Mannich reaction on the iminium species formed from <b>8</b> and <b>10</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/medium/jm-2012-01626p_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0006.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Retrosynthetic Analysis of the 2,6-Diazatricyclo[3.3.1.1∼3,7∼]decane Ring System</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301626p&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As shown in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>, the synthetic sequence used to pursue this approach began with the Mannich reaction of bisaldehyde <b>8a</b>,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> benzylamine, and acetone-1,3-dicarboxylic acid.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> This provided a 3:1 mixture of isomers favoring the enolate addition to the face of the iminium opposite that of the benzyl ether. Hydrogenolysis of the major isomer <b>11a</b> in the presence of di-<i>tert</i>-butyl dicarbonate provided bicyclic ketone <b>12</b>.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/medium/jm-2012-01626p_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0007.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Mannich/Reductive Amination Approach<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301626p&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 1,3-acetonedicarboxylic acid, BnNH<sub>2</sub>, conc HCl, H<sub>2</sub>O, 50 °C (35%); (b) H<sub>2</sub>, Pd(OH)<sub>2</sub>, Boc<sub>2</sub>O, MeOH, 23 °C (quant).</p></p></figure><div class="NLM_p">Installation of the second nitrogen via a two-step reductive amination protocol was then attempted following the conditions shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. Only recovered starting material was obtained after attempted reductive amination via sequential treatment of <b>12</b> with NH<sub>3</sub>/MeOH and Raney nickel.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The use of benzylamine<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> or methylamine with PtO<sub>2</sub> as catalyst<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> yielded similar results. Condensation of the C-3 ketone with hydroxylamine followed by LAH reduction of the oxime resulted in decomposition of the oxime to a complex mixture that was not investigated further.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The lack of success in installing the C-3 amine in this fashion necessitated exploring a different approach to the cage intermediate.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Reductive Amination Conditions</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/medium/jm-2012-01626p_0015.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">step a</th><th class="colsep0 rowsep0" align="center">step b</th><th class="colsep0 rowsep0" align="center">pressure (bar)</th><th class="colsep0 rowsep0" align="center">temp (°C)</th><th class="colsep0 rowsep0" align="center">reducing agent</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NH<sub>3</sub>/EtOH</td><td class="colsep0 rowsep0" align="left">EtOH</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">Raney Ni</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BnNH<sub>2</sub>/EtOH</td><td class="colsep0 rowsep0" align="left">EtOH</td><td class="colsep0 rowsep0" align="left">70</td><td class="colsep0 rowsep0" align="left">70</td><td class="colsep0 rowsep0" align="left">Raney Ni</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MeNH<sub>2</sub>/EtOH</td><td class="colsep0 rowsep0" align="left">EtOH/NH<sub>4</sub>OAc</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">PtO<sub>2</sub></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NH<sub>2</sub>OH·HCl,NaOAc/MeOH</td><td class="colsep0 rowsep0" align="left">THF</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">30–40</td><td class="colsep0 rowsep0" align="left">LiAlH<sub>4</sub></td></tr></tbody></table></div></div><div class="NLM_p">An alternative approach was to exploit the work of Rassat et al. who, in 1974, disclosed the synthesis of a 2,6-diazatricyclo[3.3.1.1∼3,7∼]decane (2,6-diazaadamantane) derivative via Hofmann–Löffler–Freytag (HLF) ring closure (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Despite the fact that Li<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> failed to reproduce the Rassat work, the simplicity of the approach compelled us to further explore this free radical chain cyclization process.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/medium/jm-2012-01626p_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0008.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Rassat’s Route to 2,6-Diazaadamantane Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301626p&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Br<sub>2</sub>, cyclohexane, 0 °C; (b) 84% H<sub>2</sub>SO<sub>4</sub>, 65 °C, 30 min (<b>15</b>, 30%, <b>18</b>, 33%).</p></p></figure><div class="NLM_p">Consistent with the work of Li, our attempts to follow the sequence in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a> using the published conditions with Br<sub>2</sub> or <i>N</i>-bromosuccinimide failed to provide any of the desired <b>17</b>. In both cases, the compounds isolated from the reaction were benzaldimine <b>18</b> arising from the formal loss of HBr and recovered starting material. Presumably if <b>18</b> was formed from the aminyl radical derived from homolytic cleavage of the N–Br bond, the rate of hydrogen atom abstraction from the benzylic methylene must be greater than that of the cross-ring abstraction required to form <b>17</b>. It is also possible that under the reaction conditions in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>, no homolytic bond cleavage occurs, only elimination of HBr.</div><div class="NLM_p">Although studies have shown that homolytic cleavage of <i>N</i>-chloroamines under acidic conditions leads to protonated aminyl radicals that are less prone to disproportionation/dimerization and undergo more efficient HLF reaction,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> we did not try this acidic halide variation. Instead, we explored the acid free conditions reported by Ban as shown in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> In this case <i>N</i>-chlorosuccinimide was used to N-chlorinate <b>15</b> and homolysis was achieved by first addition of triethylamine followed by photolysis. Substantial amounts of the benzaldimine <b>18</b> were still obtained. However, for the first time, small amounts of the desired cage compound <b>17</b> were produced. While this was an encouraging result, significant improvements in yield would be needed to supply sufficient quantities of <b>17</b> for the rapid synthesis of analogues.</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/medium/jm-2012-01626p_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0009.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Initial Hofmann–Löffler–Freytag Reaction<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301626p&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NCS, Et<sub>2</sub>O, 0 °C, 5 min; then Et<sub>3</sub>N, hν, 0 °C, 45 min (<b>17</b>, 29%; <b>18</b>, 40%).</p></p></figure><div class="NLM_p">To improve the yield of the cyclization step, we needed to identify an HLF precursor less prone to unproductive side reactions. One possibility was to replace the troublesome <i>N</i>-benzyl with a more inert protective group. The more efficient approach was to forego a protective group altogether.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div><div class="NLM_p">As shown in Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>, treatment of commercially available endo-3-amino-9-methyl-9-azabicyclo[3.3.1]nonane <b>19</b> with <i>t</i>-BuOCl, followed by ultraviolet irradiation of the mixture, provided a 68% yield of a 3:1 mixture of <b>20</b> and starting material as a hygroscopic solid. Switching to <i>t</i>-BuOCl eliminated the succinimide byproduct formed when <i>N</i>-chlorosuccinimide was used as the chloronium source and simplified the isolation of the product. The cage intermediate <b>20</b> was easily converted to the <i>tert</i>-butyl (<b>21a</b>) and 1-methylcyclopropyl (<b>21b</b>) carbamate derivatives in 54% and 44% yield, respectively, from <b>19</b>. To complete the synthesis of the cage intermediate needed for our analogue work, we needed to demethylate <b>21a</b> and <b>21b</b>. Compound <b>21b</b> was demethylated with 1-chloroethyl chloroformate (ACE-Cl) using the standard conditions to provide <b>5b</b> in 93% yield.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> For the demethylation of <b>21a</b>, we used an alternative method because of concerns with the HCl content of commercial sources of ACE-Cl and the acid instability of the Boc group. Thus, intermediate <b>21a</b> was demethylated under oxidative conditions with KMNO<sub>4</sub> to afford <b>5a</b> in 90% yield.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/medium/jm-2012-01626p_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0010.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Optimization of the Hofmann–Löffler–Freytag Reaction<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301626p&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>t</i>-BuOCl, Et<sub>2</sub>O, 23 °C, 15 min; then hν, 35 °C, 60 min, (68%) of 3:1 mix <b>20</b>/<b>19</b>; (b) Boc<sub>2</sub>O, Et<sub>3</sub>N, MeOH, 23 °C, 30 min (54%, steps a and b); (c) 1-methylcyclopropyl 4-nitrophenylcarbonate, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 16 h, (44%, steps a and c); (d) KMnO<sub>4</sub>, NaOH (1.5 N), THF, 68 h (90%); (e) ACE-Cl, 1,2-DCE, 90 °C, 1.5 h; MeOH, 90 °C, 1.5 h (93%).</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Synthesis and SAR of Cage Analogues</h3><div class="NLM_p">With an efficient and scalable method to prepare 2,6-diazatricyclo[3.3.1.1∼3,7∼]decane derivatives we were ready to investigate the impact of this novel piperidine surrogate on human GPR119 pharmacology. The compounds shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> were synthesized using the general sequence shown in Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>. The synthesis of <b>25a</b>–<b>c</b> began with the addition of 2-fluoro-4-(methylsulfonyl)phenol to 4,6-dichloro-5-methylpyrimidine <b>22a</b>. The resulting biaryl ether <b>23</b><a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> underwent nucleophilic aromatic substitution with the Boc-cage derivative <b>20</b> followed by N-demethylation to provide pyrimidine <b>24</b>. The desired carbamates derivatives <b>25a</b>–<b>c</b> were then obtained by standard acylation. The pharmacology of these analogues was compared with that of the unbridged piperidine analogue <b>26</b><a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).</div><figure id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/medium/jm-2012-01626p_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0011.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Addition of the 2,6-Diazatricyclo[3.3.1.1∼3,7∼]decane to Biaryl Chloropyrimidine via S<sub>N</sub>Ar<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301626p&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2-fluoro-4-(methylsulfonyl)phenol, Cs<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, microwave 120 °C, 1.5 h (57%); (b) 2-methyl-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane, Cs<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, microwave 180 °C, 1 h (57%); (c) ACE-Cl, 1,2-DCE, 90 °C, 1.5 h; MeOH, 90 °C, 1.5 h; (d) Boc<sub>2</sub>O, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 23 °C, 30 min (17%, steps c and d); (e) isopropyl chloroformate, DIPEA, CH<sub>2</sub>Cl<sub>2</sub>, 23 °C, 18 h (74%); (f) 1-methylcyclopropyl 4-nitrophenylcarbonate, DIPEA, CH<sub>2</sub>Cl<sub>2</sub>, 16 h (57%).</p></p></figure><figure id="fig2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/medium/jm-2012-01626p_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0003.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Piperidinol comparator.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301626p&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Consistent with our hypothesis, direct comparison of <b>25b</b> and <b>26</b> showed that the cage analogue indeed elicits a greater agonist response than its piperidinol counterpart in our 3′,5′-cyclic adenosine monophosphate (cAMP) functional assay. To investigate whether the conformational disposition of the cage group resembles the conformation of the oxoazabicyclo[3.2.1]octane headgroup we explored earlier, we obtained a single crystal X-ray structure for <b>25b</b>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In Vitro Human GPR119 Pharmacology for <b>25a</b>–<b>c</b> and <b>26</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">cAMP EC<sub>50</sub> (nM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">IA (%)</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">ClogP (ElogD)<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25a</b></td><td class="colsep0 rowsep0" align="left">40 ± 12</td><td class="colsep0 rowsep0" align="left">87 ± 8</td><td class="colsep0 rowsep0" align="left">41 ± 24</td><td class="colsep0 rowsep0" align="left">3.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>n</i> = 6</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>n</i> = 5</td><td class="colsep0 rowsep0" align="left">(4.6)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25b</b></td><td class="colsep0 rowsep0" align="left">121 ± 34</td><td class="colsep0 rowsep0" align="left">74 ± 4</td><td class="colsep0 rowsep0" align="left">141 ± 71</td><td class="colsep0 rowsep0" align="left">2.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>n</i> = 9</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>n</i> = 5</td><td class="colsep0 rowsep0" align="left">(4.4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25c</b></td><td class="colsep0 rowsep0" align="left">169 ± 49</td><td class="colsep0 rowsep0" align="left">91 ± 8</td><td class="colsep0 rowsep0" align="left">131 ± 45</td><td class="colsep0 rowsep0" align="left">2.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>n</i> = 4</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>n</i> = 4</td><td class="colsep0 rowsep0" align="left">(4.3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">29 ± 28</td><td class="colsep0 rowsep0" align="left">49 ± 7</td><td class="colsep0 rowsep0" align="left">53 ± 56</td><td class="colsep0 rowsep0" align="left">2.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>n</i> = 24</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>n</i> = 9</td><td class="colsep0 rowsep0" align="left">(4.5)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">See ref <a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">21</a> for assay conditions.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">See ref <a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">38</a>.</p></div></div></div><figure id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/medium/jm-2012-01626p_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0004.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. ORTEP of <b>25b</b> with ellipsoids drawn at the 50% confidence level.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301626p&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As seen in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>, the cage structure places the “crown” methine in a similar torsional arrangement as in the case of the piperidinol,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> just out of plane with one of the pyrimidine nitrogens. In effect this places the carbamate in the same area as the “agonist” conformation of <b>1</b>.</div><div class="NLM_p">To make the comparison with analogues in the oxoazabicyclo[3.2.1]octane series, we next wanted to incorporate the methylpyridyloxy tail. Our experience showed that the methylpyridyloxy group generally provides a lower agonist response relative to the fluoro(methylsulfonyl)phenoxy group. Having a baseline comparator with near 50% of the maximal response would allow both positive and negative changes in intrinsic activity (IA) to be readily assessed, thus revealing the contribution of various cage groups on agonist response. Also, methylpyridyloxy analogues exhibit superior aqueous solubility relative to those having fluoro(methylsulfonyl)phenoxy tails.<a onclick="showRef(event, 'ref21 ref39'); return false;" href="javascript:void(0);" class="ref ref21 ref39">(21, 39)</a></div><div class="NLM_p">The synthesis of the methylpyridyloxy analogues is shown in Scheme <a class="ref internalNav" href="#sch7" aria-label="7">7</a>. Nucleophilic aromatic substitution reaction between <b>5a</b> and commercially available chloropyrimidine <b>27a</b> followed by Boc cleavage provided the pyrimidine derivative <b>28a</b>, which was used for the synthesis of the carbamate analogues <b>3a</b>–<b>i</b> in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>.</div><figure id="sch7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/medium/jm-2012-01626p_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0012.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of 2,6-Diazatricyclo[3.3.1.1∼3,7∼]decane Pyridyloxypyrimidine Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301626p&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>tert</i>-butyl 2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate <b>5a</b>, Na<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, 1200 °C, 42 h (53%); (b) 4 N HCl/1,4-dioxane, MeOH, 20 °C, 16 h; (c) R<sub>1</sub>OC(O)X, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 23 °C, 12–16 h (31–94%, steps b and c).</p></p></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. In Vitro Human GPR119 Pharmacology for <b>3a</b>–<b>i</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub>, Scheme <a class="ref internalNav" href="#sch7" aria-label="7">7</a></th><th class="colsep0 rowsep0" align="center">cAMP EC<sub>50</sub> (nM)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">IA (%)</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub> (nM)</th><th class="colsep0 rowsep0" align="center">ClogP (ElogD)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3a</b></td><td class="colsep0 rowsep0" align="left">isopropyl</td><td class="colsep0 rowsep0" align="left">559 ± 1128</td><td class="colsep0 rowsep0" align="left">64 ± 16</td><td class="colsep0 rowsep0" align="left">2233 ± 1608</td><td class="colsep0 rowsep0" align="left">3.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>n</i> = 10</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>n</i> = 5</td><td class="colsep0 rowsep0" align="left">(3.8)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3b</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">5562 ± 2223</td><td class="colsep0 rowsep0" align="left">56% at 10 μM</td><td class="colsep0 rowsep0" align="left">1970 ± 914</td><td class="colsep0 rowsep0" align="left">3.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>n</i> = 3</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>n</i> = 4</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3c</b></td><td class="colsep0 rowsep0" align="left">1-methylcyclopropyl</td><td class="colsep0 rowsep0" align="left">636 ± 1201</td><td class="colsep0 rowsep0" align="left">81 ± 10</td><td class="colsep0 rowsep0" align="left">586 ± 668</td><td class="colsep0 rowsep0" align="left">3.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>n</i> = 21</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>n</i> = 4</td><td class="colsep0 rowsep0" align="left">(4.0)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3d</b></td><td class="colsep0 rowsep0" align="left">cyclobutyl</td><td class="colsep0 rowsep0" align="left">130 ± 59</td><td class="colsep0 rowsep0" align="left">53 ± 6</td><td class="colsep0 rowsep0" align="left">682 ± 409</td><td class="colsep0 rowsep0" align="left">3.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>n</i> = 5</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>n</i> = 3</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3e</b></td><td class="colsep0 rowsep0" align="left"><i>tert</i>-butyl</td><td class="colsep0 rowsep0" align="left">40 ± 11</td><td class="colsep0 rowsep0" align="left">61 ± 13</td><td class="colsep0 rowsep0" align="left">486 ± 204</td><td class="colsep0 rowsep0" align="left">3.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>n</i> = 3</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>n</i> = 3</td><td class="colsep0 rowsep0" align="left">(4.3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3f</b></td><td class="colsep0 rowsep0" align="left">isobutyl</td><td class="colsep0 rowsep0" align="left">88 ± 75</td><td class="colsep0 rowsep0" align="left">27 ± 5</td><td class="colsep0 rowsep0" align="left">231 ± 78</td><td class="colsep0 rowsep0" align="left">3.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>n</i> = 7</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>n</i> = 5</td><td class="colsep0 rowsep0" align="left">(4.5)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3g</b></td><td class="colsep0 rowsep0" align="left">(<i>R</i>)-<i>sec</i>-butyl</td><td class="colsep0 rowsep0" align="left">145 ± 59</td><td class="colsep0 rowsep0" align="left">44 ± 7</td><td class="colsep0 rowsep0" align="left">290 ± 53</td><td class="colsep0 rowsep0" align="left">3.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>n</i> = 3</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>n</i> = 3</td><td class="colsep0 rowsep0" align="left">(4.4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3h</b></td><td class="colsep0 rowsep0" align="left">(<i>S</i>)-<i>sec</i>-butyl</td><td class="colsep0 rowsep0" align="left">155 ± 62</td><td class="colsep0 rowsep0" align="left">45 ± 4</td><td class="colsep0 rowsep0" align="left">493 ± 24</td><td class="colsep0 rowsep0" align="left">3.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>n</i> = 3</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>n</i> = 3</td><td class="colsep0 rowsep0" align="left">(4.4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3i</b></td><td class="colsep0 rowsep0" align="left">1-methylcyclobutyl</td><td class="colsep0 rowsep0" align="left">75 ± 19</td><td class="colsep0 rowsep0" align="left">46 ± 3</td><td class="colsep0 rowsep0" align="left">136 ± 41</td><td class="colsep0 rowsep0" align="left">3.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>n</i> = 3</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>n</i> = 3</td><td class="colsep0 rowsep0" align="left">(4.5)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">See ref <a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">21</a> for assay conditions.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">See ref <a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">38</a>.</p></div></div></div><div class="NLM_p">Given the apparent positional contribution of the carbamate on the functional profiles of <b>1</b> and <b>2</b>, enforced by their distinct conformations, we also wanted to explore the nature of the carbamate on the functional response. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, branching near the carbamate oxygen led to the compounds with the highest agonist response. Interestingly, the methylpyridyloxy tail did not lower the IA relative to the sulfone-based tail to the extent anticipated with some overlap remaining in the standard deviation for the maximal agonist response. With the exception of <b>3b</b>, a lower agonist response could not be ascribed to reduced binding affinity. The aqueous solubility of the representative <b>3c</b> (0.5 μg/mL, phosphate buffered saline, pH 7.4, and 6.8 mg/mL at pH 1.2) suggested the potential for good aqueous solubility at low pH. The in vitro human liver microsomal clearance for the compounds tracked with lipophilicity. Of the compounds tested in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, only compounds with ClogP greater than 3.7 demonstrated scaled apparent intrinsic clearance (Cl<sub>int,app,scaled</sub>) greater than 30 mL min<sup>–1</sup> kg<sup>–1</sup> in human liver microsomes.</div><div class="NLM_p">Unfortunately, when straightforward changes to the terminal nitrogen of the cage headgroup were employed, it was not possible to obtain a sufficiently potent full agonist using the methylpyridyloxy tail. While we had demonstrated that the cage was beneficial for eliciting an agonist response, it was at the cost of adding molecular weight and limited options for easy substitutions. Unable to overcome the lower IA for the methylpyridyloxy tail with changes to the cage head, alternative tail–core combinations would be needed to achieve the desired pharmacologic profile and would potentially limit options for retaining desirable physicochemical properties.</div><div class="NLM_p">Next we explored the impact of different substitution on the core pyrimidine ring. As mentioned previously, there was concern that such changes would create a more congested environment around the cage headgroup relative to the piperidinol.</div><figure id="sch8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/medium/jm-2012-01626p_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0013.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthesis of C-5 Substituted Pyrimidine Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301626p&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2-methylpyridin-3-ol, KO-<i>t</i>-Bu, THF/DMF, 0–23 °C (81–90%); (b) <i>tert</i>-butyl 2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate <b>5a</b>, Na<sub>2</sub>CO<sub>3</sub> or NaHCO<sub>3</sub>, DMF or DMA, 80–120 °C, 1–16.5 h (51–87%); (c) 4 N HCl/1,4-dioxane, MeOH or TFA, CH<sub>2</sub>Cl<sub>2</sub>, 23 °C, 1.25–3 h; (d) R<sub>1</sub>OC(O)X, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 23 °C, 12–16 h (7–93%, steps c and d).</p></p></figure><div class="NLM_p">Scheme <a class="ref internalNav" href="#sch8" aria-label="8">8</a> describes the synthesis of the modified core analogues. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, changes to R<sub>2</sub> on the central pyrimidine ring generally resulted in weaker agonists compared to compounds where R<sub>2</sub> is methyl. In certain cases, such as when R is H, this is a consequence of a loss in binding affinity to the receptor. No additional effort was applied to this region of the molecule.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. In Vitro Human GPR119 Pharmacology for <b>29a</b>–<b>j</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub>, Scheme <a class="ref internalNav" href="#sch8" aria-label="8">8</a></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub>, Scheme <a class="ref internalNav" href="#sch8" aria-label="8">8</a></th><th class="colsep0 rowsep0" align="center">cAMP EC<sub>50</sub> (nM)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">IA (%)</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub> (nM)</th><th class="colsep0 rowsep0" align="center">ClogP (ElogD)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29a</b></td><td class="colsep0 rowsep0" align="left">1-methylcyclopropyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>10000</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>8148</td><td class="colsep0 rowsep0" align="left">2.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>n</i> = 3</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>n</i> = 1</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29b</b></td><td class="colsep0 rowsep0" align="left"><i>tert</i>-butyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>10000</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>8148</td><td class="colsep0 rowsep0" align="left">3.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>n</i> = 3</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>n</i> = 2</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29c</b></td><td class="colsep0 rowsep0" align="left">isopropyl</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">164 ± 153</td><td class="colsep0 rowsep0" align="left">36 ± 0.2</td><td class="colsep0 rowsep0" align="left">197 ± 55</td><td class="colsep0 rowsep0" align="left">3.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>n</i> = 3</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>n</i> = 3</td><td class="colsep0 rowsep0" align="left">(4.3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29d</b></td><td class="colsep0 rowsep0" align="left">1-methylcyclopropyl</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">49 ± 21</td><td class="colsep0 rowsep0" align="left">52 ± 5</td><td class="colsep0 rowsep0" align="left">123 ± 33</td><td class="colsep0 rowsep0" align="left">3.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>n</i> = 6</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>n</i> = 3</td><td class="colsep0 rowsep0" align="left">(4.4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29e</b></td><td class="colsep0 rowsep0" align="left"><i>tert</i>-butyl</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">16 ± 7</td><td class="colsep0 rowsep0" align="left">37 ± 4</td><td class="colsep0 rowsep0" align="left">18 ± 6</td><td class="colsep0 rowsep0" align="left">4.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>n</i> = 5</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>n</i> = 3</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29f</b></td><td class="colsep0 rowsep0" align="left">1-methylcyclopropyl</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">>10000</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>7318 ± 1027</td><td class="colsep0 rowsep0" align="left">2.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>n</i> = 3</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>n</i> = 3</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29g</b></td><td class="colsep0 rowsep0" align="left"><i>tert</i>-butyl</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">>3014 ± 4665</td><td class="colsep0 rowsep0" align="left">47 ± 3</td><td class="colsep0 rowsep0" align="left">814 ± 569</td><td class="colsep0 rowsep0" align="left">3.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>n</i> = 4</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>n</i> = 3</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29h</b></td><td class="colsep0 rowsep0" align="left">isopropyl</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">691 ± 184</td><td class="colsep0 rowsep0" align="left">28 ± 5</td><td class="colsep0 rowsep0" align="left">1496 ± 103</td><td class="colsep0 rowsep0" align="left">3.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>n</i> = 3</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>n</i> = 3</td><td class="colsep0 rowsep0" align="left">(3.6)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29i</b></td><td class="colsep0 rowsep0" align="left">1-methylcyclopropyl</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">1028 ± 482</td><td class="colsep0 rowsep0" align="left">43 ± 4</td><td class="colsep0 rowsep0" align="left">3123</td><td class="colsep0 rowsep0" align="left">3.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>n</i> = 3</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>n</i> = 1</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29j</b></td><td class="colsep0 rowsep0" align="left"><i>tert</i>-butyl</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">144 ± 71</td><td class="colsep0 rowsep0" align="left">35 ± 7</td><td class="colsep0 rowsep0" align="left">163 ± 33</td><td class="colsep0 rowsep0" align="left">3.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>n</i> = 3</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>n</i> = 3</td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">See ref <a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">21</a> for assay conditions.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">See ref <a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">38</a>.</p></div></div></div><figure id="sch9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/medium/jm-2012-01626p_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0014.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Synthesis of 2,6-Diazatricyclo[3.3.1.1–3,7∼]decane Analogues with Tail Variations<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301626p&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) R<sub>3</sub>OH, Cs<sub>2</sub>CO<sub>3</sub> or K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN or DMF, 23–120 °C, 1–24 h (43–90%); (b) <i>tert</i>-butyl 2,6-diazatricyclo[3.3.1.1–3,7∼]decane-2-carboxylate <b>5a</b>, NaHCO<sub>3</sub>, Cs<sub>2</sub>CO<sub>3</sub>, or DIPEA, DMF, DMSO, or CH<sub>3</sub>CN, 60–120 °C, 2–64 h, (13–72%); (c) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 23 °C, 3 h; (d) R<sub>1</sub>OC(O)Cl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 23 °C, 12–16 h (24–72%, steps c and d).</p></p></figure><div class="NLM_p">Finally, the tail portion of the molecule was explored starting with <b>22a</b>, attaching the tail piece and then coupling to cage <b>5a</b> (Scheme <a class="ref internalNav" href="#sch9" aria-label="9">9</a>). Cage <b>5a</b> was selected because removal of a Boc group rather than a methyl was anticipated to provide greater flexibility in the choices of tail groups. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>, we explored a number of phenoxy groups terminated with motifs that would project a hydrogen bond acceptor in a position similar to that of the sulfonyl compounds <b>25a</b>–<b>c</b>. With the possible exception of the 4-cyano-2-fluorophenoxy group, the changes led to a higher maximal agonist response than that associated with the methylpyridyloxy tail. Indeed, in some instances the IA was greater than that seen for the prototype sulfone analogues <b>25a</b>–<b>c</b>. In comparing the various five-membered heterocycles examined, both the tetrazole and triazole isomers led to examples with some of the better agonist profiles. Interestingly, methyl substitution on the 1,2,4-triazole was poorly tolerated (see <b>32m</b>; cf. <b>32g</b>). The reduced binding affinity and corresponding loss in functional activity with this change suggest a disruption to the coplanarity of the phenyl ring and the terminal triazole and/or a steric clash between the added methyl group and the receptor.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. In Vitro Human GPR119 Pharmacology for <b>32a</b>–<b>n</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/medium/jm-2012-01626p_0016.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>Table a</sup><p class="last">See ref <a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">21</a> for assay conditions.</p></div><div class="footnote" id="t5fn2"><sup>Table b</sup><p class="last">See ref <a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">38</a>.</p></div></div><div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Selection and Characterization of Compound <b>32i</b> as a Potential Candidate</h3><div class="NLM_p">Ultimately, identifying the most compelling agonist in the cage series was not difficult since relatively few full agonists with EC<sub>50</sub> below 100 nM were identified. The tetrazole-containing compounds (<b>32d</b>,<b>e</b>,<b>f</b>,<b>h</b>,<b>i</b>,<b>j</b>) proved to be the best at providing a low EC<sub>50</sub> and a relatively full agonist response. Among these, <b>32i</b> was one of the most potent agonists that retained good human liver microsomal stability (Cl<sub>int,app,scaled</sub> < 9.5 mL min<sup>–1</sup> kg<sup>–1</sup>).</div><div class="NLM_p">Others have reportedly<a onclick="showRef(event, 'ref15 ref39'); return false;" href="javascript:void(0);" class="ref ref15 ref39">(15, 39)</a> optimized their GPR119 agonists by tracking a property termed ligand lipophilic efficiency (LLE),<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40, 41)</a> a combined measure of potency and lipophilicity. Although we did not use this methodology to identify our best agonists, we performed a retrospective analysis of the compounds in this manuscript using LLE to highlight the limitations of such efficiency measures when applied to agonist programs. We also present an agonist weighted alternative.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></div><div class="NLM_p">Over the past decade a number of calculated terms that integrate physicochemical or molecular properties and primary pharmacology have been reported. These include ligand efficiency (LE),<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43, 44)</a> LLE, and the related term LipE.<a onclick="showRef(event, 'ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref45 ref46">(45, 46)</a> The widespread use of these terms can be understood from the way in which they indirectly relate to efficacious concentration and unbound clearance, two major determinants of dose. Although the increased use of these properties has made for “ready reckoners”<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> or easier visualization of superior compounds in plots and tables of compounds, it has increased the potential for users of these concepts to forget the parameters that form their basis.</div><div class="NLM_p">LipE, although introduced with an agonist program using the agonist EC<sub>50</sub> for the potency contribution, was done in the context of the unusual situation where all the compounds apparently achieved the same full agonist response (100% IA).<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> No correction would therefore be needed. The concept of LLE was originally introduced specifically using pIC<sub>50</sub> and p<i>K</i><sub>i</sub> presumably to avoid the complication of agonist pharmacology. However, it was later<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> expanded to include pEC<sub>50</sub> as well and in so doing exposed the issue of how to appropriately treat partial agonists.</div><div class="NLM_p">Clearly, the weighing of the agonist response can be applied in different ways, but penalizing poor agonists would have to be the consistent outcome of any correction factor. As recently introduced,<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> one solution is to correct LLE for IA to derive the “agonist lipophilic ligand efficiency” (AgLLE) as shown in eq <a class="ref internalNav" href="#eq1" aria-label="1">1</a>.<span class="NLM_disp-formula" id="eq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/jm-2012-01626p_m001.gif" alt="" /></img><span class="labelSpan">(1)</span></span></div><div class="NLM_p">As with many agonist programs, our GPR119 functional data were derived from a comparison to control agonists having the same pharmacology. The IA of a test compound is thus the fractional efficacy<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> relative to the maximum response of the control agonist chosen. The choice of control agonist is an important decision particularly for an orphan G-protein-coupled receptor (GPCR) where the endogenous ligand is not firmly established or unknown. In the case of our GPR119 program the control molecules we selected achieve the same maximal response as oleleoylethanolamide (OEA).<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></div><div class="NLM_p">The results of the analysis for the compounds reported in this manuscript are plotted Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>. The 45° lines trace the indicated LLE values. On the basis of a straightforward LLE analysis, better compounds should map to the upper left quadrant of the plot. However, from an accounting for the agonist response, a very different picture emerges and it is no longer true that only better agonists will be found in the upper left region. This can be visualized in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> where the diameters of the circles are sized according to AgLLE. Bigger circles equate to better agonists and better (larger) AgLLE values; smaller circles equate to poor agonists and smaller AgLLE values. The upper left quadrant is, in fact, populated with compounds with poor IA, thereby underscoring why LLE should not be used in agonist programs for assessing compounds. The use of AgLLE correctly distinguishes agonists from partial agonists and antagonists. In fact, the full spectrum of functional activity from inverse agonists (negative AgLLE) to superagonists (IA > 100%) can be accommodated by this term.</div><figure id="fig4" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/medium/jm-2012-01626p_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0005.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Plot of pEC<sub>50</sub> vs ClogP sized by AgLLE with lines of constant LLE.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301626p&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Interestingly, <b>32i</b> has the highest AgLLE value (4.4) of all the cage compounds,<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> as well as having one of the top LLE values (4.3). On the basis of LLE, the top compound in the data set is actually <b>26</b> (LLE = 4.7; AgLLE = 2.3), a partial agonist. It is perhaps not surprising to have partial agonists result in high LLE scores. For two compounds that trace the same agonist response curves, differing only in their maximum response, the lower EC<sub>50</sub> will be associated with the compound with the lower IA.</div><div class="NLM_p">Having profiled <b>32i</b> as a compound of interest in vitro, we proceeded to characterize the molecule in vivo. Given the inherent risks associated with species differences in pharmacology, especially translation of agonism to human, our priorities were to project human oral exposure and prepare for high dose toxicology studies rather than to demonstrate preclinical efficacy.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> On the basis of our own experience, as well as the work of others working on GPR119 agonists, the potential for low solubility and hence solubility limited absorption was a concern.<a onclick="showRef(event, 'ref39 ref51'); return false;" href="javascript:void(0);" class="ref ref39 ref51">(39, 51)</a> Thus, before in vivo studies were run, it was important to first check the thermodynamic solubility of crystalline <b>32i</b>. Consistent with the high melting point (234 °C, determined by differential scanning calorimetry) the thermodynamic solubility of <b>32i</b> in aqueous media was poor (solubility at pH 7.4 is 0.7 μg/mL; that at pH 1.2 is 4.8 μg/mL). This suggested a need for using solubilizing formulations to administer the compound.</div><div class="NLM_p">The baseline intravenous (iv) and oral rat pharmacokinetics (PK) for <b>32i</b> are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>. The poor bioavailability (<i>F</i>) at the lowest oral dose could be overcome by reducing the average particle size by milling (2–25 μm premilling to approximately 190 nm postmilling). This was consistent with a problem of poor solubility and not permeability. This notion is supported by the apparent permeability (<i>P</i><sub>app</sub>) for <b>32i</b>, which at 3.5 × 10<sup>–6</sup> cm/s was indicative of moderate flux.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Unfortunately, there was a limit to the increases in exposure and bioavailability achievable using nanomilled material. Further increases in exposure with increasing dose was achieved by preparing an amorphous spray dried dispersion (SDD)<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> of the molecule with HPMCAS-HF (hydroxypropylmethylcellulose acetate succinate high fine). By use of SDD, an added 3-fold increase in maximum plasma concentrations (<i>C</i><sub>max</sub>) and area under the curve (AUC) over nanomilled material was achieved.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Oral and Intravenous Pharmacokinetics for <b>32i</b> in Sprague–Dawley Rats</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">route and formulation</th><th class="colsep0 rowsep0" align="center">dose (mpk)<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">AUC <a class="ref internalNav" href="#t6fn2" aria-label="b">b</a><sup>,</sup><a class="ref internalNav" href="#t6fn8" aria-label="h">h</a>(ng·h/mL)</th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>1/2</sub> <a class="ref internalNav" href="#t6fn8" aria-label="h">h</a> (h)</th><th class="colsep0 rowsep0" align="center">Cl <a class="ref internalNav" href="#t6fn8" aria-label="h">h</a>(mL min<sup>–1</sup> kg<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center"><i>V</i><sub>ss</sub> <a class="ref internalNav" href="#t6fn8" aria-label="h">h</a>(L/kg)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub> <a class="ref internalNav" href="#t6fn2" aria-label="b">b</a><sup>,</sup><a class="ref internalNav" href="#t6fn8" aria-label="h">h</a>(ng/mL)</th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>max</sub> <a class="ref internalNav" href="#t6fn8" aria-label="h">h</a> (h)</th><th class="colsep0 rowsep0" align="center"><i>F</i> <a class="ref internalNav" href="#t6fn3" aria-label="c">c</a> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">iv<a class="ref internalNav" href="#t6fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">1360 ± 592</td><td class="colsep0 rowsep0" align="left">4.34 ± 0.79</td><td class="colsep0 rowsep0" align="left">13.2 ± 5.6</td><td class="colsep0 rowsep0" align="left">3.96 ± 2.0</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">po 0.5% MC<a class="ref internalNav" href="#t6fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">312 ± 139</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">24.2 ± 8.5</td><td class="colsep0 rowsep0" align="left">3.00 ± 1.41</td><td class="colsep0 rowsep0" align="left">7.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">nanomilled<a class="ref internalNav" href="#t6fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">3180 ± 695</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">255 ± 75.0</td><td class="colsep0 rowsep0" align="left">4.7 ± 1.2</td><td class="colsep0 rowsep0" align="left">78</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">nanomilled</td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="left">12533 ± 289</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">912 ± 39.0</td><td class="colsep0 rowsep0" align="left">6.0 ± 0.0</td><td class="colsep0 rowsep0" align="left">31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SDD<a class="ref internalNav" href="#t6fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">6137 ± 1577</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">484 ± 172</td><td class="colsep0 rowsep0" align="left">4.7 ± 1.2</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SDD<a class="ref internalNav" href="#t6fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="left">49133 ± 9279</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">3490 ± 825</td><td class="colsep0 rowsep0" align="left">4.0 ± 0.0</td><td class="colsep0 rowsep0" align="left">>100</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Milligram per kilogram (mpk).</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">All concentrations are reported as total drug; the fraction unbound in rat plasma is 1.0%.</p></div><div class="footnote" id="t6fn3"><sup>c</sup><p class="last"><i>F</i> calculations are based on 1 mpk rat iv PK data.</p></div><div class="footnote" id="t6fn4"><sup>d</sup><p class="last">iv vehicle = 10% <i>N</i>-methylpyrrolidone and 90% sulfobutyl ether−β-cyclodextrin (SBE-CD) solution prepared at 30%.</p></div><div class="footnote" id="t6fn5"><sup>e</sup><p class="last">Per os (po) dosing in 0.5% methylcellulose (MC).</p></div><div class="footnote" id="t6fn6"><sup>f</sup><p class="last">po dosing of milled material in 0.5% MC.</p></div><div class="footnote" id="t6fn7"><sup>g</sup><p class="last">po at 0.6 mL/kg as 25% SDD in 20 mM Tris buffer with 0.5% MC + 0.5% HPMCAS-HF, pH 7.4.</p></div><div class="footnote" id="t6fn8"><sup>h</sup><p class="last">Data reported are the mean ± SD for studies conducted in three animals.</p></div></div></div><div class="NLM_p">A similar PK evaluation was conducted in dog as shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>. In this instance SDD was used straight away. In general the exposure was similar to rat. As another indicator of solubility-driven exposure, the best bioavailability was achieved at low doses with the larger dosing volumes. Disappointingly, the bioavailability in dog was substantially reduced with increasing dose (cf. 10–100 mpk).</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Oral and Intravenous Pharmacokinetics for <b>32i</b> in Male Beagle Dogs<a class="ref internalNav" href="#tbl7-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">route and formulation</th><th class="colsep0 rowsep0" align="center" char=".">dose (mpk)<a class="ref internalNav" href="#t7fn1" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">AUC <a class="ref internalNav" href="#t7fn2" aria-label="c">c</a>(ng·h/mL)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char=".">Cl (mL min<sup>–1</sup> kg<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>ss</sub>(L/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> <a class="ref internalNav" href="#t7fn2" aria-label="c">c</a>(ng/mL)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>max</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> <a class="ref internalNav" href="#t7fn3" aria-label="d">d</a> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">iv<a class="ref internalNav" href="#t7fn4" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">4730</td><td class="colsep0 rowsep0" align="char" char=".">26.8</td><td class="colsep0 rowsep0" align="char" char=".">1.74</td><td class="colsep0 rowsep0" align="char" char=".">3.7</td><td class="colsep0 rowsep0" align="char" char=".">515</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">po SDD<a class="ref internalNav" href="#t7fn5" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">8580</td><td class="colsep0 rowsep0" align="char" char=".">20.0</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">812</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">po SDD<a class="ref internalNav" href="#t7fn6" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">41000</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">1950</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">87</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">po SDD<a class="ref internalNav" href="#t7fn6" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="char" char=".">30</td><td class="colsep0 rowsep0" align="char" char=".">76800</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">3750</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">54</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">po SDD<a class="ref internalNav" href="#t7fn6" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">151000</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">6030</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td><td class="colsep0 rowsep0" align="char" char=".">32</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl7-fn1"><div class="footnote" id="tbl7-fn1"><sup>a</sup><p class="last">PK parameters reported are the mean values obtained from two animals.</p></div><div class="footnote" id="t7fn1"><sup>b</sup><p class="last">Milligram per kilogram (mpk).</p></div><div class="footnote" id="t7fn2"><sup>c</sup><p class="last">All concentrations are reported as total drug; the fraction unbound in dog plasma is 1.4%.</p></div><div class="footnote" id="t7fn3"><sup>d</sup><p class="last"><i>F</i> calculations are based on 1 mpk dog IV pk data.</p></div><div class="footnote" id="t7fn4"><sup>e</sup><p class="last">1 mg/kg iv at 2 mL/kg in 5% dimethylacetamide (DMA)/75% polyethylene glycol 200 (PEG200)/20% (30% SBE-CD).</p></div><div class="footnote" id="t7fn5"><sup>f</sup><p class="last">po at 0.6 mL/kg as 25% SDD in 20 mM Tris buffer with 0.5% MC + 0.5% HPMCAS-HF, pH 7.4.</p></div><div class="footnote" id="t7fn6"><sup>g</sup><p class="last">10, 30, or 100 mpk po at 5 mL/kg as 25% SDD in 20 mM Tris buffer in 0.5% MC and 0.5% HPMCAS-HF, pH 7.4.</p></div></div></div><div class="NLM_p">The major concern with these exposure data was how they compared to our projected efficacious concentration for human. On a free exposure basis, the 30 mpk SDD doses in rat and dog only achieve between 69 and 104 nM free drug at <i>C</i><sub>max</sub>. Absent actual human efficacy data for comparison and mindful of the theoretical risk of receptor desensitization, our target trough efficacious drug concentration was set at approximately 75% receptor activation from the cAMP assay. For compound <b>32i</b> this is estimated to be 50–70 nM. Therefore, even at the highest dose used in dog (100 mpk) only an approximate 3-fold margin above our projected efficacious concentration was achieved at <i>C</i><sub>max</sub> (167 nM free drug). Furthermore, the decline in bioavailability with increasing dose would make it hard to achieve greater multiples over the projected efficacious concentration. Given the challenge of trying to further develop this compound, we chose to abandon the cage series.</div><div class="NLM_p last">In summary we have described an efficient synthesis of the complex 2,6-diazatricyclo[3.3.1.1∼3,7∼]decane system and have demonstrated the benefits of this conformationally restricted framework on eliciting an agonist response from the human GPR119 receptor. In spite of the advantages of this cage group, achieving the desired overlap in agonist pharmacology and metabolic stability was only possible with larger substituents on the tail end of the molecule. Smaller compounds such as <b>3c</b> with superior solubility characteristics did not have the desired agonist properties. It was also shown that the direct use of LLE is not sufficient to identify more desirable agonists. The application of AgLLE, which applies a simple correction for IA to LLE, makes it possible to use this concept to triage potentially more interesting compounds. Compound <b>32i</b> was shown to be one of the better cage agonists overall. However, interest in this cage series diminished when it was established that it would be difficult to progress <b>32i</b> because of challenges in achieving adequate exposure relative to the projected efficacious concentration.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20588" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20588" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Commercial reagents were used without further purification. All final compounds were purified using flash chromatography on Isco Combiflash systems or by preparative HPLC on a Waters Sunfire C<sub>18</sub> column (19 mm × 100 mm, 5 μm particle size), eluting with a H<sub>2</sub>O/CH<sub>3</sub>CN, using NH<sub>4</sub>OH or TFA as a modifiers. Compounds of pharmacologic interest are greater than 95% pure as judged by five separate UPLC methods, using the method reporting the largest percent impurity. Except where indicated, reactions were magnetically stirred and monitored by thin-layer chromatography using Merck silica gel 60 F254 by fluorescence quenching under UV light or by LC/MS detection. NMR spectra were obtained on a Varian INOVA spectrometer (400 or 500 MHz). Chemical shifts are expressed in δ (ppm) units relative to solvent residual peak, and peak multiplicities are expressed as follows: singlet (s), doublet (d), doublet of doublets (dd), triplet (t), quartet (q), multiplet (m), broad singlet (br s). Chemical shifts (δ) are reported in ppm downfield from internal tetramethylsilane (TMS), and coupling constants (<i>J</i>) are in hertz (Hz). The synthesis of representative compounds is given below.</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> (1<i>R</i>,5<i>S</i>,7<i>r</i>)-9-Benzyl-7-(benzyloxy)-9-azabicyclo[3.3.1]nonan-3-one (<b>11a</b>) and (1<i>R</i>,5<i>S</i>,7<i>s</i>)-9-Benzyl-7-(benzyloxy)-9-azabicyclo[3.3.1]nonan-3-one (<b>11b</b>)</h3><div class="NLM_p last">To a stirred solution of 4-(benzyloxy)cyclopentane-1,2-diol<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> (8.50 g, 40.82 mmol) in H<sub>2</sub>O (88.0 mL) was added NaIO<sub>4</sub> (4.41 mg, 20.4 mmol) at 23 °C. After 18 h, CH<sub>3</sub>CN (60 mL) was added and stirring was continued for an additional 30 min. The mixture was filtered, and the filtrate was concentrated. Acetonitrile (60 mL) was added. The mixture was filtered and the filtrate was concentrated to provide a clear oil. To the crude oil in H<sub>2</sub>O (40 mL) were added acetone-1,3-dicarboxylic acid (6.15 g, 40.8 mmol) and concentrated HCl (2.2 mL), followed by dropwise addition of benzylamine (3.6 mL, 33.6 mmol). The mixture was stirred for 1.5 h at 23 °C, then heated at 50 °C for 6 h. After cooling, the mixture was placed in an ice bath and basified to pH >9 using 1 N NaOH. The basic solution was extracted 3× with CH<sub>2</sub>Cl<sub>2</sub> (60 mL). The organic phase was dried over K<sub>2</sub>CO<sub>3</sub>, filtered, and the filtrate was concentrated to dryness. The resulting brown viscous oil was purified by silica gel chromatography using 40% EtOAc/heptanes to provide <b>11a</b> (3.59 g, 10.7 mmol) as a semisolid. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 1.85–1.95 (m, 4H), (m, 2H), 2.31 (d, <i>J</i> = 16.4 Hz, 2H), 2.73 (dd, <i>J</i> = 6.8 Hz, <i>J</i> = 16.6 Hz, 2H), 3.45 (br s, 2H), 3.64–3.75 (m, 1H), 3.92 (s, 2H), 4.47 (s, 2H), 4.69 (d, <i>J</i> = 5.87 Hz), 7.24–7.39 (m, 10 H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz) δ 34.7, 44.9, 53.7, 56.6, 65.6, 70.1, 127.2, 127.9, 128.6, 128.8, 138.7, 139.2, 141.1, 210.3. LCMS: 336.1 (M + 1). Compound <b>11b</b> (1.198 g, 3.57 mmol) as a yellow solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 1.80 (d, <i>J</i> = 13.7 Hz, 2H), 1.95–2.05 (m, 2H), 2.37 (d, <i>J</i> = 17.8 Hz, 2H), 2.62 (dd, <i>J</i> = 7.3 Hz, <i>J</i> = 17.6 Hz, 2H), 3.28 (br s, 2H), 3.77 (s, 1H), 3.88 (s, 2H), 4.40 (s, 2H), 7.20–7.40 (m, 10 H). <sup>13</sup>C NMR (CDCl3, 100 MHz) δ 32.2, 42.4, 50.5, 57.0, 69.2, 70.9, 127.4, 127.6, 127.9, 128.5, 128.7, 138.7, 206.5. LCMS: 336.1 (M + 1).</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> (1<i>R</i>,3<i>r</i>,5<i>S</i>)-<i>tert</i>-Butyl 3-Hydroxy-7-oxo-9-azabicyclo[3.3.1]nonane-9-carboxylate (<b>12</b>)</h3><div class="NLM_p last">To a solution of <b>11a</b> (3.20 g, 9.54 mmol) in EtOH (48 mL) was added di-<i>tert</i>-butyl dicarbonate (4.21 g, 19.1 mmol). Hydrogenolysis of the material was achieved via a continuous flow process on an ThalesNano H-Cube apparatus with a long Pd(OH)<sub>2</sub> cartridge as the metal catalyst at 70 bar and 70 °C for 1 h. The mixture was concentrated and purified by silica gel chromatography using a gradient elution of 10–90% EtOAc/heptanes over 40 min to give <b>12</b> (2.4 g, 9.50 mmol) as a white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 1.43 (s, 9H), 1.55–1.65 (m, 2H), 1.90–2.00 (m, 2H), 2.32 (s, 2H), 2.36 (s, 2H), 2.48–2.61 (m, 3H), 3.89 (m, 1H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz) δ 28.6, 40.0, 45.7, 45.8, 47.6, 48.7, 80.9, 153.8, 208.6. LCMS: 256.1 (M + 1).</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> (1<i>R</i>,3r,5<i>S</i>,<i>Z</i>)-<i>N</i>-Benzylidene-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine (<b>18</b>)</h3><div class="NLM_p last">To a solution of <b>15</b> (5.2 g, 21.3 mmol) in cyclohexane (100 mL) and 12% NaOH (15 mL) was added a solution of Br<sub>2</sub> (1 mL) in cyclohexane (150 mL) dropwise over 1.5 h. During the addition the mixture was cooled in an ice bath. The cyclohexane solution of the bromoamine intermediate was separated, and the aqueous layer was extracted with cyclohexane (20 mL). The extracts were combined, washed with 12% NaOH (50 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and filtered, and the filtrate was concentrated under reduced pressure. The <i>N</i>-bromoamine <b>16</b> (6.2 g) thus obtained was used in the next step without purification. The <i>N</i>-bromoamine <b>16</b> was dissolved in 70 mL of cold 84% H<sub>2</sub>SO<sub>4</sub> (80 mL of concentrated sulfuric acid, 20 mL of H<sub>2</sub>O). The solution was then heated at 65–70 °C for 30 min. After cooling, the mixture was added to 200 mL of ice–water, rendered strongly alkaline with 50% NaOH solution, and then extracted with CH<sub>2</sub>Cl<sub>2</sub>. The extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and the filtrate was concentrated to yield 4 g of a crude viscous oil. This crude mixture was purified by silica gel chromatography using 1:7 Et<sub>3</sub>N/EtOAc to give SM <b>15</b> (1.56 g, 30%) as a clear oil and <b>18</b> (1.70 g, 33%) as an off-white gel. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 1.09–1.13 (m, 2H), 1.49–1.55 (m, 1H), 1.66–1.74 (m, 2H), 1.97–2.05 (m, 2H), 2.18–1.25 (m, 2H), 2.30–2.41 (m, 1H), 2.54 (s, 3H), 3.06 (d, <i>J</i> = 10.98 Hz, 2H), 3.74–3.81 (m, 1H), 7.40 (dd, <i>J</i> = 3.17 Hz, 3H), 7.74–7.75 (m, 2H), 8.36 (s, 1H). GCMS (<i>m</i>/<i>z</i>): 242.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 2-Benzyl-6-methyl-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane (<b>17</b>)</h3><div class="NLM_p last">To <i>N</i>-benzyl-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine <b>15</b> (5.15 g, 21.1 mmol) dissolved in Et<sub>2</sub>O (250 mL) in a Pyrex flask, under nitrogen, was added recrystallized <i>N</i>-chlorosuccinimide (5.68 g, 42.1 mmol) at 23 °C with stirring. After 13 min, Et<sub>3</sub>N (11.7 mL, 84.3 mmol) was added rapidly and the mixture was irradiated for 50 min using a mercury lamp (450 W). The mixture was cooled to 23 °C and filtered through a Pall GHP filter (0.45 μm). The solid was rinsed with Et<sub>2</sub>O, and the filtrate was concentrated to dryness under vacuum. The residue was purified by chromatography on 120 g silica gel (50–100% ethyl acetate in heptanes for 3 min, followed by 1:7 Et<sub>3</sub>N/EtOAc) to afford the title compound as a yellow oil (1.46 g, 29%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.83–1.97 (m, 8H), 2.57 (s, 3H), 2.88 (br s, 2H), 2.92 (br s, 2H), 3.87 (s, 2H), 7.17–7.44 (m, 5H). GCMS (<i>m</i>/<i>z</i>): 242.</div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 2-Methyl-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane·2HCl (<b>20</b>)</h3><div class="NLM_p last">To a stirred, cold (0 °C) solution of <i>endo</i>-3-amino-9-methylazabicyclo[3,3,1]nonane <b>19</b> (4.85 g, 31.47 mmol) in Et<sub>2</sub>O (1 L) in a 2 L Pyrex round-bottom flask was added <i>tert</i>-butyl hypochlorite dropwise under a nitrogen atmosphere. During the addition the mixture became a milky color. The bath was removed, and the mixture was stirred for 15 min at 23 °C. The flask was equipped with a reflux condenser and placed in a plastic bucket that was wrapped in aluminum foil. The mercury lamp (450 W) photoreactor equipped with a quartz jacketed cooling condenser was placed next to the 2 L flask inside the bucket. A pump was used to circulate ice cold H<sub>2</sub>O through the inner well of the photoreactor and the reflux condenser of the flask. Aluminum foil was used to wrap the bucket and condenser to prevent light exposure. The mixture was irradiated for 45 min over which time the mixture became light orange with some solids present. The power supply was shut off, and after 5 min a small aliquot of the reaction mixture was taken and analyzed by GCMS. The mixture was filtered, and the resulting filter cake (somewhat hygroscopic) was collected, dried, and analyzed by GCMS. The crude material contained a 3:1 mixture of the title compound <b>20</b> to SM. A small aliquot was purified by silica gel chromatography using 1:7 Et<sub>3</sub>N/EtOAc for characterization. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.87 (d, <i>J</i> = 12.93 Hz, 4H), 2.07 (d, <i>J</i> = 12.93 Hz, 4H), 2.44 (s, 3H), 2.87 (br s, 2H), 3.60 (br s, 2H), 9.13 (br s, 1H). GCMS (<i>m</i>/<i>z</i>): 152.</div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> <i>tert</i>-Butyl 6-Methyl-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (<b>21a</b>)</h3><div class="NLM_p last">To a stirred solution of crude (3:1) 2-methyl-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane·2HCl <b>20</b> (3.25 g, 21.4 mmol) in MeOH (100 mL) was added Et<sub>3</sub>N (6.72 mL, 48 mmol) followed by di-<i>tert</i>-butyl dicarbonate (5.10 g, 23.4 mmol). The reaction was complete after 1 h, but the mixture was stirred at 23 °C under nitrogen for 13 h. The yellow suspension was reduced to dryness under vacuum and diluted with 1 N NaOH (30 mL). The resulting mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 50 mL). The combined extracts were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and the filtrate was concentrated to dryness under vacuum. The residue was purified by silica gel chromatography with a gradient elution (20% of (1:9) Et<sub>3</sub>N/EtOAc solution in heptanes to 100% (1:9) Et<sub>3</sub>N/EtOAc) to give the title compound as a light yellow oil that solidified under vacuum (2.91 g, 54%). Product <i>R<sub>f</sub></i> = 0.23 in 75% (1:9, Et<sub>3</sub>N/EtOAc)/heptane. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.47 (s, 9H), 1.66 (d, 4H), 2.04 (t, 4H), 2.56 (s, 3H), 2.93 (br s, 2H), 4.28 (br s, 1H), 4.39 (br s, 1H). <sup>13</sup>C NMR (500 MHz,CDCl<sub>3</sub>) δ 28.5, 30.6, 31.8, 41.2, 45.2, 46.4, 51.8, 79.2, 154.3. GCMS (<i>m</i>/<i>z</i>): 252.</div></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> <i>tert</i>-Butyl 2,6-Diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (<b>5a</b>)</h3><div class="NLM_p last"><i>tert</i>-Butyl 6-methyl-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate <b>21a</b> (2.59 g, 10.28 mmol) was dissolved in THF (8.6 mL) and cooled to 0 °C. A solution of 1.5 N NaOH (206 mL, 308 mmol) was added slowly by addition funnel. To the resulting white suspension was added in four portions solid KMNO<sub>4</sub> (12.20 g, 77.10 mmol). The mixture was stirred at 0 °C for 10 min and then stirred at 23 °C for 68 h. Additional KMNO<sub>4</sub> (3.05 g, 19.28 mmol) and H<sub>2</sub>O (50 mL) were added, and the reaction mixture was stirred for another 8 h. The mixture was then extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 75 mL). The combined extracts were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and the filtrate was concentrated to dryness under vacuum to afford the title compound as a colorless oil that became a white solid under vacuum (2.207 g, 90%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.47 (s, 9H), 1.77–2.00 (m, 8H), 3.30 (s, 2H), 4.36 (s, 1H), 4.48 (s, 1H). <sup>13</sup>C NMR (500 MHz, CDCl<sub>3</sub>) δ 28.5, 35.6, 35.7, 45.4, 45.9, 46.8, 79.2, 154.6. GCMS (<i>m</i>/<i>z</i>): 238. LCMS (ES+): 239.3 (M + 1).</div></div><div id="sec3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 1-Methylcyclopropyl-6-methyl-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (<b>21b</b>)</h3><div class="NLM_p last">To a stirred solution of crude 2-methyl-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane <b>20</b> in CH<sub>2</sub>Cl<sub>2</sub> (525 mL) at 0 °C was added Et<sub>3</sub>N (26.4 mL, 189 mmol), followed by 1-methylcyclopropyl 4-nitrophenylcarbonate (37.4 g, 158 mmol). After 15 h, the mixture was concentrated under reduced pressure. The resulting residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub>, poured into a 2 L separatory funnel, followed by the addition of a 1:1 mixture of 1 N NaOH and saturated NH<sub>4</sub>Cl (500 mL). The mixture was shaken, and the CH<sub>2</sub>Cl<sub>2</sub> layer was removed. More CH<sub>2</sub>Cl<sub>2</sub> (200 mL) was added, and the procedure was repeated twice. The combined organic phase was concentrated to dryness under reduced pressure and adsorbed onto silica gel. This silica gel was loaded atop a 330 g ISCO column and eluted using 9:1 (EtOAc/10% NH<sub>4</sub>OH in MeOH) to give 17 g (44%) of the title compound <b>21b</b> as an amber oil. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 0.64 (dd, <i>J</i> = 5.85, 7.07 Hz, 2H), 0.88 (t, <i>J</i> = 6.59 Hz, 2H), 1.57 (t, 3H), 1.6–1.7 (m, 4H), 2.01–2.10 (m, 4H), 2.57 (s, 3H), 2.94 (br s, 2H), 4.24 (br s, 1H), 4.42 (br s, 1H). GCMS (<i>m</i>/<i>z</i>): 250.</div></div><div id="sec3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Preparation of 1-Methylcyclopropyl-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (<b>5b</b>)</h3><div class="NLM_p last">To a stirred, cold (0 °C) solution of 1-methylcyclopropyl-6-methyl-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate <b>21b</b> (17.0, 64.8 mmol) in 1,2-dichloroethane (324 mL) was added dropwise 1-chloroethyl chloroformate (8.47 mL, 77.7 mmol). After 10 min at 0 °C, the ice bath was removed and the yellow reaction mixture was allowed to warm to 23 °C over 5 min. The reaction mixture was heated at reflux (∼90 °C) for 1.5 h and then allowed to cool to 23 °C. The solvent was removed under reduced pressure, and MeOH (324 mL) was added. The mixture was heated at 90 °C for 1 h. The reaction mixture was cooled to 23 °C and concentrated under reduced pressure. To the resulting residue was added a 1:9 mixture of MeOH/Et<sub>2</sub>O. Upon addition a tan solid began to precipitate. The solid was collected and washed with Et<sub>2</sub>O to give the title compound <b>5b</b> as a tan solid, 14 g (93% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 0.67 (t, <i>J</i> = 7.32 Hz, 2H), 0.88 (t, <i>J</i> = 6.34 Hz, 2H), 1.50–1.65 (m, 7H) 1.86–1.96 (m, 4H) 2.90 (br s, 2H), 3.52 (s, 1H) 4.35 (br s, 1H), 4.55 (br s, 1H). GCMS (<i>m</i>/<i>z</i>): 236.</div></div><div id="sec3_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 4-Chloro-6-(2-fluoro-4-(methylsulfonyl)phenoxy)-5-methylpyrimidine (<b>23</b>)<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></h3><div class="NLM_p last">To a solution of 4,6-dichloro-5-methylpyrimidine (700 mg, 4.29 mmol) and 2-fluoro-4-methylsulfonylphenol (743 mg, 3.91 mmol) and CH<sub>3</sub>CN (15.8 mL) in a 20 mL microwave vial was added Cs<sub>2</sub>CO<sub>3</sub> (1.65 g, 5.07 mmol). The vial was capped and irradiated at 120 °C for 40 min using a microwave. The reaction mixture was passed through a pad of Celite, and the filtrate was diluted with EtOAc (25 mL) and H<sub>2</sub>O (15 mL). The layers were separated and the organic phase was washed with brine, dried over MgSO<sub>4</sub>, filtered, and the filtrate was evaporated. The crude material was purified by flash chromatography using an 80 g ISCO column with a gradient elution of 20–50% EtOAc/heptanes over 20 min and then an isocratic elution of 50% EtOAc/heptanes to afford the title compound <b>23</b> (775 mg, 57%) as a white solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 2.44 (s, 3H), 3.10 (s, 3H), 7.44 (dd, <i>J</i> = 6.64, 8.40 Hz, 1H), 7.78–7.83 (m, 2H), 8.35 (s, 1H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 125 MHz) δ 12.1, 44.8, 116.9, 117.1, 117.4, 124.6, 125.2, 154.8, 161.9. LCMS: 317.0 (M + 1).</div></div><div id="sec3_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 2-{6-[2-Fluoro-4-(methylsulfonyl)phenoxy]-5-methylpyrimidin-4-yl}-6-methyl-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane (<b>24</b>)</h3><div class="NLM_p last">A solution of 2-benzyl-6-methyl-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane <b>17</b> (456 mg, 1.88 mmol) in MeOH (12.0 mL) was passed through a long Pd/C cartridge on a ThalesNano H-Cube apparatus at full hydrogen pressure and 60 °C. The mixture was circulated through the instrument for a total of 4 h. The mixture was concentrated to give 288 mg of hydrogenolysis product (crude). A 0.1 M solution of the crude material and 4-chloro-6-[2-fluoro-4-(methylsulfonyl)phenoxy]-5-methylpyrimidine <b>23</b> in CH<sub>3</sub>CN (14 mL) was prepared in a 20 mL microwave vial, and Cs<sub>2</sub>CO<sub>3</sub> (766 mg, 2.35 mmol) was added. The vial was capped and irradiated in the microwave at 180 °C for 1 h. The crude material was concentrated and purified by silica gel chromatography using 14% Et<sub>3</sub>N/EtOAc as the eluent to give the title compound as an off-white foam (387 mg, 57%). Product <i>R<sub>f</sub></i> = 0.2 in 14% Et<sub>3</sub>N/EtOAc. LCMS (ES+): 433.2 (M + 1).</div></div><div id="sec3_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> <i>tert</i>-Butyl 6-{6-[2-Fluoro-4-(methylsulfonyl)phenoxy]-5-methylpyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (<b>25a</b>)</h3><div class="NLM_p last">To a stirred, cold (0 °C) solution of 2-{6-[2-fluoro-4-(methylsulfonyl)phenoxy]-5-methylpyrimidin-4-yl}-6-methyl-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane <b>24</b> (361 mg, 0.835 mmol) in 1,2-dichloroethane (8.35 mL) was added dropwise 1-chloroethyl chloroformate (244 mg, 1.67 mmol). The solution was stirred for 10 min, and the ice bath was removed. The mixture was placed in a DrySyn heating vessel and heated at reflux for 2 h. The mixture was cooled and concentrated. Methanol (10.0 mL) was added, and the mixture was heated at reflux for 2 h. The crude mixture was concentrated to dryness. Dichloromethane (10.0 mL) was added, followed by di-<i>tert</i>-butyl dicarbonate (552 mg, 2.50 mL) and triethylamine (422 mg, 4.18 mmol) at 23 °C. After 2 h, the mixture was concentrated to dryness. Purification of the crude residue was performed on silica gel using 50% EtOAc/heptanes as the eluent to give the title compound as a white solid (84 mg, 17%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.47 (s, 9H), 1.87 (app t, <i>J</i> = 12.1 Hz, 4H), 1.98–2.08 (m, 4H), 2.18 (s, 3H), 3.07 (s, 3H), 4.27 (s, 2H), 4.43 (s, 2H), 4.56 (s, 1H), 7.4 (t, <i>J</i> = 7.80 Hz, 1H,), 7.72–7.78 (m, 2H), 8.19 (s, 1H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 12.6, 28.7, 34.0, 34.2, 44.8, 46.4, 49.3, 79.8, 102.0, 116.7, 116.9, 124.4, 125.1, 138.2, 138.3, 145.7, 145.9, 153.2, 154.2, 154.5, 155.8, 166.3, 167.2. LCMS (ES+): 519.0 (M + 1).</div></div><div id="sec3_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Isopropyl-6-{5-methyl-6-[(2-fluoro-4-methanesulfonyl-phenyl)oxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (<b>25b</b>)</h3><div class="NLM_p">To a stirred suspension of <i>tert</i>-butyl 6-{5-methyl-6-[(2-fluoro-4-methanesulfonylphenyl)oxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (28 mg, 0.054 mmol) in MeOH (0.50 mL) was added 2.0 M HCl in Et<sub>2</sub>O (0.40 mL, 0.80 mmol). The resulting solution was stirred for 16 h at 23 °C. The solvents were removed under vacuum to give the amine intermediate as a white solid (29.5 mg) which was used without further purification. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 2.28 (s, 3H), 2.29–2.38 (m, 8H), 3.15 (s, 3H), 3.93 (br s, 2H), 4.36 (br s, 2H), 7.49 (t, <i>J</i> = 7.81 Hz, 1H), 7.53 (d, <i>J</i> = 2.20 Hz, 1H), 7.78–7.85 (m, 2H), 8.24 (s, 1H). LCMS (ES+): 419.5 (M + 1).</div><div class="NLM_p last">To a stirred suspension of crude 2-{5-methyl-6-[(2-fluoro-4-methanesulfonylphenyl)oxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane·HCl <b>25a</b> (14 mg, 0.028 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (0.5 mL) was added <i>N</i>,<i>N</i>-diisopropylethylamine (20.0 μL, 0.112 mmol), and the resulting solution was stirred at 23 °C for 10 min. Isopropyl chloroformate (31.00 mL, 0.031 mmol) was added, and the yellow mixture was stirred at 23 °C for 1 h. The solvent was evaporated to give 20 mg (92%) of a pale yellow solid which was purified by silica gel chromatography, eluting with a linear gradient of 40–80% EtOAc/heptanes to afford the title compound as a white solid (10.5 mg, 74%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.28 (d, 6H), 1.92 (d, <i>J</i> = 9.27 Hz, 4H), 2.02–2.12 (m, 4H), 2.22 (s, 3H), 3.11 (s, 3H), 4.31 (br s, 2H), 4.53 (br s, 1H), 4.63 (br s, 1H), 4.9–5.04 (m, 1H), 7.41–7.47 (m, 1H), 7.80 (ddd, <i>J</i> = 2.07, 6.34, 8.42 Hz, 2H), 8.22 (s, 1H). LCMS (ES+): 505.5 (M + 1).</div></div><div id="sec3_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 1-Methylcyclopropyl-6-{5-methyl-6-[(2-fluoro-4-methanesulfonyl-phenyl)oxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (<b>25c</b>)</h3><div class="NLM_p last">To a stirred suspension of 2-{5-methyl-6-[(2-fluoro-4-methanesulfonylphenyl)oxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane·HCl (14 mg, 0.028 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (0.5 mL) was added <i>N</i>,<i>N</i>-diisopropylethylamine (20.0 μL, 0.112 mmol), and the resulting solution was stirred at 23 °C for 10 min. 1-Methylcyclopropyl 4-nitrophenylcarbonate (7.5 mg, 0.031 mmol) was added, and the yellow mixture was stirred at 23 °C for 18 h. Additional <i>N</i>,<i>N</i>-diisopropylethylamine (10.0 μL, 0.056 mmol) and 1-methylcyclopropyl 4-nitrophenyl carbonate (3.6 mg, 0.015 mmol) were added, and the mixture was stirred at 23 °C for another 18 h. The reaction was quenched with 0.5 N NaOH (2 mL), and extraction was with CH<sub>2</sub>Cl<sub>2</sub> (4 mL). The aqueous layer was extracted two additional times with CH<sub>2</sub>Cl<sub>2</sub> (4 mL). The combined organic layers were washed with a 0.5 N NaOH. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and the filtrate was evaporated to give 15.5 mg of a pale yellow solid which was purified by preparative reverse phase HPLC on a Waters Sunfire C<sub>18</sub> column (19 mm × 100 mm, 5 μm particle size), eluting with a gradient of H<sub>2</sub>O/CH<sub>3</sub>CN (0.05% TFA modifier) to afford 8.1 mg (57%) of the title compound. Analytical LCMS: retention time 3.35 min (Atlantis C<sub>18</sub> 4.6 mm × 50 mm, 5 μm particle size; 95% H<sub>2</sub>O/CH<sub>3</sub>CN linear gradient to 5% H<sub>2</sub>O/CH<sub>3</sub>CN for 4.0 min with a hold at 5% H<sub>2</sub>O/CH<sub>3</sub>CN to 5.0 min; 0.05% TFA modifier; flow rate 2.0 mL/min). LCMS (ES+): 517.25 (M + 1).</div></div><div id="sec3_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 4-Chloro-5-methyl-6-((2-methylpyridin-3-yl)oxy)pyrimidine (<b>27a</b>)</h3><div class="NLM_p last">To a stirred solution of 2-methylpyridin-3-ol (6.29 g, 57.6 mmol) in THF (45 mL) and DMF (30 mL) at 23 °C was added KO-<i>t</i>-Bu (57.6 mmol, 57.6 mL) in one portion to give a brown solution. In a separate flask, a stirred solution of 4,6-dichloro-5-methylpyrimidine (8.95 g, 54.9 mmol) in THF (120 mL) under N<sub>2</sub> was heated to 70 °C. The potassium salt solution was added via cannula to the stirred pyrimidine solution in a slow steady stream. After the addition was complete, the mixture became brownish white. After 1.5 h at 70 °C, the heating bath was removed and the mixture was allowed to cool to 23 °C. The solvents were removed under reduced pressure, and the remaining residue was diluted with 0.1 M KOH (100 mL) and MTBE (150 mL). The layers were separated, and the basic aqueous layer was extracted with MTBE (2 × 50 mL). The MTBE layers were combined, washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>), filtered, and the filtrate was concentrated under reduced pressure to a clear colorless oil. The colorless oil was crystallized from heptanes to give the title compound as a white solid (5.5 g, 43%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 2.41 (s, 3 H), 2.48 (s, 3H), 7.25–7.28 (m, 1 H), 7.41 (d, <i>J</i> = 10.0 Hz, 1 H), 8.36 (s, 1 H), 8.47 (d, <i>J</i> = 4.64 Hz, 1H). LCMS (ES+): 236.2 (M + 1).</div></div><div id="sec3_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> <i>tert</i>-Butyl 6-{5-Methyl-6-[(2-methylpyridin-3-yl)oxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (<b>3e</b>)</h3><div class="NLM_p last">To a mixture of <i>tert</i>-butyl 2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (400 mg, 1.70 mmol) <b>5a</b>, 4-chloro-5-methyl-6-[(2-methylpyridin-3-yl)oxy]pyrimidine (404 mg, 1.70 mmol), and Na<sub>2</sub>CO<sub>3</sub> (214 mg, 2.55 mmol) in a 10 mL microwave vial was added <i>N</i>,<i>N</i>-dimethylacetamide (4.2 mL). The vial was sealed, and the resulting suspension was stirred at 120 °C for 42 h. The mixture was cooled to 23 °C and then poured into H<sub>2</sub>O (80 mL) that was externally cooled by an ice bath. After the resulting mixture was stirred for 5 min, the ice bath was removed and stirring was continued for an additional 90 min. The solids that formed were collected by filtration on a Pall GHP filter (0.45 μm), rinsed with H<sub>2</sub>O, and dried for 30 min under a stream of nitrogen. The solid was dissolved in EtOAc and saturated brine. The aqueous mixture was extracted with EtOAc (2 × 20 mL), and the combined extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and the filtrate was dried under vacuum to give an off-white solid that was purified by chromatography on silica gel (40–100% EtOAc/heptanes, followed by a period of 2% MeOH/EtOAc) to give the title compound as a white solid (391 mg, 53%). Product <i>R<sub>f</sub></i> = 0.36 in 70% EtOAc/heptanes. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.50 (s, 9H), 1.80–1.98 (m, 4H), 1.99–2.14 (m, 4 H), 2.22 (s, 3 H), 2.43 (s, 3 H), 4.27 (br s, 2 H), 4.46 (br s, 1 H), 4.59 (br s, 1H), 7.21 (dd, <i>J</i> = 8.05, 4.88 Hz, 1 H), 7.39 (d, <i>J</i> = 7.07 Hz, 1 H), 8.22 (s, 1 H), 8.40 (d, <i>J</i> = 3.66 Hz, 1 H). LCMS (ES+): 438.4 (M + 1).</div></div><div id="sec3_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 2-{5-Methyl-6-[(2-methylpyridin-3-yl)oxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane·HCl (<b>28a</b>)</h3><div class="NLM_p">To a stirred solution of <i>tert</i>-butyl 6-{5-methyl-6-[(2-methylpyridin-3-yl)oxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate <b>3e</b> (132 mg, 0.30 mmol) in MeOH (2.3 mL) was added 4 N HCl in 1,4-dioxane (1.13 mL, 4.53 mmol), dropwise. The mixture was stirred for 16 h at 20 °C before the solvents were removed under vacuum to give the title compound as a hygroscopic, yellow solid (165 mg). This material was used without further purification. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 2.03–2.19 (m, 8H), 2.22 (s, 3H), 2.43 (s, 3H), 3.56 (br s, 2H), 4.29 (br s, 2H), 7.21 (dd, <i>J</i> = 4.64, 8.05 Hz, 1H), 7.39 (d, <i>J</i> = 8.05 Hz, 1H), 8.22 (s, 1H), 8.40 (d, <i>J</i> = 3.66 Hz, 1H). LCMS (ES+): 338.3 (M + 1).</div><div class="NLM_p">The free base of the above compound was prepared as follows.</div><div class="NLM_p last">To a stirred solution of <i>tert</i>-butyl 6-{5-methyl-6-[(2-methylpyridin-3-yl)oxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate <b>3e</b> (389 mg, 0.89 mmol) in dichloromethane (3 mL) was added trifluoroacetic acid (0.9 mL, 11.6 mmol). The reaction mixture was stirred at 23 °C for 5 h and then concentrated to dryness under vacuum. The residue was dissolved in 1 N NaOH solution and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 20 mL) and then with 2-butanol (3 × 20 mL). The combined extracts were pooled, dried over a mixture of MgSO<sub>4</sub>, filtered, and the filtrate was concentrated to dryness under vacuum. The resulting solid was dissolved in a mixture of EtOAc and THF and was filtered. The filtrate was concentrated to give the title compound as a white solid (306 mg), which was used in the subsequent steps without purification. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 2.20 (d, <i>J</i> = 13.42 Hz, 4H), 2.29 (s, 3H), 2.31–2.43 (m, 7H), 3.94 (br s, 2H), 4.33 (br s, 2H), 7.36 (dd, <i>J</i> = 4.88, 8.29 Hz, 1H), 7.54 (d, <i>J</i> = 8.05 Hz, 1H), 8.15 (s, 1H), 8.33 (d, <i>J</i> = 4.63 Hz, 1H). LCMS (ES+): 338.3 (M + 1).</div></div><div id="sec3_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Isobutyl 6-{5-Methyl-6-[(2-methylpyridin-3-yl)oxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (<b>3f</b>)</h3><div class="NLM_p">To a stirred suspension of 2-{5-methyl-6-[(2-methylpyridin-3-yl)oxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane·HCl salt (20 mg, 0.05 mmol) in dichloromethane (0.25 mL) was added triethylamine (27 mg, 0.27 mmol) followed by isobutyl chloroformate (7 μL, 0.05 mmol). The mixture was stirred at 23 °C for 2 h. Water was added to the reaction mixture, and it was extracted with dichloromethane (3 × 2 mL). The combined extracts were washed with half saturated brine, dried over sodium sulfate, filtered, and the filtrate was concentrated to dryness under vacuum to give the title compound as a tan solid (17.8 mg, 72%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 0.96 (d, <i>J</i> = 6.83 Hz, 6H), 1.86–2.03 (m, 5H), 2.10 (d, <i>J</i> = 12.20 Hz, 4H), 2.22 (s, 3H), 2.43 (s, 3H), 3.93 (d, <i>J</i> = 6.59 Hz, 2H), 4.29 (br s, 2H), 4.55 (br s, 1H), 4.64 (br s, 1H), 7.21 (dd, <i>J</i> = 4.64, 8.05 Hz, 1H), 7.39 (d, <i>J</i> = 7.81 Hz, 1H), 8.22 (s, 1H), 8.40 (d, <i>J</i> = 4.15 Hz, 1H). LCMS (ES+): 438.3 (M + 1).</div><div class="NLM_p last">Alternatively, the crude material was purified by preparative reverse phase HPLC on a Waters Sunfire C<sub>18</sub> column (19 mm × 100 mm, 5 μm particle size), eluting with a gradient of H<sub>2</sub>O/CH<sub>3</sub>CN (0.05% TFA modifier) to afford the title compound as the TFA salt. Analytical LCMS: retention time 2.59 min (Atlantis C<sub>18</sub> 4.6 mm × 50 mm, 5 μm particle size; 95% H<sub>2</sub>O/CH<sub>3</sub>CN linear gradient to 5% H<sub>2</sub>O/CH<sub>3</sub>CN for 4.0 min with a hold at 5% H<sub>2</sub>O/CH<sub>3</sub>CN to 5.0 min; 0.05% TFA modifier; flow rate 2.0 mL/min). LCMS (ES+): 438.2 (M + 1).</div></div><div id="sec3_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Ethyl 6-{5-Methyl-6-[(2-methylpyridin-3-yl)oxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (<b>3a</b>)</h3><div class="NLM_p last">The title compound was prepared from 2-{5-methyl-6-[(2-methylpyridin-3-yl)oxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane (12 mg, 0.03 mmol) in a manner similar to that described for the preparation of isobutyl 6-{5-methyl-6-[(2-methylpyridin-3-yl)oxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate <b>3f</b>. The crude material was purified by preparative reverse phase HPLC on a Waters Sunfire C<sub>18</sub> column (4.6 mm × 100 mm, 5 μm particle size), eluting with a gradient of H<sub>2</sub>O/CH<sub>3</sub>CN (0.05% formic acid modifier) to afford 4.8 mg of the title compound. Analytical LCMS: retention time 2.31 min (Atlantis C<sub>18</sub> 4.6 mm × 50 mm, 5 μm particle size; 95% H<sub>2</sub>O/CH<sub>3</sub>CN linear gradient to 5% H<sub>2</sub>O/CH<sub>3</sub>CN for 4.0 min with a hold at 5% H<sub>2</sub>O/CH<sub>3</sub>CN to 5.0 min; 0.05% formic acid modifier; flow rate 2.0 mL/min). LCMS (ES+): 410.1 (M + 1).</div></div><div id="sec3_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Isopropyl 6-{5-Methyl-6-[(2-methylpyridin-3-yl)oxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (<b>3b</b>)</h3><div class="NLM_p last">To a mixture of isopropyl 2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (50 mg, 0.22 mmol), 4-chloro-5-methyl-6-[(2-methylpyridin-3-yl)oxy]pyrimidine (53 mg, 0.22 mmol), and Na<sub>2</sub>CO<sub>3</sub> (28 mg, 0.36 mmol) in a 5 mL microwave vial was added <i>N</i>,<i>N</i>-dimethylformamide (1.1 mL). The vial was sealed, and the resulting suspension was stirred at 120 °C for 45 h. The mixture was cooled to 23 °C, diluted with H<sub>2</sub>O (20 mL) and aqueous 10% LiCl solution (5 mL), and extracted with EtOAc (3 × 15 mL). The combined extracts were washed with aqueous 10% LiCl solution (15 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and the filtrate was dried under vacuum to yield a white solid that was purified by silica gel chromatography (with a gradient elution of 50–100% EtOAc/heptanes, followed by a period of 2% MeOH/EtOAc) to give the title compound as a white solid (56 mg). This material was further purified by stirring the solid in 50% EtOAc/heptanes (3 mL) for 3 days, filtering, and rinsing the solid with 50% EtOAc/heptanes (2 × 1 mL) to give the title compound as a white solid (30 mg, 31%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.28 (d, <i>J</i> = 6.10 Hz, 6H), 1.81–2.00 (m, 4H), 2.02–2.15 (m, 4H), 2.22 (s, 3H), 2.43 (s, 3H), 4.28 (br s, 2H), 4.52 (br s, 1H), 4.63 (br s, 1 H), 4.91–5.07 (m, 1H), 7.21 (dd, <i>J</i> = 4.88, 8.05 Hz, 1H), 7.39 (d, <i>J</i> = 7.81 Hz, 1H), 8.22 (s, 1H), 8.40 (d, <i>J</i> = 4.39 Hz, 1H). LCMS (ES+): 424.3 (M + 1).</div></div><div id="sec3_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 1-Methylcyclopropyl 6-{5-Methyl-6-[(2-methylpyridin-3-yl)oxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (<b>3c</b>)</h3><div class="NLM_p last">To a stirred solution of <i>tert</i>-butyl 6-{5-methyl-6-[(2-methylpyridin-3-yl)oxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate <b>3e</b> (400 mg, 0.91 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (3 mL) was slowly added TFA (1.0 mL) at 23 °C. After 2 h, toluene (10 mL) was added and the reaction mixture was reduced to dryness under vacuum. The residue was diluted with 6 mL of toluene, and the mixture was sonicated. The solvent was again removed under vacuum to give a light yellow residue. This residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (5 mL), and to the resulting solution were added Et<sub>3</sub>N (0.67 mL, 4.81 mmol) and 1-methylcyclopropyl 4-nitrophenylcarbonate (251 mg, 1.06 mmol). The mixture was stirred for 16 h at 40 °C. The mixture was cooled to 23 °C, and additional Et<sub>3</sub>N (0.3 mL) and 1-methylcyclopropyl 4-nitrophenylcarbonate (46 mg, 0.18 mmol) were added. The mixture was heated at 40 °C for another 3.5 h. The mixture was cooled to 23 °C, diluted with 1 N NaOH solution (20 mL), stirred for 10 min, and extracted with CH<sub>2</sub>Cl<sub>2</sub> (three times, 20 mL). The combined extracts were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and the filtrate was reduced to dryness under vacuum, giving a light yellow solid which was purified by silica gel chromatography (with a gradient elution of 40–100% EtOAc/heptanes, followed by a period of 2% MeOH/EtOAc) to give the title compound as a white solid (395 mg, 94%). This solid was suspended in EtOAc (4 mL) and was stirred for 20 h. The mixture was filtered through a Pall GHP 0.45 μm membrane. The solid was rinsed with cold EtOAc (3 mL) and dried under a stream of nitrogen for 30 min. The solid was further dried under vacuum to give the title compound as a white, crystalline solid (309 mg, 74%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 0.60–0.73 (m, 2H), 0.84–0.97 (m, 2H), 1.59 (s, 3H), 1.76–1.98 (m, 4H), 1.99–2.14 (m, 4H), 2.21 (s, 3H), 2.42 (s, 3H), 4.27 (br s, 2H), 4.41 (br s, 1H), 4.61 (br s, 1H), 7.21 (dd, <i>J</i> = 4.88, 8.05 Hz, 1H), 7.38 (d, <i>J</i> = 7.81 Hz, 1H), 8.21 (s, 1H), 8.39 (d, <i>J</i> = 3.90 Hz, 1H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 12.3, 13.0, 19.5, 21.7, 33.8, 34.0, 45.3, 46.2, 48.9, 56.5, 102.1, 121.9, 129.5, 145.8, 148.2, 151.9, 154.3, 154.6, 166.1, 167.5. LCMS (ES+): 436.4 (M + 1).</div></div><div id="sec3_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> Cyclobutyl 6-{5-Methyl-6-[(2-methylpyridin-3-yl)oxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (<b>3d</b>)</h3><div class="NLM_p last">The title compound was prepared from 2-{5-methyl-6-[(2-methylpyridin-3-yl)oxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane <b>28a</b> (15 mg, 0.05 mmol) in a manner similar to that described for the preparation of 1-methylcyclobutyl 6-{5-methyl-6-[(2-methylpyridin-3-yl)oxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate <b>3c</b> but with a heating time of 18 h. The crude material was purified by preparative reverse phase HPLC on a Waters Sunfire C<sub>18</sub> column (19 mm × 100 mm, 5 μm particle size), eluting with a gradient of H<sub>2</sub>O in CH<sub>3</sub>CN (0.05% TFA modifier) to afford 17.3 mg of the title compound as the mono-TFA salt. Analytical LCMS: retention time 2.55 min (Atlantis C<sub>18</sub> 4.6 mm × 50 mm, 5 μm particle size; 95% H<sub>2</sub>O/CH<sub>3</sub>CN linear gradient to 5% H<sub>2</sub>O/CH<sub>3</sub>CN for 4.0 min with a hold at 5% H<sub>2</sub>O/CH<sub>3</sub>CN to 5.0 min; 0.05% TFA modifier; flow rate 2.0 mL/min). LCMS (ES+): 436.3 (M + 1).</div></div><div id="sec3_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 3-Methyl-1-({[(1<i>R</i>)-1-methylpropyl]oxy}carbonyl)-1<i>H</i>-imidazol-3-ium Iodide</h3><div class="NLM_p last">To a stirred solution of (<i>R</i>)-2-butanol (80 mg, 1.08 mmol) in toluene (2.8 mL) was added 1,1′-carbonyldiimidazole (175 mg, 1.08 mmol). The mixture was stirred 1 h at 23 °C. The mixture was then diluted with Et<sub>2</sub>O (20 mL), and the organic layer was washed with 0.1 N HCl solution (23 mL). The aqueous layer was again extracted with Et<sub>2</sub>O (2 × 10 mL). The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and the filtrate was concentrated under reduced pressure to give 1-({[(1<i>R</i>)-1-methylpropyl]oxy}carbonyl)-1<i>H</i>-imidazole as a clear, colorless oil (60 mg, 32%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.00 (t, <i>J</i> = 7.44 Hz, 3 H), 1.41 (d, <i>J</i> = 6.34 Hz, 3 H), 1.65–1.88 (m, 2 H), 5.08 (m, 1 H), 7.08 (s, 1 H), 7.43 (s, 1 H), 8.14 (s, 1 H). GCMS (<i>m</i>/<i>z</i>): 168. To a solution of crude imidazole (22 mg, 0.13 mmol) in CH<sub>3</sub>CN (0.5 mL) in a sealable vial, under an N<sub>2</sub> atmosphere, was added methyl iodide (0.1 mL, 2.0 mmol). The vial was sealed and heated at 50 °C for 42 h. The solvent was removed under vacuum to give a light yellow solid that was used without further purification. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.05 (t, <i>J</i> = 7.44 Hz, 3H), 1.54 (d, <i>J</i> = 6.10 Hz, 3H), 1.78–1.89 (m, 1H), 1.92–2.03 (m, 1H), 4.34 (s, 3H), 5.21 (m, 1H), 7.47 (s, 1H), 7.77 (s, 1H), 10.83 (s, 1H). LCMS (ES+): 183.1 (M).</div></div><div id="sec3_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> (1<i>R</i>)-1-Methylpropyl 6-{5-Methyl-6-[(2-methylpyridin-3-yl)oxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (<b>3g</b>)</h3><div class="NLM_p last">To a stirred solution of the crude 3-methyl-1-({[(1<i>R</i>)-1-methylpropyl]oxy}carbonyl)-1<i>H</i>-imidazol-3-ium iodide (22 mg, 0.12 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (0.5 mL) was added Et<sub>3</sub>N (0.028 mL, 0.20 mmol) followed by 2-{5-methyl-6-[(2-methylpyridin-3-yl)oxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane (41 mg, 0.12 mmol). The amber colored solution was stirred for 2 h, diluted with H<sub>2</sub>O, and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 3 mL). The combined extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and the filtrate was concentrated to dryness under vacuum to give a tan solid that was purified by preparative reverse phase HPLC on a Waters Sunfire C<sub>18</sub> column (19 mm × 100 mm, 5 μm particle size), eluting with a gradient of H<sub>2</sub>O/CH<sub>3</sub>CN (0.05% TFA modifier) to afford 22.5 mg of the title compound as the mono-TFA salt. Analytical LCMS: retention time 2.81 min (Atlantis C<sub>18</sub> 4.6 mm × 50 mm, 5 μm particle size; 95% H<sub>2</sub>O/CH<sub>3</sub>CN linear gradient to 5% H<sub>2</sub>O/CH<sub>3</sub>CN for 4.0 min with a hold at 5% H<sub>2</sub>O/CH<sub>3</sub>CN to 5.0 min; 0.05% TFA modifier; flow rate 2.0 mL/min). LCMS (ES+): 452.4 (M + 1).</div></div><div id="sec3_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> (1<i>S</i>)-1-Methylpropyl 6-{5-Methyl-6-[(2-methylpyridin-3-yl)oxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (<b>3h</b>)</h3><div class="NLM_p last">The title compound was prepared from crude 3-methyl-1-({[(1<i>S</i>)-1-methylpropyl]oxy}carbonyl)-1<i>H</i>-imidazol-3-ium iodide and 2-{5-methyl-6-[(2-methylpyridin-3-yl)oxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane <b>28a</b> (41 mg, 0.12 mmol) in a manner similar to that of 1-methylpropyl 6-{5-methyl-6-[(2-methylpyridin-3-yl)oxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate <b>3g</b>. The crude material was purified by chromatography on silica gel, eluting with EtOAc/heptanes to give the title compound as a white solid (22 mg, 42%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 0.94 (t, <i>J</i> = 7.44 Hz, 3H), 1.26 (d, <i>J</i> = 6.34 Hz, 3H), 1.50–1.73 (m, 2H), 1.82–2.00 (m, 4H), 2.08 (d, <i>J</i> = 8.05 Hz, 4H), 2.22 (s, 3H), 2.46 (s, 3H), 4.29 (br s, 2H), 4.54 (br s, 1H), 4.63 (br s, 1H), 4.82 (m, 1H), 7.22–7.29 (m, 1H), 7.44 (d, <i>J</i> = 7.81 Hz, 1H), 8.21 (s, 1H), 8.40 (d, <i>J</i> = 4.64 Hz, 1H). LCMS (ES+): 438.2.</div></div><div id="sec3_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 1-Methylcyclobutyl 6-{5-methyl-6-[(2-methylpyridin-3-yl)oxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (<b>3i</b>)</h3><div class="NLM_p last">To a stirred suspension of 2-{5-methyl-6-[(2-methylpyridin-3-yl)oxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane·HCl salt <b>28a</b> (20 mg, 0.05 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (0.25 mL) was added Et<sub>3</sub>N (27 mg, 0.27 mmol) followed by 1-methylcyclobutyl 4-nitrophenylcarbonate (14 mg, 0.05 mmol). After 4.5 h at 45 °C the reaction mixture was cooled to 23 °C, diluted with 1 N NaOH, and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 2 mL). The combined extracts were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and the filtrate was concentrated to dryness to produce a yellow solid. The crude material was purified by preparative reverse phase HPLC on a Waters Sunfire C<sub>18</sub> column (19 mm × 100 mm, 5 μm particle size), eluting with a gradient of H<sub>2</sub>O/CH<sub>3</sub>CN (0.05% TFA modifier) to afford 14.1 mg of the title compound as the mono-TFA salt. Analytical LCMS: retention time 2.63 min (Atlantis C<sub>18</sub> 4.6 mm × 50 mm, 5 μm particle size; 95% H<sub>2</sub>O/CH<sub>3</sub>CN linear gradient to 5% H<sub>2</sub>O/CH<sub>3</sub>CN for 4.0 min with a hold at 5% H<sub>2</sub>O/CH<sub>3</sub>CN to 5.0 min; 0.05% TFA modifier; flow rate 2.0 mL/min). LCMS (ES+): 450.2 (M + 1).</div></div><div id="sec3_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> <i>tert</i>-Butyl 6-{6-[(2-Methylpyridin-3-yl)oxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (<b>29b</b>)</h3><div class="NLM_p last">To a 5 mL microwave vial charged with <i>tert</i>-butyl 2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (200 mg, 0.90 mmol) <b>5a</b>, 4-chloro-5-methyl-6-[(2-methylpyridin-3-yl)oxy]pyrimidine (215 mg, 0.90 mmol), and Na<sub>2</sub>CO<sub>3</sub> (114 mg, 1.35 mmol) was added <i>N</i>,<i>N</i>-dimethylformamide (4.5 mL). The mixture was stirred, put under an N<sub>2</sub> atmosphere, sealed, and heated at 120 °C for 16.5 h. The mixture was cooled to 23 °C, diluted with H<sub>2</sub>O (80 mL), 10% aqueous LiCl (20 mL), and extracted with EtOAc (3 × 30 mL). The combined organic extracts were washed with 10% aqueous LiCl (40 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and the filtrate was reduced to dryness under vacuum. The residue was suspended in heptane, and the solvent was removed under vacuum. The process was repeated to give 393 mg of crude material as an orange solid. The crude material was purified by chromatography on 25 g silica, eluting with EtOAc/heptanes using a linear gradient from 25% to 85% EtOAc over 18.5 min, followed by a linear gradient from 85% to 100% EtOAc over 2.6 min, then a period of EtOAc for 10 min to give the title compound as a white foam (332 mg, 87%). Product <i>R<sub>f</sub></i> = 0.24 in 70% EtOAc/heptanes. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.51 (s, 9H), 1.85–2.00 (m, 8H), 2.43 (s, 3H), 4.46 (br s, 1H), 4.59 (br s, 1 H), 6.02 (s, 1H), 7.21 (dd, <i>J</i> = 4.88, 8.05 Hz, 1H), 7.39 (d, <i>J</i> = 7.07 Hz, 1H), 8.28 (s, 1H), 8.41 (d, <i>J</i> = 3.66 Hz, 1H). LCMS (ES+): 424.3 (M + 1).</div></div><div id="sec3_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 1-Methylcyclopropyl 6-{6-[(2-Methylpyridin-3-yl)oxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (<b>29a</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>29b</b> in a manner similar to <b>3c</b> from <b>3e</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 0.60–0.73 (m, 2H), 0.84–0.97 (m, 2H), 1.60 (s, 3H), 1.75–1.98 (m, 8H), 2.46 (s, 3H), 4.42 (br s, 1H), 4.62 (br s, 1H), 6.02 (s, 1H), 7.21 (dd, <i>J</i> = 4.88, 8.05 Hz, 1H), 7.38 (d, <i>J</i> = 7.81 Hz, 1H), 8.28 (s, 1H), 8.39 (d, <i>J</i> = 3.90 Hz, 1H). LCMS (ES+): 422.3 (M + 1).</div></div><div id="sec3_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 4-Chloro-5-ethyl-6-[(2-methylpyridin-3-yl)oxy]pyrimidine (<b>27b</b>)</h3><div class="NLM_p last">The title compound was prepared from 4,6-dichloro-5-ethylpyrimidine (783 mg, 4.42 mmol) in a manner similar to that used to prepare 4-chloro-5-methyl-6-((2-methylpyridin-3-yl)oxy)pyrimidine. The title compound was obtained as a tan solid (892 mg, 81%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.32 (t, <i>J</i> = 7.56 Hz, 3H), 2.42 (s, 3H), 2.95 (q, <i>J</i> = 7.40 Hz, 2H), 7.22–7.30 (m, 1H), 7.41 (d, <i>J</i> = 8.05 Hz, 1H), 8.35 (s, 1H), 8.47 (d, <i>J</i> = 4.64 Hz, 1H). LCMS (ES+): 250.2 (M + 1).</div></div><div id="sec3_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> <i>tert</i>-Butyl 6-{5-Methoxy-6-[(2-methylpyridin-3-yl)oxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (<b>29e</b>)</h3><div class="NLM_p last">The title compound was prepared from 4-chloro-5-ethyl-6-[(2-methylpyridin-3-yl)oxy]pyrimidine (100 mg, 0.40 mmol) in a manner similar to that used to prepare <i>tert</i>-butyl 6-{5-methyl-6-[(2-methylpyridin-3-yl)oxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate <b>3e</b>. Silica gel chromatography was carried out using EtOAc/heptanes followed by a second chromatography using EtOAc/CH<sub>2</sub>Cl<sub>2</sub>. The title compound was isolated as a white solid (107 mg, 59%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.36 (t, <i>J</i> = 7.32 Hz, 3H), 1.50 (s, 9H), 1.85–1.98 (m, 3H), 2.02–2.14 (m, 3H), 2.54 (br s, 2H), 2.63 (d, <i>J</i> = 7.56 Hz, 2H), 3.50 (d, <i>J</i> = 2.20 Hz, 3H), 4.27 (br s, 2H), 4.41–4.50 (m, 1H), 4.54–4.64 (m, 1H), 7.21–7.37 (m, 1H), 7.44–7.61 (m, 1H), 8.19 (s, 1H), 8.42 (d, <i>J</i> = 4.88 Hz, 1H). LCMS (ES+): 452.2 (M + 1).</div></div><div id="sec3_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> Isopropyl 6-{5-Ethyl-6-[(2-methylpyridin-3-yl)oxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (<b>29c</b>)</h3><div class="NLM_p last">To a stirred solution of <i>tert</i>-butyl 6-{5-ethyl-6-[(2-methylpyridin-3-yl)oxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate <b>29e</b> (20 mg, 0.044 mmol) in MeOH (0.3 mL) was added 4 N HCl in 1,4-dioxane (0.33 mL, 1.32 mmol), and the mixture was stirred for 75 min. The solvent was removed under vacuum, and the residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (1 mL) and Et<sub>3</sub>N (0.031 mL, 0.22 mmol). The reaction mixture was cooled to 0 °C, at which point 1 M isopropyl chloroformate in toluene (0.048 mL, 0.048 mmol) was added dropwise. The mixture was stirred for 1 h at 0 °C and then allowed to warm to 23 °C. After a total of 15 h, the reaction mixture was diluted with 1 N NaOH and extracted with CH<sub>2</sub>Cl<sub>2</sub> (2×). The combined extracts were pooled, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and the filtrate was concentrated to dryness. The residue was dissolved in DMSO (0.9 mL) and purified by preparative reverse-phase HPLC on a Waters Sunfire C<sub>18</sub> 19 mm × 100 mm, 0.005 mm column, eluting with a linear gradient of 90% H<sub>2</sub>O/CH<sub>3</sub>CN (0.05% TFA modifier) to 0% H<sub>2</sub>O/CH<sub>3</sub>CN in 8.5 min and holding at 0% H<sub>2</sub>O/CH<sub>3</sub>CN for 1.5 min (flow rate, 25 mL/min) to give the title compound as the mono-TFA salt (19 mg, 78%). Analytical LCMS: retention time 2.61 min (Waters Atlantis C<sub>18</sub> 4.6 mm × 50 mm, 0.005 mm column; 95% H<sub>2</sub>O/CH<sub>3</sub>CN linear gradient to 5% H<sub>2</sub>O/CH<sub>3</sub>CN over 4.0 min and held at 5% H<sub>2</sub>O/CH<sub>3</sub>CN for 1.0 min; 0.05% TFA modifier; flow rate 2.0 mL/min). LCMS (ES+): 438.1 (M + 1).</div></div><div id="sec3_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 1-Methylcyclopropyl 6-{5-Ethyl-6-[(2-methylpyridin-3-yl)oxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (<b>29d</b>)</h3><div class="NLM_p last">The title compound was prepared using <i>tert</i>-butyl 6-{5-ethyl-6-[(2-methylpyridin-3-yl)oxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate <b>29e</b> (20 mg, 0.044 mmol) in a manner similar to that used to prepare 1-methylcyclopropyl 6-{5-methyl-6-[(2-methylpyridin-3-yl)oxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate <b>3c</b>. The residue was dissolved in DMSO (0.9 mL) and purified by preparative reverse-phase HPLC on a Waters Sunfire C<sub>18</sub> 19 mm × 100 mm, 0.005 mm column, eluting with a linear gradient of 90% H<sub>2</sub>O/CH<sub>3</sub>CN (0.05% TFA modifier) to 0% H<sub>2</sub>O/CH<sub>3</sub>CN in 8.5 min and holding at 0% H<sub>2</sub>O/CH<sub>3</sub>CN for 1.5 min (flow rate, 25 mL/min) to give the title compound as the mono-TFA salt (23.1 mg, 93%). Analytical LCMS: retention time 2.60 min (Waters Atlantis C<sub>18</sub> 4.6 mm × 50 mm, 0.005 mm column; 95% H<sub>2</sub>O/CH<sub>3</sub>CN linear gradient to 5% H<sub>2</sub>O/CH<sub>3</sub>CN over 4.0 min and held at 5% H<sub>2</sub>O/CH<sub>3</sub>CN for 1.0 min; 0.05% TFA modifier; flow rate 2.0 mL/min). LCMS (ES+): 450.1 (M + 1).</div></div><div id="sec3_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 4-Chloro-5-fluoro-6-[(2-methylpyridin-3-yl)oxy]pyrimidine (<b>27c</b>)</h3><div class="NLM_p last">The title compound was prepared from 4,6-dichloro-5-fluoropyrimidine (300 mg, 1.77 mmol) in a manner similar to that used to prepare 4-chloro-5-methyl-6-((2-methylpyridin-3-yl)oxy)pyrimidine. The title compound was obtained as a clear, colorless oil (382 mg, 90%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 2.46 (s, 3H), 7.22–7.33 (m, 1H), 7.47 (d, <i>J</i> = 8.05 Hz, 1H), 8.29 (s, 1H), 8.50 (d, <i>J</i> = 4.88 Hz, 1H). LCMS (ES+): 240.1 (M + 1).</div></div><div id="sec3_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> <i>tert</i>-Butyl 6-{5-Fluoro-6-[(2-methylpyridin-3-yl)oxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (<b>29g</b>)</h3><div class="NLM_p last">To a microwave vial charge with <i>tert</i>-butyl 2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate <b>5a</b> (47 mg, 0.20 mmol), 4-chloro-5-fluoro-6-[(2-methylpyridin-3-yl)oxy]pyrimidine <b>27c</b> (47 mg, 0.20 mmol), and NaHCO<sub>3</sub> (25 mg, 0.29 mmol) was added <i>N</i>,<i>N</i>-dimethylformamide (0.49 mL). The vial was capped, and the resulting suspension was stirred at 90 °C for 1 h, then 80 °C for 6 h. The mixture was cooled to 23 °C, diluted with H<sub>2</sub>O (25 mL), and extracted with EtOAc (3 × 15 mL). The combined organic extracts were washed with 10% aqueous LiCl (15 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and the filtrate was dried under vacuum to give an off-white solid that was purified using silica gel chromatography, eluting with an EtOAc/heptanes gradient. The title compound was obtained as a white solid (67 mg, 77%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.51 (s, 9H), 1.90–2.06 (m, 8H), 2.50 (s, 3H), 4.46 (br s, 1H), 4.59 (br s, 1H), 4.90 (br s, 2H), 7.25 (br s, 1H), 7.42–7.54 (m, 1H), 7.99 (s, 1H), 8.43 (br s, 1H). LCMS (ES+): 442.3 (M + 1). Product <i>R<sub>f</sub></i> = 0.20 in 60% EtOAc/heptanes.</div></div><div id="sec3_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 1-Methylcyclopropyl 6-{5-Fluoro-6-[(2-methylpyridin-3-yl)oxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (<b>29f</b>)</h3><div class="NLM_p last">To a stirred solution of <i>tert</i>-butyl 6-{5-fluoro-6-[(2-methylpyridin-3-yl)oxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate <b>29g</b> (15 mg, 0.034 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (0.5 mL) was added TFA (0.2 mL). After being stirred at 23 °C for 3 h, the mixture was concentrated to dryness under vacuum. The residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (0.5 mL) and Et<sub>3</sub>N (0.024 mL, 0.13 mmol). 1-Methylcyclopropyl 4-nitrophenylcarbonate (10 mg, 0.044 mmol) was added, and the mixture was heated to 45 °C. After 18 h, the reaction mixture was cooled to 23 °C, diluted with 1 N NaOH, and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 2 mL). The combined extracts were pooled, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and the filtrate was concentrated to dryness under vacuum. The residue was dissolved in DMSO (0.9 mL) and purified by preparative reverse-phase HPLC on a Waters XBridge C<sub>18</sub> 19 mm × 100 mm, 0.005 mm column, eluting with 60% H<sub>2</sub>O/CH<sub>3</sub>CN (0.03% NH<sub>4</sub>OH modifier) holding for 1 min, then a linear gradient of 60% H<sub>2</sub>O/CH<sub>3</sub>CN to 40% H<sub>2</sub>O/CH<sub>3</sub>CN in 5.75 min, followed by a linear gradient of 40% H<sub>2</sub>O/CH<sub>3</sub>CN to 0% H<sub>2</sub>O/CH<sub>3</sub>CN in 0.25 min and holding at 0% H<sub>2</sub>O/CH<sub>3</sub>CN for 1.0 min (flow rate 30 mL/min) to obtain the title compound (3.4 mg, 23%). Analytical LCMS: retention time 2.58 min (Waters Atlantis dC<sub>18</sub> 4.6 mm × 50 mm, 0.005 mm column; 95% H<sub>2</sub>O/CH<sub>3</sub>CN linear gradient to 5% H<sub>2</sub>O/CH<sub>3</sub>CN over 4.0 min and a hold at 5% H<sub>2</sub>O/CH<sub>3</sub>CN for 1 min; 0.05% TFA modifier; flow rate 2.0 mL/min). LCMS (ES+): 440.1 (M + 1).</div></div><div id="sec3_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 4-Chloro-5-methoxy-6-[(2-methylpyridin-3-yl)oxy]pyrimidine (<b>27d</b>)</h3><div class="NLM_p last">The title compound was prepared from 4,6-dichloro-5-methoxypyrimidine (500 mg, 2.79 mmol) in a manner similar to that used to prepare 4-chloro-5-methyl-6-((2-methylpyridin-3-yl)oxy)pyrimidine. The title compound was obtained as a white solid (607 mg, 87%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 2.45 (s, 3H), 4.10 (s, 3H), 7.24–7.29 (m, 1 H), 7.44 (d, <i>J</i> = 8.05 Hz, 1 H), 8.23 (s, 1H), 8.48 (dd, <i>J</i> = 1.22, 4.64 Hz, 1H). LCMS (ES+): 252.1 (M + 1).</div></div><div id="sec3_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> <i>tert</i>-Butyl 6-{5-Methoxy-6-[(2-methylpyridin-3-yl)oxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (<b>29j</b>)</h3><div class="NLM_p last">To a microwave vial charged with <i>tert</i>-butyl 2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (95 mg, 0.40 mmol) <b>5a</b>, 4-chloro-5-methoxy-6-[(2-methylpyridin-3-yl)oxy]pyrimidine <b>27d</b> (100 mg, 0.40 mmol), and NaHCO<sub>3</sub> (50 mg, 0.60 mmol) was added <i>N</i>,<i>N</i>-dimethylacetamide (1.0 mL). The vial was capped, and the resulting suspension was stirred at 120 °C for 15 h. The mixture was cooled to 23 °C, diluted with H<sub>2</sub>O, and extracted with EtOAc (3 × 20 mL). The combined organic extracts were washed with 10% aqueous LiCl, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and the filtrate was dried under vacuum. The residue was purified by silica gel chromatography, eluting with an EtOAc/heptanes gradient. The title compound was obtained as an off-white solid (90 mg, 51%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.50 (s, 9H), 1.85–2.10 (m, 8 H), 2.52 (s, 3H), 3.87 (s, 3H), 4.36–4.48 (m, 1H), 4.51–4.63 (m, 1H), 5.01 (br s, 2H), 7.23–7.30 (m, 1H), 7.43–7.51 (m, 1H), 8.02 (s, 1H), 8.41 (d, <i>J</i> = 4.88 Hz, 1 H). LCMS (ES+): 454.2 (M + 1). Product <i>R<sub>f</sub></i> = 0.17 in 75% EtOAc/heptanes.</div></div><div id="sec3_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> Isopropyl 6-{5-Methoxy-6-[(2-methylpyridin-3-yl)oxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (<b>29h</b>)</h3><div class="NLM_p last">To a stirred solution of <i>tert</i>-butyl 6-{5-methoxy-6-[(2-methylpyridin-3-yl)oxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate <b>29j</b> (21 mg, 0.047 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (0.3 mL) was added TFA (0.1 mL). After being stirred at 23 °C for 3 h, the mixture was concentrated to dryness under vacuum. The residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (0.5 mL) and Et<sub>3</sub>N (0.040 mL, 0.24 mmol) before isopropyl chloroformate (1 M in toluene, 0.056 mL, 0.056 mmol) was added. After 2 h, the reaction mixture was cooled to 23 °C, diluted with 1 N NaOH, and extracted with CH<sub>2</sub>Cl<sub>2</sub> (2×). The combined organic extracts were pooled, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and the filtrate was concentrated to dryness under vacuum. The residue was purified using silica gel chromatography, eluting with EtOAc/heptanes. The title compound was isolated as a white solid (10 mg, 48%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.28 (d, <i>J</i> = 6.34 Hz, 6H), 1.87–2.15 (m, 8H), 2.55 (br s, 3H), 3.87 (s, 3H), 4.47–4.55 (m, 1H), 4.57–4.65 (m, 1H), 4.95–5.06 (m, 3H), 7.22–7.33 (m, 1 H), 7.43–7.58 (m, 1H), 8.02 (s, 1H), 8.42 (d, <i>J</i> = 4.63 Hz, 1H). LCMS (ES+): 440.2 (M + 1).</div></div><div id="sec3_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 1-Methylcyclopropyl 6-{5-Methoxy-6-[(2-methylpyridin-3-yl)oxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (<b>29i</b>)</h3><div class="NLM_p last">To a stirred solution of <i>tert</i>-butyl 6-{5-methoxy-6-[(2-methylpyridin-3-yl)oxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate <b>29j</b> (20 mg, 0.045 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (0.3 mL) was added TFA (0.1 mL). After being stirred at 23 °C for 3 h, the mixture was concentrated to dryness under vacuum. The residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (0.5 mL) and Et<sub>3</sub>N (0.031 mL, 0.23 mmol) before 1-methylcyclopropyl 4-nitrophenylcarbonate (13 mg, 0.054 mmol) was added. The mixture was heated to 50 °C for 19 h. The reaction mixture was cooled to 23 °C, diluted with 1 N NaOH, and extracted with CH<sub>2</sub>Cl<sub>2</sub> (2×). The combined organic extracts were pooled, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and the filtrate was concentrated to dryness under vacuum. The residue was dissolved in DMSO (0.9 mL) and purified by preparative reverse-phase HPLC on a Waters XBridge C<sub>18</sub> 19 mm × 100 mm, 0.005 mm column, eluting with a linear gradient of 85% H<sub>2</sub>O/CH<sub>3</sub>CN (0.03% NH<sub>4</sub>OH modifier) to 0% H<sub>2</sub>O/CH<sub>3</sub>CN in 8.5 min and holding at 0% H<sub>2</sub>O/CH<sub>3</sub>CN for 1.5 min; flow rate 25 mL/min, to obtain the title compound (1.4 mg, 7%). Analytical LCMS: retention time 2.43 min (Waters Atlantis C<sub>18</sub> 4.6 mm × 50 mm, 0.005 mm column; 95% H<sub>2</sub>O/CH<sub>3</sub>CN linear gradient to 5% H<sub>2</sub>O/CH<sub>3</sub>CN over 4.0 min and a hold at 5% H<sub>2</sub>O/CH<sub>3</sub>CN for 1 min; 0.05% TFA modifier (flow rate 2.0 mL/min). LCMS (ES+): 452.2 (M + 1).</div></div><div id="sec3_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> <i>tert</i>-Butyl 6-[6-(4-Cyano-2-fluorophenoxy)-5-methylpyrimidin-4-yl)]-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (<b>32b</b>)</h3><div id="sec3_40_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> Step 1: 4-(6-Chloro-5-methylpyrimidin-4-yloxy)-3-fluorobenzonitrile</h4><div class="NLM_p last">To a stirred solution of 4,6-dichloro-5-methylpyrimidine (3.92 g, 24.1 mmol) and 3-fluoro-4-hydroxybenzonitrile (3.0 g, 22.0 mmol) in CH<sub>3</sub>CN (75 mL) was added Cs<sub>2</sub>CO<sub>3</sub> (9.27 g, 28.4 mmol). The reaction mixture was heated at reflux under nitrogen for 18 h. The reaction mixture was cooled to 23 °C, filtered, and the filtrate was evaporated under reduced pressure. The residue was taken up in EtOAc (200 mL) and H<sub>2</sub>O (100 mL), and the aqueous layer was extracted with EtOAc (2 × 50 mL). The combined organic extracts were washed with brine (50 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and the filtrate was evaporated to a cream-colored solid. This material was purified by silica chromatography (120 g silica, 25% EtOAc/heptanes as eluent, using a 25g silica precolumn) to give the title compound as a white solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 2.47 (s, 3H), 7.39 (t, <i>J</i> = 8.0 Hz, 1H), 7.53–7.58 (m, 1H), 8.37 (s, 1H). LCMS (ES+): 305.1 (M + 1 + formic acid).</div></div><div id="sec3_40_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> Step 2</h4><div class="NLM_p last">A microwave vial was charged with <i>tert</i>-butyl 2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate <b>5a</b> (125 mg, 0.52 mmol), 4-(6-chloro-5-methyl-pyrimidin-4-yloxy)-3-fluorobenzonitrile (138 mg, 0.52 mmol), NaHCO<sub>3</sub> (66.0 mg, 0.786 mmol), and dry <i>N</i>,<i>N</i>-dimethylformamide (2.5 mL). The vial was sealed and heated at 120 °C for 18 h. The mixture was cooled to 23 °C and diluted with EtOAc (50 mL) and H<sub>2</sub>O (50 mL). The aqueous layer was separated and extracted with EtOAc (2 × 20 mL). The combined organic extracts were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and the filtrate was concentrated under reduced pressure. The residue was purified by silica chromatography (12 g silica, eluting with 25% EtOAc/heptanes). The product fractions were combined and evaporated to a white solid (126.7 mg, 51.9%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.47 (s, 9H), 1.84–1.90 (m, 4H), 2.00–2.04 (m, 4H), 2.18 (s, 3H), 4.26 (br s, 2H), 4.43 (br s, 1H), 4.56 (br s, 1H), 7.32 (t, <i>J</i> = 8.4 Hz, 1H), 7.45–7.50 (m, 2H), 8.17 (s, 1H). LCMS (ES+): 466.2 (M + 1).</div></div></div><div id="sec3_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> Isopropyl 6-[6-(4-Cyano-2-fluorophenoxy)-5-methylpyrimidin-4-yl]-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (<b>32a</b>)</h3><div class="NLM_p last">To a stirred solution of 4-[6-(2,6-diazatricyclo[3.3.1.1∼3,7∼]dec-2-yl)-5-methylpyrimidin-4-yloxy]-3-fluorobenzonitrile·HCl (prepared from Boc cleavage of <b>32b</b>) (40 mg, 0.10 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (1.0 mL) and diisopropylethylamine (51.7 mg, 0.40 mmol) was added isopropyl chloroformate (1 M in toluene, 0.12 mL, 0.12 mmol) at 23 °C. The reaction vessel was sealed, and the mixture was stirred for 2.5 h. The reaction mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> and H<sub>2</sub>O and shaken. The organic layer was separated and filtered through an Alltech filter, and the filtrate was concentrated under reduced pressure. The residue was purified by preparative reverse-phase HPLC on a Waters Sunfire C<sub>18</sub> column (19 mm × 100 mm, 5 μm particle size), eluting with a gradient of H<sub>2</sub>O/CH<sub>3</sub>CN (0.05% TFA modifier) to afford the title compound (10.9 mg, 24%). Analytical LCMS: retention time 3.72 min (Atlantis C<sub>18</sub> 4.6 mm × 50 mm, 5 μm particle size; 95% H<sub>2</sub>O/CH<sub>3</sub>CN linear gradient to 5% H<sub>2</sub>O/CH<sub>3</sub>CN for 4.0 min with a hold at 5% H<sub>2</sub>O/CH<sub>3</sub>CN to 5.0 min; 0.05% TFA modifier; flow rate 2.0 mL/min). LCMS (ES+): 452.1 (M + 1).</div></div><div id="sec3_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> <i>tert</i>-Butyl 6-{5-Methyl-6-[4-(3-methyl-4<i>H</i>-1,2,4-triazol-4-yl)phenoxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (<b>32m</b>)</h3><div id="sec3_42_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> Step1: 4-Chloro-5-methyl-6-[4-(3-methyl-4<i>H</i>-1,2,4-triazol-4-yl)phenoxy]pyrimidine</h4><div class="NLM_p last">The title compound was prepared from 4-(3-methyl-4<i>H</i>-1,2,4-triazol-4-yl)phenol (234 mg, 1.34 mmol) in a manner similar to that used to prepare 4-chloro-5-methyl-6-[4-(4<i>H</i>-1,2,4-triazol-4-yl)phenoxy]pyrimidine (step 1 of <b>32g</b> preparation). Heating was carried out at 100 °C for 1 h. The title compound was obtained as a white solid (360 mg, 90%). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 2.46 (s, 3H), 2.54 (s, 3H), 7.44–7.50 (m, 2H), 7.60–7.66 (m, 2H), 8.35 (s, 1H), 8.90 (s, 1H). LCMS (ES+): 302.0 (M + 1). TLC: <i>R<sub>f</sub></i> = 0.27 in 5% MeOH/CH<sub>2</sub>Cl<sub>2</sub>.</div></div><div id="sec3_42_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> Step 2</h4><div class="NLM_p last">A mixture of 4-chloro-5-methyl-6-[4-(3-methyl-4<i>H</i>-1,2,4-triazol-4-yl)phenoxy]pyrimidine (100 mg, 0.33 mmol), <i>tert</i>-butyl 2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate <b>5a</b> (79 mg, 0.33 mmol), and <i>N</i>,<i>N</i>-diisopropylethylamine (0.115 mL, 0.66 mmol) in CH<sub>3</sub>CN (0.33 mL) was heated at 100 °C for 24 h in a sealed tube. The reaction mixture was cooled to 23 °C, diluted with H<sub>2</sub>O and brine, and extracted with EtOAc (3 × 20 mL). The combined organic extracts were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and the filtrate was concentrated under reduced pressure. A portion of the orange residue was dissolved in DMSO (0.9 mL) and purified by preparative reverse-phase HPLC on a Waters XBridge C<sub>18</sub> 19 mm × 100 mm, 0.005 mm column, eluting with a linear gradient of 85% H<sub>2</sub>O/CH<sub>3</sub>CN (0.03% NH<sub>4</sub>OH modifier) to 0% H<sub>2</sub>O/CH<sub>3</sub>CN in 8.5 min and holding at 0% H<sub>2</sub>O/CH<sub>3</sub>CN for 1.5 min (flow rate, 25 mL/min) to give the title compound (6.0 mg). Analytical LCMS: retention time 2.85 min (Waters XBridge C<sub>18</sub> 4.6 mm × 50 mm, 0.005 mm column; 95% H<sub>2</sub>O/CH<sub>3</sub>CN linear gradient to 5% H<sub>2</sub>O/CH<sub>3</sub>CN over 4.0 min and a hold at 5% H<sub>2</sub>O/CH<sub>3</sub>CN for 1 min; 0.03% NH<sub>4</sub>OH modifier; flow rate 2.0 mL/min). LCMS (ES+): 504.2 (M + 1). TLC <i>R<sub>f</sub></i> = 0.16 in 10% MeOH/CH<sub>2</sub>Cl<sub>2</sub>.</div></div></div><div id="sec3_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> <i>tert</i>-Butyl 6-{5-Methyl-6-[4-(4<i>H</i>-1,2,4-triazol-4-yl)phenoxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (<b>32g</b>)</h3><div id="sec3_43_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> Step 1: 4-Chloro-5-methyl-6-[4-(4<i>H</i>-1,2,4-triazol-4-yl)phenoxy]pyrimidine</h4><div class="NLM_p last">To a mixture of 4,6-dichloromethylpyrimidine (212 mg, 1.30 mmol) and 4-(4<i>H</i>-1,2,4-triazol-4-yl)phenol (200 mg, 1.24 mmol) in CH<sub>3</sub>CN (5 mL) in a 2–5 mL microwave vial was added Cs<sub>2</sub>CO<sub>3</sub> (526 mg, 1.61 mmol). The vial was sealed and heated at 80 °C for 2 h. The reaction mixture was cooled to 23 °C and adsorbed onto 2 g of silica gel. This silica was place on top of a silica gel column and eluted with a MeOH/CH<sub>2</sub>Cl<sub>2</sub> gradient to give the title compound as a white solid (316 mg, 89%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 2.47 (s, 3H), 7.34–7.41 (m, 2H), 7.55 (d, <i>J</i> = 7.32 Hz, 2H), 8.40 (s, 1H), 8.71 (br s, 2H). LCMS (ES+): 288.2 (M + 1). TLC: <i>R<sub>f</sub></i> = 0.22 in 5% MeOH/CH<sub>2</sub>Cl<sub>2</sub>.</div></div><div id="sec3_43_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> Step 2</h4><div class="NLM_p last">The title compound was prepared using 4-chloro-5-methyl-6-[4-(4<i>H</i>-1,2,4-triazol-4-yl)phenoxy]pyrimidine (100 mg, 0.35 mmol) in a manner similar to that used to prepare <i>tert</i>-butyl 6-{5-methyl-6-[4-(3-methyl-4<i>H</i>-1,2,4-triazol-4-yl)phenoxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate <b>32m</b> (step 2 of <b>32 m</b> preparation). This mixture was heated for 64 h instead of 24 h. A small portion of the crude product was dissolved in DMSO (0.9 mL) and purified by preparative reverse-phase HPLC on a Waters XBridge C<sub>18</sub> 19 mm × 100 mm, 0.005 mm column, eluting with a linear gradient of 85% H<sub>2</sub>O/CH<sub>3</sub>CN (0.03% NH<sub>4</sub>OH modifier) to 0% H<sub>2</sub>O/CH<sub>3</sub>CN in 8.5 min and holding at 0% H<sub>2</sub>O/CH<sub>3</sub>CN for 1.5 min (flow rate, 25 mL/min) to give the title compound (9.2 mg). Analytical LCMS: retention time 2.83 min (Waters XBridge C<sub>18</sub> 4.6 mm × 50 mm, 0.005 mm column; 95% H<sub>2</sub>O/CH<sub>3</sub>CN linear gradient to 5% H<sub>2</sub>O/CH<sub>3</sub>CN over 4.0 min and a hold at 5% H<sub>2</sub>O/CH<sub>3</sub>CN for 1 min; 0.03% NH<sub>4</sub>OH modifier; flow rate 2.0 mL/min). LCMS (ES+): 490.2 (M + 1).</div></div></div><div id="sec3_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> Isopropyl 6-[5-Methyl-6-(4-[1,2,3]triazol-1-ylphenoxy)pyrimidin-4-yl]-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (<b>32c</b>)</h3><div class="NLM_p last">A sealed 8 dram tube charged with 4-chloro-5-methyl-6-(4-[1,2,3]triazol-1-yl-phenoxy)pyrimidine (29.6 mg, 0.10 mmol), isopropyl 2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (23 mg, 0.1 mmol), NaHCO<sub>3</sub> (13 mg, 0.16 mmol), and dry <i>N</i>,<i>N</i>-dimethylformamide (0.5 mL) was heated at 120 °C for 18 h. The mixture was cooled to 23 °C and diluted with EtOAc (20 mL) and H<sub>2</sub>O (20 mL). The layers were separated, and the aqueous layer was extracted with EtOAc (10 mL). The combined organic extracts were washed with brine (5 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and the filtrate was evaporated to a yellow solid (53 mg). This solid was purified by preparative reverse-phase HPLC on a Waters Sunfire C<sub>18</sub> column (19 mm × 100 mm, 5 μm particle size), eluting with a gradient of H<sub>2</sub>O/CH<sub>3</sub>CN (0.05% TFA modifier) to give the title compound (19.8 mg, 41%). Analytical LCMS: retention time 3.28 min (Atlantis C<sub>18</sub> 4.6 mm × 50 mm, 5 μm particle size; 95% H<sub>2</sub>O/CH<sub>3</sub>CN linear gradient to 5% H<sub>2</sub>O/CH<sub>3</sub>CN for 4.0 min with a hold at 5% H<sub>2</sub>O/CH<sub>3</sub>CN to 5.0 min; 0.05% TFA modifier (flow rate 2.0 mL/min). LCMS (ES+): 476.1 (M + 1).</div></div><div id="sec3_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> <i>tert</i>-Butyl 6-{5-Methyl-6-[4-(1<i>H</i>-tetrazol-1-yl)phenoxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (<b>32f</b>)</h3><div id="sec3_45_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> Step 1: 4-Chloro-5-methyl-6-[4-(1<i>H</i>-tetrazol-1-yl)phenoxy]pyrimidine</h4><div class="NLM_p last">A mixture of 4-(1<i>H</i>-tetrazol-1-yl)phenol (4.80 g, 30 mmol), 4,6-dichloro-5-methylpyrimidine (5.71 g, 33 mmol), and potassium carbonate (8.50 g, 62 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (60 mL) was stirred at 23 °C for 18 h. The mixture was then diluted with EtOAc (500 mL), washed with brine (2 × 100 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and filtered. While the filtrate was concentrated under vacuum, a solid began to precipitate. The solid was triturated with petroleum ether and was filtered. The filter cake was washed with 10% EtOAc/petroleum ether, and the collected solid was further dried under vacuum to afford the title compound as a brown solid (5 g, 59%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.46 (s, 3H), 7.39 (d, <i>J</i> = 8.8 Hz, 2H), 7.80 (d, <i>J</i> = 8.8 Hz, 2H), 8.39 (s, 1H), 9.00 (s, 1H). GCMS: <i>m</i>/<i>z</i> 288.8.</div></div><div id="sec3_45_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> Step 2</h4><div class="NLM_p last">A microwave vial was charged with <i>tert</i>-butyl 2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate <b>5a</b> (41 mg, 0.17 mmol), 4-chloro-5-methyl-6-[4-(1<i>H</i>-tetrazol-1-yl)phenoxy]pyrimidine (50 mg, 0.17 mmol), NaHCO<sub>3</sub> (22 mg, 0.26 mmol), and <i>N</i>,<i>N</i>-dimethylformamide (0.43 mL), capped, and heated at 90 °C for 16 h. After cooling to 23 °C, the reaction mixture was diluted with H<sub>2</sub>O (25 mL) and a 10% aqueous LiCl (5 mL) and extracted with EtOAc (2 × 20 mL). The combined organic extracts were washed with 10% aqueous LiCl (15 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and the filtrate was concentrated to dryness under vacuum. The residue was purified by silica gel chromatography, eluting with an EtOAc/CH<sub>2</sub>Cl<sub>2</sub> gradient. The title compound was isolated as an off-white solid (18 mg, 21%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.51 (s, 9H), 1.84–1.99 (m, 4H), 2.01–2.13 (m, 4H), 2.22 (s, 3H), 4.32 (br s, 2H), 4.42–4.52 (m, 1H), 4.55–4.66 (m, 1H), 7.33–7.39 (m, 2H), 7.71–7.78 (m, 2H), 8.29 (s, 1H), 8.97 (s, 1H). LCMS (ES+): 491.2 (M + 1). Product <i>R<sub>f</sub></i> = 0.16 in 30% EtOAc/CH<sub>2</sub>Cl<sub>2</sub>.</div></div></div><div id="sec3_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> Isopropyl 6-{5-Methyl-6-[4-(1<i>H</i>-tetrazol-1-yl)phenoxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (<b>32d</b>)</h3><div class="NLM_p last">The title compound was prepared from <i>tert</i>-butyl 6-{5-methyl-6-[4-(1<i>H</i>-tetrazol-1-yl)phenoxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate <b>32f</b> (15 mg, 0.031 mmol) in a manner similar to that used to prepare isopropyl 6-{5-methoxy-6-[(2-methylpyridin-3-yl)oxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate <b>29h</b>. The residue was dissolved in DMSO (0.9 mL) and purified by preparative reverse-phase HPLC on a Waters XBridge C<sub>18</sub> 19 mm × 100 mm, 0.005 mm column, eluting with a linear gradient of 60% H<sub>2</sub>O/CH<sub>3</sub>CN (0.03% NH<sub>4</sub>OH modifier) to 40% H<sub>2</sub>O/CH<sub>3</sub>CN in 10.5 min, linear to 0% H<sub>2</sub>O/CH<sub>3</sub>CN for 0.5 min, and a hold at 0% H<sub>2</sub>O/CH<sub>3</sub>CN for 1.0 min (flow rate 25 mL/min) to give the title compound (5.0 mg, 33%). Analytical LCMS: retention time 3.25 min (Waters Atlantis dC<sub>18</sub> 4.6 mm × 50 mm, 0.005 mm column; 95% H<sub>2</sub>O/CH<sub>3</sub>CN linear gradient to 5% H<sub>2</sub>O/CH<sub>3</sub>CN over 4.0 min and a hold at 5% H<sub>2</sub>O/CH<sub>3</sub>CN for 1 min; 0.05% TFA modifier; flow rate 2.0 mL/min). LCMS (ES+): 477.2 (M + 1).</div></div><div id="sec3_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> 1-Methylcyclopropyl 6-{5-Methyl-6-[4-(1<i>H</i>-tetrazol-1-yl)phenoxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (<b>32e</b>)</h3><div class="NLM_p last">The title compound was prepared from <i>tert</i>-butyl 6-{5-methyl-6-[4-(1<i>H</i>-tetrazol-1-yl)phenoxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate <b>32f</b> (14 mg, 0.029 mmol) in a manner similar to that used to prepare 1-methylcyclopropyl 6-{5-methoxy-6-[(2-methylpyridin-3-yl)oxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate <b>29i</b>. The residue was dissolved in DMSO (0.9 mL) and purified by preparative reverse-phase HPLC on a Waters XBridge C<sub>18</sub> 19 mm × 100 mm, 0.005 mm column, eluting with a linear gradient of 85% H<sub>2</sub>O/CH<sub>3</sub>CN (0.03% NH<sub>4</sub>OH modifier) to 0% H<sub>2</sub>O/CH<sub>3</sub>CN in 8.5 min and holding at 0% H<sub>2</sub>O/CH<sub>3</sub>CN for 1.5 min (flow rate 25 mL/min) to give the title compound (5.3 mg, 37%). Analytical LCMS: retention time 3.23 min (Waters Atlantis dC<sub>18</sub> 4.6 mm × 50 mm, 0.005 mm column; 95% H<sub>2</sub>O/CH<sub>3</sub>CN linear gradient to 5% H<sub>2</sub>O/CH<sub>3</sub>CN over 4.0 min and a hold at 5% H<sub>2</sub>O/CH<sub>3</sub>CN for 1 min; 0.05% TFA modifier (flow rate 2.0 mL/min). LCMS (ES+): 489.2 (M + 1).</div></div><div id="sec3_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> <i>tert</i>-Butyl 6-{6-[2-Fluoro-4-(1<i>H</i>-tetrazol-1-yl)phenoxy]-5-methylpyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (<b>32j</b>)</h3><div id="sec3_48_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> Step 1: 4-Chloro-5-methyl-6-[2-fluoro-4-(1<i>H</i>-tetrazol-1-yl)phenoxy]pyrimidine</h4><div class="NLM_p last">A mixture of 2-fluoro-4-(1<i>H</i>-tetrazol-1-yl)phenol (1.00 g, 5.6 mmol), 4,6-dichloro-5-methylpyrimidine (1.09 g, 6.7 mmol), and K<sub>2</sub>CO<sub>3</sub> (1.20 g, 8.4 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (15 mL) was stirred at 70 °C for 3 h. The mixture was then diluted with EtOAc, washed with H<sub>2</sub>O and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and the filtrate was concentrated to dryness under vacuum. The residue was purified by silica gel chromatography, eluting with EtOAc/petroleum ether. The title compound was obtained as a white solid (1.00 g, 59%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.49 (s, 3H), 7.62 (m, 1H), 7.83 (m, 1H), 7.96 (m, 1H), 8.36 (s, 1H), 9.82 (s, 1H). GCMS: <i>m</i>/<i>z</i> 306.8.</div></div><div id="sec3_48_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> Step 2</h4><div class="NLM_p last">A mixture of <i>tert</i>-butyl 2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (78 mg, 0.33 mmol), 4-chloro-5-methyl-6-[2-fluoro-4-(1<i>H</i>-tetrazol-1-yl)phenoxy]pyrimidine (100 mg, 0.33 mmol), and NaHCO<sub>3</sub> (41 mg, 0.49 mmol) was suspended in <i>N</i>,<i>N</i>-dimethylformamide (0.82 mL) in a microwave vial. The vial was capped and heated at 60 °C for 14 h. The temperature was increased to 70 °C, and the mixture was heated an additional 26 h. The mixture was cooled to 23 °C, diluted with H<sub>2</sub>O and 10% aqueous LiCl, and extracted with EtOAc (2 × 20 mL). The organic extracts were combined, washed with 10% aqueous LiCl (15 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and the filtrate was concentrated to dryness under vacuum. The residue was purified by silica gel chromatography, eluting with an EtOAc/heptanes gradient. The title compound was isolated as a white solid (36 mg, 22%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.51 (s, 9H), 1.84–1.98 (m, 4H), 2.00–2.13 (m, 4H), 2.24 (s, 3H), 4.31 (br s, 2H), 4.46 (br s, 1H), 4.60 (br s, 1H), 7.46 (d, <i>J</i> = 8.05 Hz, 1H), 7.52–7.58 (m, 1H), 7.64 (dd, <i>J</i> = 2.56, 9.88 Hz, 1H), 8.23 (s, 1H), 8.99 (s, 1H). LCMS (ES+): 509.2 (M + 1).</div></div></div><div id="sec3_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> Isopropyl 6-{6-[2-Fluoro-4-(1<i>H</i>-tetrazol-1-yl)phenoxy]-5-methylpyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (<b>32h</b>)</h3><div class="NLM_p last">The title compound was prepared from <i>tert</i>-butyl 6-{5-methyl-6-[2-fluoro-4-(1<i>H</i>-tetrazol-1-yl)phenoxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate <b>32j</b> (18 mg, 0.035 mmol) in a manner similar to that used to prepare isopropyl 6-{5-ethyl-6-[(2-methylpyridin-3-yl)oxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate <b>29c</b>. The residue was dissolved in DMSO (0.9 mL) and purified by preparative reverse-phase HPLC on a Waters Sunfire C<sub>18</sub> 19 mm × 100 mm, 0.005 mm column, eluting with a linear gradient of 70% H<sub>2</sub>O/CH<sub>3</sub>CN (0.05% TFA modifier) to 30% H<sub>2</sub>O/CH<sub>3</sub>CN in 10.5 min, linear to 0% H<sub>2</sub>O/CH<sub>3</sub>CN in 0.5 min, and holding at 0% H<sub>2</sub>O/CH<sub>3</sub>CN for 1 min (flow rate 25 mL/min) to give the title compound as the free base (10 mg, 59%). Analytical LCMS: retention time 3.36 min (Waters Atlantis dC<sub>18</sub> 4.6 mm × 50 mm, 0.005 mm column; 95% H<sub>2</sub>O/CH<sub>3</sub>CN linear gradient to 5% H<sub>2</sub>O/CH<sub>3</sub>CN over 4.0 min and held at 5% H<sub>2</sub>O/CH<sub>3</sub>CN for 1.0 min; 0.05% TFA modifier (flow rate 2.0 mL/min). LCMS (ES+): 495.2 (M + 1).</div></div><div id="sec3_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> 1-Methylcyclopropyl 6-{6-[2-Fluoro-4-(1<i>H</i>-tetrazol-1-yl)phenoxy]-5-methylpyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (<b>32i</b>)</h3><div id="sec3_50_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> Step 1: 4-(6-Chloro-5-methylpyrimidin-4-yloxy)-3-fluoroaniline</h4><div class="NLM_p last">To a stirred mixture of 4,6-dichloro-5-methylpyrimidine (24.3 g, 149 mmol) and Cs<sub>2</sub>CO<sub>3</sub> (48.7 g, 149 mmol) in CH<sub>3</sub>CN (299 mL) was added 4-amino-2-fluorophenol (19.0 g, 149 mmol) at 23 °C. The mixture was allowed to stir at 23 °C for 4 h. The mixture was then filtered through Celite, rinsing the filter cake with EtOAc. The filtrate was concentrated to dryness and adsorbed onto silica. The charged silica was place on top of a 330 g silica gel column and purified by chromatography using an isocratic elution with 30% EtOAc/heptanes to give 19 g (50%) of the title compound as a tan solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 2.40 (s, 3H), 3.80 (br s, 2H), 6.49 (dd, <i>J</i> = 11.7 Hz, 21.5 1H), 6.97 (t, <i>J</i> = 17.6 Hz, 1H), 8.38 (s, 1H). LCMS (ES+): 254.0 (M + 1). TLC: <i>R<sub>f</sub></i> = 0.30 in 30% EtOAc/heptanes.</div></div><div id="sec3_50_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> Step 2: 1-Methylcyclopropyl 6-(6-{4-[Amino]-2-fluorophenoxy}-5-methylpyrimidin-4-yl)-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate</h4><div class="NLM_p last">A 250 mL flask was charged with 4-(6-chloro-5-methylpyrimidin-4-yloxy)-3-fluoroaniline (17.8 g, 82.5 mmol), 1-methylcyclopropyl-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (19.5 g, 82.5 mmol), NaHCO<sub>3</sub> (17.9 g, 211 mmol), and DMSO (82.6 mL). The reaction mixture was equipped with a reflux condenser and heated at 160 °C for 18 h. The reaction mixture was cooled to 23 °C, and H<sub>2</sub>O was added. A tan solid precipitated from the solution. This solid was filtered and dried. The solid material was adsorbed onto silica gel with the aid of CH<sub>2</sub>Cl<sub>2</sub>. The charged silica was loaded on top of a silica gel column and was purified by chromatography using 50% EtOAc/CH<sub>2</sub>Cl<sub>2</sub> to give the title compound as an off-white solid (23 g, 72%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.58–0.65 (m, 2H), 0.76–0.83 (m, 2H), 1.50 (s, 3H), 1.67–1.82 (m, 4H), 1.89–2.02 (m, 4H), 2.11 (s, 3H), 4.18 (br s, 2H), 4.25 (br s, 1H), 4.37 (br s, 1H), 5.27 (s, 2H), 6.35 (dd, <i>J</i> = 2.44, 8.54 Hz, 1H), 6.42 (dd, <i>J</i> = 2.56 Hz, 13.05, 1H), 6.87 (t, <i>J</i> = 8.90 Hz, 1H), 8.12 (s, 1H). LCMS (ES+): 454.3 (M + 1). TLC: <i>R<sub>f</sub></i> = 0.21 in 60% EtOAc/heptanes.</div></div><div id="sec3_50_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> Step 3</h4><div class="NLM_p last">A mixture of 1-methylcyclopropyl 6-[6-(4-amino-2-fluorophenoxy)-5-methylpyrimidin-4-yl]-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (23.0 g, 50.7 mmol), NaN<sub>3</sub> (3.64 g, 55.8 mmol), triethyl orthoformate (25.8 mL, 152 mmol), and acetic acid (23.3 mL, 406 mmol) was heated at 80 °C. After 2 h, the suspension became a yellow solution before transitioning to a very thick slurry, which was loosened with the addition of acetic acid (20 mL). The mixture was heated at 80 °C for an additional 2 h. After cooling to 23 °C, the mixture was diluted with H<sub>2</sub>O and was extracted with EtOAc (200 mL). The aqueous layer was extracted again with EtOAc (2 × 100 mL), and the combined organic extracts were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and the filtrate was concentrated to dryness under vacuum. The crude residue was purified by silica gel chromatography using 40% EtOAc/CH<sub>2</sub>Cl<sub>2</sub> as the eluent to give 19 g (75%) of the title compound as a white solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 0.63–0.70 (m, 2H), 0.87–0.94 (m, 2H), 1.59 (s, 3H), 1.80–1.98 (m, 4H), 2.00–2.13 (m, 4H), 2.23 (s, 3H), 4.29 (br s, 2H), 4.42 (br s, 1H), 4.62 (br s, 1H), 7.42–7.48 (m, 1H), 7.52–7.58 (m, 1H), 7.63 (dd, <i>J</i> = 2.44, 9.76 Hz, 1H), 8.22 (s, 1H), 8.99 (s, 1H). LCMS (ES+): 507.3 (M + 1). TLC <i>R<sub>f</sub></i> = 0.70 in EtOAc/CH<sub>2</sub>Cl<sub>2</sub>.</div></div></div><div id="sec3_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> <i>tert</i>-Butyl 6-{6-[2-Fluoro-4-(4<i>H</i>-1,2,4-triazol-4-yl)phenoxy]-5-methylpyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (<b>32l</b>)</h3><div class="NLM_p last">The title compound was prepared using 4-chloro-5-methyl-6-[2-fluoro-4-(4<i>H</i>-1,2,4-triazol-4-yl)phenoxy]pyrimidine (88 mg, 0.29 mmol) in a manner similar to that used to prepare <i>tert</i>-butyl 6-{5-methyl-6-[4-(3-methyl-4<i>H</i>-1,2,4-triazol-4-yl)phenoxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate <b>32g</b>. This mixture was heated for 64 h instead of 24 h. A small portion of this residue was dissolved in DMSO (0.9 mL) and purified by preparative reverse-phase HPLC on a Waters XBridge C<sub>18</sub> 19 mm × 100 mm, 0.005 mm column, eluting with a linear gradient of 85% H<sub>2</sub>O/CH<sub>3</sub>CN (0.03% NH<sub>4</sub>OH modifier) to 0% H<sub>2</sub>O/CH<sub>3</sub>CN in 8.5 min and holding at 0% H<sub>2</sub>O/CH<sub>3</sub>CN for 1.5 min (flow rate 25 mL/min) to give the title compound (10 mg). Analytical LCMS: retention time 2.93 min (Waters XBridge C<sub>18</sub> 4.6 mm × 50 mm, 0.005 mm column; 95% H<sub>2</sub>O/CH<sub>3</sub>CN linear gradient to 5% H<sub>2</sub>O/CH<sub>3</sub>CN over 4.0 min and a hold at 5% H<sub>2</sub>O/CH<sub>3</sub>CN for 1 min; 0.03% NH<sub>4</sub>OH modifier; flow rate 2.0 mL/min). LCMS (ES+): 508.1 (M + 1).</div></div><div id="sec3_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> <i>tert</i>-Butyl 6-{6-[2-Fluoro-4-(3-methyl-4<i>H</i>-1,2,4-triazol-4-yl)phenoxy]-5-methylpyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (<b>32n</b>)</h3><div class="NLM_p last">The title compound was prepared using 4-chloro-5-methyl-6-[2-fluoro-4-(3-methyl-4<i>H</i>-1,2,4-triazol-4-yl)phenoxy]pyrimidine (74 mg, 0.31 mmol) in a manner similar to that used to prepare <i>tert</i>-butyl 6-{5-methyl-6-[4-(3-methyl-4<i>H</i>-1,2,4-triazol-4-yl)phenoxy]pyrimidin-4-yl}-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate <b>32m</b>. A small portion of this residue was dissolved in DMSO (0.9 mL) and purified by preparative reverse- phase HPLC on a Waters XBridge C<sub>18</sub> 19 mm × 100 mm, 0.005 mm column, eluting with a linear gradient of 85% H<sub>2</sub>O/CH<sub>3</sub>CN (0.03% NH<sub>4</sub>OH modifier) to 0% H<sub>2</sub>O/CH<sub>3</sub>CN in 8.5 min and holding at 0% H<sub>2</sub>O/CH<sub>3</sub>CN for 1.5 min (flow rate, 25 mL/min) to give the title compound (6.3 mg). Analytical LCMS: retention time 2.93 min (Waters XBridge C<sub>18</sub> 4.6 mm × 50 mm, 0.005 mm column; 95% H<sub>2</sub>O/CH<sub>3</sub>CN linear gradient to 5% H<sub>2</sub>O/CH<sub>3</sub>CN over 4.0 min and a hold at 5% H<sub>2</sub>O/CH<sub>3</sub>CN for 1 min; 0.03% NH<sub>4</sub>OH modifier; flow rate 2.0 mL/min). LCMS (ES+): 522.2 (M + 1).</div></div><div id="sec3_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> Isopropyl 6-[6-(4-Dimethylcarbamoyl-2-fluorophenoxy)-5-methylpyrimidin-4-yl]-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (<b>32k</b>)</h3><div id="sec3_53_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> Step 1: 4-(6-Chloro-5-methylpyrimidin-4-yl oxy)-3-fluoro-<i>N</i>,<i>N</i>-dimethylbenzamide</h4><div class="NLM_p last">To a solution of 4,6-dichloro-5-methylpyrimidine (202 mg, 1.24 mmol) and 3-fluoro4-hydroxy-<i>N</i>,<i>N</i>-dimethylbenzamide (205 mg, 1.12 mmol) in CH<sub>3</sub>CN (5.0 mL) was added Cs<sub>2</sub>CO<sub>3</sub> (476 mg, 1.46 mmol). The reaction mixture was heated at reflux under nitrogen for 18 h. The mixture was cooled to 23 °C and diluted with H<sub>2</sub>O (30 mL) and EtOAc (40 mL). The aqueous layer was separated and extracted once with EtOAc (20 mL). The combined organic extracts were washed with brine (5 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and the filtrate was evaporated. The residue was purified by silica gel chromatography (12 g silica, 30% EtOAc/heptanes linear gradient to 70% EtOAc/heptanes). The product fractions were combined, evaporated, and dried under high vacuum to give the title compound as an off-white solid (150.8 mg, 43%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.46 (s, 3H), 3.07 (s, 3H), 3.17 (s, 3H), 7.25–7.33 (m, 4H). LCMS (ES+): 310.2 (M + 1).</div></div><div id="sec3_53_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> Step 2</h4><div class="NLM_p last">4-(6-Chloro-5-methylpyrimidin-4-yloxy)-3-fluoro-<i>N</i>,<i>N</i>-dimethylbenzamide (32 mg, 0.10 mmol), isopropyl 2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate (23 mg, 0.1 mmol), and NaHCO<sub>3</sub> (13 mg, 0.16 mmol) were heated at 120 °C in a sealed 8 dram tube in dry <i>N</i>,<i>N</i>-dimethylformamide (0.5 mL) for 18 h. The mixture was cooled to 23 °C, diluted with EtOAc (20 mL) and H<sub>2</sub>O (20 mL), and the layers were separated. The aqueous layer was extracted with EtOAc (10 mL). The combined organic extracts were washed with brine (5 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and the filtrate was evaporated to a yellow solid (53 mg). This solid was purified by preparative reverse-phase HPLC on a Waters Sunfire C<sub>18</sub> column (19 mm × 100 mm, 5 μm particle size), eluting with a gradient of H<sub>2</sub>O/CH<sub>3</sub>CN (0.05% TFA modifier) to afford the title compound (6.7 mg, 13%). Analytical LCMS: retention time 3.19 min (Atlantis C<sub>18</sub> 4.6 mm × 50 mm, 5 μm particle size; 95% H<sub>2</sub>O/CH<sub>3</sub>CN linear gradient to 5% H<sub>2</sub>O/CH<sub>3</sub>CN for 4.0 min with a hold at 5% H<sub>2</sub>O/CH<sub>3</sub>CN to 5.0 min; 0.05% TFA modifier (flow rate 2.0 mL/min). LCMS (ES+): 498.1 (M + 1).</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i91"><a href="/doi/suppl/10.1021/jm301626p">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43677" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43677" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">X-ray experimental conditions for the structure determination of <b>25b</b> and the results. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm301626p/suppl_file/jm301626p_si_001.pdf">jm301626p_si_001.pdf (177.12 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm301626p" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73624" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73624" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kim F. McClure</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry,
Discovery Biology, Drug Metabolism, and Pharmaceutical Sciences, Pfizer Worldwide Research and Development, 620 Memorial
Drive, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#c4afada9eaa2eaa9a7a7a8b1b6a184b4a2adbea1b6eaa7aba9"><span class="__cf_email__" data-cfemail="a4cfcdc98ac28ac9c7c7c8d1d6c1e4d4c2cddec1d68ac7cbc9">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Etzer Darout</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry,
Discovery Biology, Drug Metabolism, and Pharmaceutical Sciences, Pfizer Worldwide Research and Development, 620 Memorial
Drive, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ralph P. Robinson</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry,
Discovery Biology, Drug Metabolism, and Pharmaceutical Sciences, Pfizer Worldwide Research and Development, Eastern
Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew Corbett</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry,
Discovery Biology, Drug Metabolism, and Pharmaceutical Sciences, Pfizer Worldwide Research and Development, Eastern
Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bryan Li</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry,
Discovery Biology, Drug Metabolism, and Pharmaceutical Sciences, Pfizer Worldwide Research and Development, Eastern
Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrei Shavnya</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry,
Discovery Biology, Drug Metabolism, and Pharmaceutical Sciences, Pfizer Worldwide Research and Development, Eastern
Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Melissa P. Andrews</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry,
Discovery Biology, Drug Metabolism, and Pharmaceutical Sciences, Pfizer Worldwide Research and Development, Eastern
Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher S. Jones</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry,
Discovery Biology, Drug Metabolism, and Pharmaceutical Sciences, Pfizer Worldwide Research and Development, Eastern
Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qifang, Li</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry,
Discovery Biology, Drug Metabolism, and Pharmaceutical Sciences, Pfizer Worldwide Research and Development, Eastern
Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martha L. Minich</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry,
Discovery Biology, Drug Metabolism, and Pharmaceutical Sciences, Pfizer Worldwide Research and Development, Eastern
Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vincent Mascitti</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry,
Discovery Biology, Drug Metabolism, and Pharmaceutical Sciences, Pfizer Worldwide Research and Development, Eastern
Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cristiano R. W. Guimarães</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry,
Discovery Biology, Drug Metabolism, and Pharmaceutical Sciences, Pfizer Worldwide Research and Development, 620 Memorial
Drive, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael J. Munchhof</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry,
Discovery Biology, Drug Metabolism, and Pharmaceutical Sciences, Pfizer Worldwide Research and Development, Eastern
Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin B. Bahnck</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry,
Discovery Biology, Drug Metabolism, and Pharmaceutical Sciences, Pfizer Worldwide Research and Development, Eastern
Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cuiman Cai</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry,
Discovery Biology, Drug Metabolism, and Pharmaceutical Sciences, Pfizer Worldwide Research and Development, Eastern
Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David A. Price</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry,
Discovery Biology, Drug Metabolism, and Pharmaceutical Sciences, Pfizer Worldwide Research and Development, 620 Memorial
Drive, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Spiros Liras</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry,
Discovery Biology, Drug Metabolism, and Pharmaceutical Sciences, Pfizer Worldwide Research and Development, 620 Memorial
Drive, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul D. Bonin</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry,
Discovery Biology, Drug Metabolism, and Pharmaceutical Sciences, Pfizer Worldwide Research and Development, Eastern
Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter Cornelius</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry,
Discovery Biology, Drug Metabolism, and Pharmaceutical Sciences, Pfizer Worldwide Research and Development, Eastern
Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ruduan Wang</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry,
Discovery Biology, Drug Metabolism, and Pharmaceutical Sciences, Pfizer Worldwide Research and Development, Eastern
Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Victoria Bagdasarian</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry,
Discovery Biology, Drug Metabolism, and Pharmaceutical Sciences, Pfizer Worldwide Research and Development, Eastern
Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Colleen P. Sobota</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry,
Discovery Biology, Drug Metabolism, and Pharmaceutical Sciences, Pfizer Worldwide Research and Development, Eastern
Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sam Hornby</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry,
Discovery Biology, Drug Metabolism, and Pharmaceutical Sciences, Pfizer Worldwide Research and Development, Eastern
Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Victoria M. Masterson</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry,
Discovery Biology, Drug Metabolism, and Pharmaceutical Sciences, Pfizer Worldwide Research and Development, Eastern
Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Reena M. Joseph</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry,
Discovery Biology, Drug Metabolism, and Pharmaceutical Sciences, Pfizer Worldwide Research and Development, Eastern
Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Amit S. Kalgutkar</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry,
Discovery Biology, Drug Metabolism, and Pharmaceutical Sciences, Pfizer Worldwide Research and Development, 620 Memorial
Drive, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yue Chen</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry,
Discovery Biology, Drug Metabolism, and Pharmaceutical Sciences, Pfizer Worldwide Research and Development, Eastern
Point Road, Groton, Connecticut 06340, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d1067e6598-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i92">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14175" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14175" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Brian Samas for the X-ray structure determination of <b>25b</b>.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i93" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i93"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i94" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i94"> Abbreviations Used</h2><tr><td class="NLM_term">GPR119</td><td class="NLM_def"><p class="first last">G-protein-coupled receptor 119</p></td></tr><tr><td class="NLM_term">GLP-1</td><td class="NLM_def"><p class="first last">glucagon-like peptide 1</p></td></tr><tr><td class="NLM_term">DPPIV</td><td class="NLM_def"><p class="first last">dipetidyl dipeptidase IV</p></td></tr><tr><td class="NLM_term">FPG</td><td class="NLM_def"><p class="first last">fasting plasma glucose</p></td></tr><tr><td class="NLM_term">HbA<sub>1c</sub></td><td class="NLM_def"><p class="first last">hemoglobin A<sub>1c</sub></p></td></tr><tr><td class="NLM_term">GPCR</td><td class="NLM_def"><p class="first last">G-protein-coupled receptor</p></td></tr><tr><td class="NLM_term">cAMP</td><td class="NLM_def"><p class="first last">3′,5′-cyclic adenosine monophosphate</p></td></tr><tr><td class="NLM_term">IA</td><td class="NLM_def"><p class="first last">intrinsic activity</p></td></tr><tr><td class="NLM_term">OEA</td><td class="NLM_def"><p class="first last">oleoylethanolamide</p></td></tr><tr><td class="NLM_term">LLE</td><td class="NLM_def"><p class="first last">ligand lipophilic efficiency</p></td></tr><tr><td class="NLM_term">LE</td><td class="NLM_def"><p class="first last">ligand efficiency</p></td></tr><tr><td class="NLM_term">AgLLE</td><td class="NLM_def"><p class="first last">agonist ligand lipophilic efficiency</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>max</sub></td><td class="NLM_def"><p class="first last">maximum plasma concentration</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term">iv</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term">po</td><td class="NLM_def"><p class="first last">per os</p></td></tr><tr><td class="NLM_term">UPLC</td><td class="NLM_def"><p class="first last">ultrahigh pressure liquid chromatography</p></td></tr><tr><td class="NLM_term">mpk</td><td class="NLM_def"><p class="first last">milligram per kilogram</p></td></tr><tr><td class="NLM_term"><i>F</i></td><td class="NLM_def"><p class="first last">bioavailability</p></td></tr><tr><td class="NLM_term">SDD</td><td class="NLM_def"><p class="first last">spray dried dispersion</p></td></tr><tr><td class="NLM_term">HPMCAS-HF</td><td class="NLM_def"><p class="first last">hydroxypropylmethylcellulose acetate succinate high fine</p></td></tr><tr><td class="NLM_term">MC</td><td class="NLM_def"><p class="first last">methylcellulose</p></td></tr><tr><td class="NLM_term">DMA</td><td class="NLM_def"><p class="first last">dimethylacetamide</p></td></tr><tr><td class="NLM_term">PEG200</td><td class="NLM_def"><p class="first last">polyethylene glycol 200</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i95">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83663" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83663" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 53 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span>Diabetes Fact Sheet. <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva, Switzerland</span>, August<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Diabetes+Fact+Sheet.+World+Health+Organization%3A+Geneva%2C+Switzerland%2C+August+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26pub%3DWorld%2520Health%2520Organization%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span> </span><span class="NLM_article-title">International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes</span>.  <span class="citation_source-journal">Diabetes Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1327</span><span class="NLM_x">–</span> <span class="NLM_lpage">1334</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=International+Expert+Committee+Report+on+the+Role+of+the+A1C+Assay+in+the+Diagnosis+of+Diabetes.+Diabetes+Care+2009%2C+32%2C+1327%E2%80%931334."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26atitle%3DInternational%2520Expert%2520Committee%2520Report%2520on%2520the%2520Role%2520of%2520the%2520A1C%2520Assay%2520in%2520the%2520Diagnosis%2520of%2520Diabetes%26jtitle%3DDiabetes%2520Care%26date%3D2009%26volume%3D32%26spage%3D1327%26epage%3D1334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Krentz, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, C. J.</span><span> </span><span class="NLM_article-title">Oral Antidiabetic Agents: Current Role in Type 2 Diabetes Mellitus</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">411</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=385-411&author=A.+J.+Krentzauthor=C.+J.+Bailey&title=Oral+Antidiabetic+Agents%3A+Current+Role+in+Type+2+Diabetes+Mellitus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKrentz%26aufirst%3DA.%2BJ.%26aulast%3DBailey%26aufirst%3DC.%2BJ.%26atitle%3DOral%2520Antidiabetic%2520Agents%253A%2520Current%2520Role%2520in%2520Type%25202%2520Diabetes%2520Mellitus%26jtitle%3DDrugs%26date%3D2005%26volume%3D65%26spage%3D385%26epage%3D411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">DeFronzo, R. A.</span><span> </span><span class="NLM_article-title">From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">773</span><span class="NLM_x">–</span> <span class="NLM_lpage">795</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2009&pages=773-795&author=R.+A.+DeFronzo&title=From+the+Triumvirate+to+the+Ominous+Octet%3A+A+New+Paradigm+for+the+Treatment+of+Type+2+Diabetes+Mellitus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeFronzo%26aufirst%3DR.%2BA.%26atitle%3DFrom%2520the%2520Triumvirate%2520to%2520the%2520Ominous%2520Octet%253A%2520A%2520New%2520Paradigm%2520for%2520the%2520Treatment%2520of%2520Type%25202%2520Diabetes%2520Mellitus%26jtitle%3DDiabetes%26date%3D2009%26volume%3D58%26spage%3D773%26epage%3D795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Chao, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, R. R.</span><span> </span><span class="NLM_article-title">SGLT2 Inhibition—A Novel Strategy for Diabetes Treatment</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">551</span><span class="NLM_x">–</span> <span class="NLM_lpage">559</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=551-559&author=E.+C.+Chaoauthor=R.+R.+Henry&title=SGLT2+Inhibition%E2%80%94A+Novel+Strategy+for+Diabetes+Treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChao%26aufirst%3DE.%2BC.%26aulast%3DHenry%26aufirst%3DR.%2BR.%26atitle%3DSGLT2%2520Inhibition%25E2%2580%2594A%2520Novel%2520Strategy%2520for%2520Diabetes%2520Treatment%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D551%26epage%3D559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Briones, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajaj, M.</span><span> </span><span class="NLM_article-title">Exenatide: A GLP-1 Receptor Agonist As Novel Therapy for Type 2 Diabetes Mellitus</span> <span class="citation_source-journal">Expert Opin. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1055</span><span class="NLM_x">–</span> <span class="NLM_lpage">1064</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm301626p&amp;key=10.1517%2F14656566.7.8.1055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm301626p&amp;key=16722815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm301626p&amp;key=1%3ACAS%3A528%3ADC%252BD28XltVOgsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=1055-1064&author=M.+Brionesauthor=M.+Bajaj&title=Exenatide%3A+A+GLP-1+Receptor+Agonist+As+Novel+Therapy+for+Type+2+Diabetes+Mellitus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Exenatide: a GLP-1 receptor agonist as novel therapy for Type 2 diabetes mellitus</span></div><div class="casAuthors">Briones, Mariele; Bajaj, Mandeep</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1055-1064</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Exenatide is a glucagon-like peptide 1 receptor agonist, which has recently received FDA approval in the US for the treatment of Type 2 diabetes.  Exenatide is an incretin mimetic that improves glycemic control in patients with diabetes through acute mechanisms, such as glucose-dependent stimulation of insulin secretion, suppression of inappropriate glucagon secretion and slowing of gastric emptying, as well as chronic mechanisms that include enhancement of β-cell mass in rodent studies and wt. loss and inhibition of food intake in humans.  This article reviews the mechanisms of exenatide action, as well as its efficacy in the treatment of Type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB6R6S9GYNNbVg90H21EOLACvtfcHk0ljZThHqAaebNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltVOgsrk%253D&md5=b37a4213cd24bd2219d1886b66d1307c</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1517%2F14656566.7.8.1055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.7.8.1055%26sid%3Dliteratum%253Aachs%26aulast%3DBriones%26aufirst%3DM.%26aulast%3DBajaj%26aufirst%3DM.%26atitle%3DExenatide%253A%2520A%2520GLP-1%2520Receptor%2520Agonist%2520As%2520Novel%2520Therapy%2520for%2520Type%25202%2520Diabetes%2520Mellitus%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2006%26volume%3D7%26spage%3D1055%26epage%3D1064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Derosa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maffioli, P.</span><span> </span><span class="NLM_article-title">Dipeptidyl Peptidase-4 Inhibitors: 3 Years of Experience</span> <span class="citation_source-journal">Diabetes Technol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">350</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm301626p&amp;key=10.1089%2Fdia.2011.0204" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm301626p&amp;key=22324384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm301626p&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvFSnsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=350-364&author=G.+Derosaauthor=P.+Maffioli&title=Dipeptidyl+Peptidase-4+Inhibitors%3A+3+Years+of+Experience"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl Peptidase-4 Inhibitors: 3 Years of Experience</span></div><div class="casAuthors">Derosa, Giuseppe; Maffioli, Pamela</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes Technology & Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">350-364</span>CODEN:
                <span class="NLM_cas:coden">DTTHFH</span>;
        ISSN:<span class="NLM_cas:issn">1520-9156</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">According to the latest American Diabetes Assocn. guidelines, lowering glycated Hb (HbA1c) to below or around 7% has been shown to reduce microvascular and neuropathic complications of diabetes and, if implemented soon after the diagnosis of diabetes, is assocd. with long-term redn. in macrovascular disease.  Recently a new class of antidiabetes drugs has been developed, dipeptidyl peptidase-4 (DPP-4) inhibitors, which act by inhibiting DPP-4, the enzyme that inactivates glucagon-like peptide-1 (GLP-1).  Through the inhibition of DPP-4, DPP-4 inhibitors enhance the effects of GLP-1 and glucose-dependent insulinotropic peptide, increasing glucose-mediated insulin secretion and suppressing glucagon secretion.  We conducted a review analyzing clin. efficacy and safety of DPP-4 inhibitors, both alone and in combination with other antidiabetes drugs, including randomized controlled trials about sitagliptin, vildagliptin, saxagliptin, and linagliptin conducted in the latest 15 years.  We concluded that, once metformin fails to maintain glycemic control, addn. of DPP-4 inhibitors should be the logical choice: they seems to lower HbA1c levels by 0.6-0.9 percentage points and to have a comparable effect on HbA1c vs. the addn. of a sulfonylurea or glitazone.  They also have pos. effects on β-cell function, and they have neutral effects on body wt.  Furthermore, DPP-4 inhibitors prevent the risk of hypoglycemia posed by sulfonylureas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWF2HG6yjq3bVg90H21EOLACvtfcHk0ljZThHqAaebNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvFSnsrk%253D&md5=c17b5978ffa303d88b1ad76dca040199</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1089%2Fdia.2011.0204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fdia.2011.0204%26sid%3Dliteratum%253Aachs%26aulast%3DDerosa%26aufirst%3DG.%26aulast%3DMaffioli%26aufirst%3DP.%26atitle%3DDipeptidyl%2520Peptidase-4%2520Inhibitors%253A%25203%2520Years%2520of%2520Experience%26jtitle%3DDiabetes%2520Technol.%2520Ther.%26date%3D2012%26volume%3D14%26spage%3D350%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Ohishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, S.</span><span> </span><span class="NLM_article-title">The Therapeutic Potential of GPR119 Agonists for Type 2 Diabetes</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">321</span><span class="NLM_x">–</span> <span class="NLM_lpage">328</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=321-328&author=T.+Ohishiauthor=S.+Yoshida&title=The+Therapeutic+Potential+of+GPR119+Agonists+for+Type+2+Diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOhishi%26aufirst%3DT.%26aulast%3DYoshida%26aufirst%3DS.%26atitle%3DThe%2520Therapeutic%2520Potential%2520of%2520GPR119%2520Agonists%2520for%2520Type%25202%2520Diabetes%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2012%26volume%3D21%26spage%3D321%26epage%3D328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Dhayal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, N. G.</span><span> </span><span class="NLM_article-title">The Significance of GPR119 Agonists as a Future Treatment for Type 2 Diabetes</span> <span class="citation_source-journal">Drug News Perspect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">418</span><span class="NLM_x">–</span> <span class="NLM_lpage">424</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm301626p&amp;key=20862393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm301626p&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1Squ7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2010&pages=418-424&author=S.+Dhayalauthor=N.+G.+Morgan&title=The+Significance+of+GPR119+Agonists+as+a+Future+Treatment+for+Type+2+Diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The significance of GPR119 agonists as a future treatment for type 2 diabetes</span></div><div class="casAuthors">Morgan, Noel G.; Dhayal, Shalinee</div><div class="citationInfo"><span class="NLM_cas:title">Drug News & Perspectives</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">418-424</span>CODEN:
                <span class="NLM_cas:coden">DNPEED</span>;
        ISSN:<span class="NLM_cas:issn">0214-0934</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  GPR119 is a G protein-coupled receptor that is expressed on only a limited no. of tissues, including pancreatic β-cells and enteroendocrine cells in the small intestine, and that appears to be involved in the regulation of metabolic homeostasis.  The protein was originally defined as an orphan receptor, but it has subsequently been shown to bind a variety of lipid-derived ligands, as well as a range of small synthetic mols.  There is still debate as to the identity of its principal endogenous ligand, but certain lysophospholipids species, various fatty acyl-ethanolamides and N-oleoyldopamine have all been proposed as potential agonists.  GPR119 is coupled to the signal transducer Gαs and activation of the receptor leads to increased adenylate cyclase activity via Gαs and a rise in intracellular cAMP.  This then potentiates glucose-induced insulin secretion or promotes the release of intestinal incretin hormones, according to cell type.  Both mechanisms ultimately lead to a rise in insulin secretion (either directly or indirectly) and improved glucose control.  Thus, GPR119 may represent an important new therapeutic target for the design of insulin secretagogues able to promote improvements in blood glucose control in patients with type 2 diabetes.  Accordingly, a range of lead compds. are in development as potential therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCF8Hp9CJ0irVg90H21EOLACvtfcHk0ljZThHqAaebNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1Squ7nN&md5=87b158bbda240cd2b595edb3b68dfefe</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDhayal%26aufirst%3DS.%26aulast%3DMorgan%26aufirst%3DN.%2BG.%26atitle%3DThe%2520Significance%2520of%2520GPR119%2520Agonists%2520as%2520a%2520Future%2520Treatment%2520for%2520Type%25202%2520Diabetes%26jtitle%3DDrug%2520News%2520Perspect.%26date%3D2010%26volume%3D23%26spage%3D418%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Gao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weng, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhagroo, N. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorenson, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Z.</span><span> </span><span class="NLM_article-title">Stimulating beta Cell Replication and Improving Islet Graft Function by GPR119 Agonists</span> <span class="citation_source-journal">Transplant Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1124</span><span class="NLM_x">–</span> <span class="NLM_lpage">1134</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm301626p&amp;key=10.1111%2Fj.1432-2277.2011.01332.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm301626p&amp;key=21902730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm301626p&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2rsbzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=1124-1134&author=J.+Gaoauthor=L.+Tianauthor=G.+Wengauthor=N.+V.+Bhagrooauthor=R.+L.+Sorensonauthor=T.+D.+O%E2%80%99Brienauthor=J.+Luoauthor=Z.+Guo&title=Stimulating+beta+Cell+Replication+and+Improving+Islet+Graft+Function+by+GPR119+Agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Stimulating beta cell replication and improving islet graft function GPR119 agonists</span></div><div class="casAuthors">Gao, Jie; Tian, Lei; Weng, Guobin; Bhagroo, Nicholas V.; Sorenson, Robert L.; O'Brien, Timothy D.; Luo, Jian; Guo, Zhiguang</div><div class="citationInfo"><span class="NLM_cas:title">Transplant International</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1124-1134</span>CODEN:
                <span class="NLM_cas:coden">TRINE5</span>;
        ISSN:<span class="NLM_cas:issn">0934-0874</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">G protein-coupled receptor 119 (GPR119) is predominantly expressed in β cells and intestinal L cells.  In this study, we investigated whether oleoylethanolamide (OEA), a GPR119 endogenous ligand, and PSN632408, a GPR119 synthetic agonist, can stimulate β-cell replication in vitro and in vivo and improve islet graft function in diabetic mice.  We found that OEA and PSN632408 significantly increased nos. of insulin+/5-bromo-2'-deoxyuridine (BrdU)+ β cells in cultured mouse islets in a dose-dependent manner.  All diabetic recipient mice, given marginal syngeneic islet transplants with OEA or PSN632408 or vehicle, achieved normoglycemia at 4 wk after transplantation.  However, normoglycemia was achieved significantly faster in OEA- or PSN632408-treated diabetic mice than in vehicle-treated diabetic mice (P < 0.05).  The percentage of insulin+/BrdU+ β cells in islet grafts in OEA- and PSN632408-treated mice was significantly higher than in vehicle-treated mice (P < 0.01).  Our data demonstrated that OEA and PSN632408 can stimulate β-cell replication in vitro and in vivo and improve islet graft function.  Targeting GPR119 is a novel therapeutic approach to increase β-cell mass and to improve islet graft function by stimulating β-cell replication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobMOzNy5VWoLVg90H21EOLACvtfcHk0lgz0S86QDTzHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2rsbzI&md5=0e70e491b52e5b734442ae0cf27c509d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-2277.2011.01332.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-2277.2011.01332.x%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DTian%26aufirst%3DL.%26aulast%3DWeng%26aufirst%3DG.%26aulast%3DBhagroo%26aufirst%3DN.%2BV.%26aulast%3DSorenson%26aufirst%3DR.%2BL.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DT.%2BD.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DZ.%26atitle%3DStimulating%2520beta%2520Cell%2520Replication%2520and%2520Improving%2520Islet%2520Graft%2520Function%2520by%2520GPR119%2520Agonists%26jtitle%3DTransplant%2520Int.%26date%3D2011%26volume%3D24%26spage%3D1124%26epage%3D1134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Katz, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gambale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothenberg, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanapalli, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaccaro, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polidori, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vets, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarich, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, P. P.</span><span> </span><span class="NLM_article-title">Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of JNJ-38431055, a Novel GPR119 Receptor Agonist and Potential Antidiabetes Agent, in Healthy Male Subjects</span> <span class="citation_source-journal">Clin. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">685</span><span class="NLM_x">–</span> <span class="NLM_lpage">692</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm301626p&amp;key=10.1038%2Fclpt.2011.169" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm301626p&amp;key=21975348" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm301626p&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlGlsLnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2011&pages=685-692&author=L.+B.+Katzauthor=J.+J.+Gambaleauthor=P.+L.+Rothenbergauthor=S.+R.+Vanapalliauthor=N.+Vaccaroauthor=L.+Xiauthor=D.+C.+Polidoriauthor=E.+Vetsauthor=T.+C.+Sarichauthor=P.+P.+Stein&title=Pharmacokinetics%2C+Pharmacodynamics%2C+Safety%2C+and+Tolerability+of+JNJ-38431055%2C+a+Novel+GPR119+Receptor+Agonist+and+Potential+Antidiabetes+Agent%2C+in+Healthy+Male+Subjects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of JNJ-38431055, a Novel GPR119 Receptor Agonist and Potential Antidiabetes Agent, in Healthy Male Subjects</span></div><div class="casAuthors">Katz, L. B.; Gambale, J. J.; Rothenberg, P. L.; Vanapalli, S. R.; Vaccaro, N.; Xi, L.; Polidori, D. C.; Vets, E.; Sarich, T. C.; Stein, P. P.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">685-692</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The incidence of type 2 diabetes mellitus is increasing worldwide.  Several G-protein-coupled receptor agonists are being studied for their efficacy as antidiabetes agents.  JNJ-38431055 is a novel, potent, and orally available selective agonist of the glucose-dependent insulinotropic (GPR119) receptor.  Double-blind, randomized, placebo-controlled studies were conducted to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of JNJ-38431055 (2.5-800 mg) in healthy male volunteers.  The systemic exposure of JNJ-38431055 in plasma increased in proportion to the dose and was not influenced by coadministration of food.  The terminal elimination half-life was ∼13 h when administered as an oral suspension formulation.  JNJ-38431055 was well tolerated and was not assocd. with hypoglycemia.  As compared with placebo, single-dose oral JNJ-38431055 increased postmeal plasma glucagon-like peptide 1 (GLP-1), glucose-dependent insulinotropic peptide (GIP), and peptide YY (PYY) concns. but did not significantly decrease glucose excursion or increase insulin secretion.  However, in a graded glucose infusion study, JNJ-38431055 was shown to induce a higher insulin secretion rate (ISR) relative to placebo at elevated plasma glucose levels.  These studies provide evidence for the potential efficacy of JNJ-38431055 as an antidiabetes agent in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu9J3wfDOF_LVg90H21EOLACvtfcHk0lgz0S86QDTzHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlGlsLnP&md5=a9345cd8b438a8568505c0ff327f522f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fclpt.2011.169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fclpt.2011.169%26sid%3Dliteratum%253Aachs%26aulast%3DKatz%26aufirst%3DL.%2BB.%26aulast%3DGambale%26aufirst%3DJ.%2BJ.%26aulast%3DRothenberg%26aufirst%3DP.%2BL.%26aulast%3DVanapalli%26aufirst%3DS.%2BR.%26aulast%3DVaccaro%26aufirst%3DN.%26aulast%3DXi%26aufirst%3DL.%26aulast%3DPolidori%26aufirst%3DD.%2BC.%26aulast%3DVets%26aufirst%3DE.%26aulast%3DSarich%26aufirst%3DT.%2BC.%26aulast%3DStein%26aufirst%3DP.%2BP.%26atitle%3DPharmacokinetics%252C%2520Pharmacodynamics%252C%2520Safety%252C%2520and%2520Tolerability%2520of%2520JNJ-38431055%252C%2520a%2520Novel%2520GPR119%2520Receptor%2520Agonist%2520and%2520Potential%2520Antidiabetes%2520Agent%252C%2520in%2520Healthy%2520Male%2520Subjects%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D2011%26volume%3D90%26spage%3D685%26epage%3D692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Katz, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gambale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothenberg, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanapalli, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaccaro, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarich, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, P. P.</span><span> </span><span class="NLM_article-title">Effects of JNJ-38431055, a Novel GPR119 Receptor Agonist, in Randomized, Double-Blind, Placebo-Controlled Studies in Subjects with Type 2 Diabetes</span> <span class="citation_source-journal">Diabetes Obes. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=1-8&author=L.+B.+Katzauthor=J.+J.+Gambaleauthor=P.+L.+Rothenbergauthor=S.+R.+Vanapalliauthor=N.+Vaccaroauthor=L.+Xiauthor=T.+C.+Sarichauthor=P.+P.+Stein&title=Effects+of+JNJ-38431055%2C+a+Novel+GPR119+Receptor+Agonist%2C+in+Randomized%2C+Double-Blind%2C+Placebo-Controlled+Studies+in+Subjects+with+Type+2+Diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKatz%26aufirst%3DL.%2BB.%26aulast%3DGambale%26aufirst%3DJ.%2BJ.%26aulast%3DRothenberg%26aufirst%3DP.%2BL.%26aulast%3DVanapalli%26aufirst%3DS.%2BR.%26aulast%3DVaccaro%26aufirst%3DN.%26aulast%3DXi%26aufirst%3DL.%26aulast%3DSarich%26aufirst%3DT.%2BC.%26aulast%3DStein%26aufirst%3DP.%2BP.%26atitle%3DEffects%2520of%2520JNJ-38431055%252C%2520a%2520Novel%2520GPR119%2520Receptor%2520Agonist%252C%2520in%2520Randomized%252C%2520Double-Blind%252C%2520Placebo-Controlled%2520Studies%2520in%2520Subjects%2520with%2520Type%25202%2520Diabetes%26jtitle%3DDiabetes%2520Obes.%2520Metab.%26date%3D2012%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Semple, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruce, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sage, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebring, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, Z. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Shamma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grottick, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demarest, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. M.</span><span> </span><span class="NLM_article-title">Discovery of a Second Generation Agonist of the Orphan G-Protein Coupled Receptor GPR119 with an Improved Profile</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1750</span><span class="NLM_x">–</span> <span class="NLM_lpage">1755</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1750-1755&author=G.+Sempleauthor=J.+Lehmannauthor=A.+Wongauthor=A.+Renauthor=M.+Bruceauthor=Y.+J.+Shinauthor=C.+R.+Sageauthor=M.+Morganauthor=W.+C.+Chenauthor=K.+Sebringauthor=Z.+L.+Chuauthor=J.+N.+Leonardauthor=H.+Al-Shammaauthor=A.+J.+Grottickauthor=F.+Duauthor=Y.+Liangauthor=K.+Demarestauthor=R.+M.+Jones&title=Discovery+of+a+Second+Generation+Agonist+of+the+Orphan+G-Protein+Coupled+Receptor+GPR119+with+an+Improved+Profile"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSemple%26aufirst%3DG.%26aulast%3DLehmann%26aufirst%3DJ.%26aulast%3DWong%26aufirst%3DA.%26aulast%3DRen%26aufirst%3DA.%26aulast%3DBruce%26aufirst%3DM.%26aulast%3DShin%26aufirst%3DY.%2BJ.%26aulast%3DSage%26aufirst%3DC.%2BR.%26aulast%3DMorgan%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DW.%2BC.%26aulast%3DSebring%26aufirst%3DK.%26aulast%3DChu%26aufirst%3DZ.%2BL.%26aulast%3DLeonard%26aufirst%3DJ.%2BN.%26aulast%3DAl-Shamma%26aufirst%3DH.%26aulast%3DGrottick%26aufirst%3DA.%2BJ.%26aulast%3DDu%26aufirst%3DF.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DDemarest%26aufirst%3DK.%26aulast%3DJones%26aufirst%3DR.%2BM.%26atitle%3DDiscovery%2520of%2520a%2520Second%2520Generation%2520Agonist%2520of%2520the%2520Orphan%2520G-Protein%2520Coupled%2520Receptor%2520GPR119%2520with%2520an%2520Improved%2520Profile%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D1750%26epage%3D1755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Mascitti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClure, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guimarães, C. R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farley, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munchhof, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Futatsugi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavergne, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefker, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornelius, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonin, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span> </span><span class="NLM_article-title">Design and Evaluation of a 2-(2,3,6-Trifluorophenyl)acetamide Derivative as an Agonist of the GPR119 Receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1306</span><span class="NLM_x">–</span> <span class="NLM_lpage">1309</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=1306-1309&author=V.+Mascittiauthor=B.+D.+Stevensauthor=C.+Choiauthor=K.+F.+McClureauthor=C.+R.+W.+Guimar%C3%A3esauthor=K.+A.+Farleyauthor=M.+J.+Munchhofauthor=R.+P.+Robinsonauthor=K.+Futatsugiauthor=S.+Y.+Lavergneauthor=B.+A.+Lefkerauthor=P.+Corneliusauthor=P.+D.+Boninauthor=A.+S.+Kalgutkarauthor=R.+Sharmaauthor=Y.+Chen&title=Design+and+Evaluation+of+a+2-%282%2C3%2C6-Trifluorophenyl%29acetamide+Derivative+as+an+Agonist+of+the+GPR119+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMascitti%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DB.%2BD.%26aulast%3DChoi%26aufirst%3DC.%26aulast%3DMcClure%26aufirst%3DK.%2BF.%26aulast%3DGuimar%25C3%25A3es%26aufirst%3DC.%2BR.%2BW.%26aulast%3DFarley%26aufirst%3DK.%2BA.%26aulast%3DMunchhof%26aufirst%3DM.%2BJ.%26aulast%3DRobinson%26aufirst%3DR.%2BP.%26aulast%3DFutatsugi%26aufirst%3DK.%26aulast%3DLavergne%26aufirst%3DS.%2BY.%26aulast%3DLefker%26aufirst%3DB.%2BA.%26aulast%3DCornelius%26aufirst%3DP.%26aulast%3DBonin%26aufirst%3DP.%2BD.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DY.%26atitle%3DDesign%2520and%2520Evaluation%2520of%2520a%25202-%25282%252C3%252C6-Trifluorophenyl%2529acetamide%2520Derivative%2520as%2520an%2520Agonist%2520of%2520the%2520GPR119%2520Receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D1306%26epage%3D1309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Brocklehurst, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butlin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidsson, Ö.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groombridge, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKerrecher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poucher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schofield, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teague, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westgate, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M. J. M.</span><span> </span><span class="NLM_article-title">Discovery, Optimisation and in Vivo Evaluation of Novel GPR119 Agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">7310</span><span class="NLM_x">–</span> <span class="NLM_lpage">7316</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=7310-7316&author=K.+J.+Brocklehurstauthor=A.+Brooauthor=R.+J.+Butlinauthor=H.+S.+Brownauthor=D.+S.+Clarkeauthor=%C3%96.+Davidssonauthor=K.+Goldbergauthor=S.+D.+Groombridgeauthor=E.+E.+Kellyauthor=A.+Leachauthor=D.+McKerrecherauthor=C.+O%E2%80%99Donnellauthor=S.+Poucherauthor=P.+Schofieldauthor=J.+S.+Scottauthor=J.+Teagueauthor=L.+Westgateauthor=M.+J.+M.+Wood&title=Discovery%2C+Optimisation+and+in+Vivo+Evaluation+of+Novel+GPR119+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrocklehurst%26aufirst%3DK.%2BJ.%26aulast%3DBroo%26aufirst%3DA.%26aulast%3DButlin%26aufirst%3DR.%2BJ.%26aulast%3DBrown%26aufirst%3DH.%2BS.%26aulast%3DClarke%26aufirst%3DD.%2BS.%26aulast%3DDavidsson%26aufirst%3D%25C3%2596.%26aulast%3DGoldberg%26aufirst%3DK.%26aulast%3DGroombridge%26aufirst%3DS.%2BD.%26aulast%3DKelly%26aufirst%3DE.%2BE.%26aulast%3DLeach%26aufirst%3DA.%26aulast%3DMcKerrecher%26aufirst%3DD.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%26aulast%3DPoucher%26aufirst%3DS.%26aulast%3DSchofield%26aufirst%3DP.%26aulast%3DScott%26aufirst%3DJ.%2BS.%26aulast%3DTeague%26aufirst%3DJ.%26aulast%3DWestgate%26aufirst%3DL.%26aulast%3DWood%26aufirst%3DM.%2BJ.%2BM.%26atitle%3DDiscovery%252C%2520Optimisation%2520and%2520in%2520Vivo%2520Evaluation%2520of%2520Novel%2520GPR119%2520Agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D7310%26epage%3D7316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Negoro, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yonetoku, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, M.</span><span> </span><span class="NLM_article-title">Synthesis and Structure–Activity Relationship of 4-Amino-2-phenylpyrimidine Derivatives as a Series of Novel GPR119 Agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2369</span><span class="NLM_x">–</span> <span class="NLM_lpage">2375</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=2369-2375&author=K.+Negoroauthor=Y.+Yonetokuauthor=T.+Maruyamaauthor=S.+Yoshidaauthor=M.+Takeuchiauthor=M.+Ohta&title=Synthesis+and+Structure%E2%80%93Activity+Relationship+of+4-Amino-2-phenylpyrimidine+Derivatives+as+a+Series+of+Novel+GPR119+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNegoro%26aufirst%3DK.%26aulast%3DYonetoku%26aufirst%3DY.%26aulast%3DMaruyama%26aufirst%3DT.%26aulast%3DYoshida%26aufirst%3DS.%26aulast%3DTakeuchi%26aufirst%3DM.%26aulast%3DOhta%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520Structure%25E2%2580%2593Activity%2520Relationship%2520of%25204-Amino-2-phenylpyrimidine%2520Derivatives%2520as%2520a%2520Series%2520of%2520Novel%2520GPR119%2520Agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D2369%26epage%3D2375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Negoro, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yonetoku, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misawa-Mukai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamaguchi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, M.</span><span> </span><span class="NLM_article-title">Discovery and Biological Evaluation of Novel 4-Amino-2-phenylpyrimidine Derivatives as Potent and Orally Active GPR119 Agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">5235</span><span class="NLM_x">–</span> <span class="NLM_lpage">5246</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=5235-5246&author=K.+Negoroauthor=Y.+Yonetokuauthor=H.+Misawa-Mukaiauthor=W.+Hamaguchiauthor=T.+Maruyamaauthor=S.+Yoshidaauthor=M.+Takeuchiauthor=M.+Ohta&title=Discovery+and+Biological+Evaluation+of+Novel+4-Amino-2-phenylpyrimidine+Derivatives+as+Potent+and+Orally+Active+GPR119+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNegoro%26aufirst%3DK.%26aulast%3DYonetoku%26aufirst%3DY.%26aulast%3DMisawa-Mukai%26aufirst%3DH.%26aulast%3DHamaguchi%26aufirst%3DW.%26aulast%3DMaruyama%26aufirst%3DT.%26aulast%3DYoshida%26aufirst%3DS.%26aulast%3DTakeuchi%26aufirst%3DM.%26aulast%3DOhta%26aufirst%3DM.%26atitle%3DDiscovery%2520and%2520Biological%2520Evaluation%2520of%2520Novel%25204-Amino-2-phenylpyrimidine%2520Derivatives%2520as%2520Potent%2520and%2520Orally%2520Active%2520GPR119%2520Agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D5235%26epage%3D5246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Negoro, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yonetoku, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moritomo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayakawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iikubo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, M.</span><span> </span><span class="NLM_article-title">Synthesis and Structure–Activity Relationship of Fused-Pyrimidine Derivatives as a Series of Novel GPR119 Agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">6442</span><span class="NLM_x">–</span> <span class="NLM_lpage">6451</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=6442-6451&author=K.+Negoroauthor=Y.+Yonetokuauthor=A.+Moritomoauthor=M.+Hayakawaauthor=K.+Iikuboauthor=S.+Yoshidaauthor=M.+Takeuchiauthor=M.+Ohta&title=Synthesis+and+Structure%E2%80%93Activity+Relationship+of+Fused-Pyrimidine+Derivatives+as+a+Series+of+Novel+GPR119+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNegoro%26aufirst%3DK.%26aulast%3DYonetoku%26aufirst%3DY.%26aulast%3DMoritomo%26aufirst%3DA.%26aulast%3DHayakawa%26aufirst%3DM.%26aulast%3DIikubo%26aufirst%3DK.%26aulast%3DYoshida%26aufirst%3DS.%26aulast%3DTakeuchi%26aufirst%3DM.%26aulast%3DOhta%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520Structure%25E2%2580%2593Activity%2520Relationship%2520of%2520Fused-Pyrimidine%2520Derivatives%2520as%2520a%2520Series%2520of%2520Novel%2520GPR119%2520Agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D6442%26epage%3D6451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Hansen, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenkilde, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knop, F. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wellner, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diep, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rehfeld, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, U. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holst, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, H. S.</span><span> </span><span class="NLM_article-title">2-Oleoyl Glycerol Is a GPR119 Agonist and Signals GLP-1 Release in Humans</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">E1409</span><span class="NLM_x">–</span> <span class="NLM_lpage">1417</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2011&pages=E1409-1417&author=K.+B.+Hansenauthor=M.+M.+Rosenkildeauthor=F.+K.+Knopauthor=N.+Wellnerauthor=T.+A.+Diepauthor=J.+F.+Rehfeldauthor=U.+B.+Andersenauthor=J.+J.+Holstauthor=H.+S.+Hansen&title=2-Oleoyl+Glycerol+Is+a+GPR119+Agonist+and+Signals+GLP-1+Release+in+Humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DRosenkilde%26aufirst%3DM.%2BM.%26aulast%3DKnop%26aufirst%3DF.%2BK.%26aulast%3DWellner%26aufirst%3DN.%26aulast%3DDiep%26aufirst%3DT.%2BA.%26aulast%3DRehfeld%26aufirst%3DJ.%2BF.%26aulast%3DAndersen%26aufirst%3DU.%2BB.%26aulast%3DHolst%26aufirst%3DJ.%2BJ.%26aulast%3DHansen%26aufirst%3DH.%2BS.%26atitle%3D2-Oleoyl%2520Glycerol%2520Is%2520a%2520GPR119%2520Agonist%2520and%2520Signals%2520GLP-1%2520Release%2520in%2520Humans%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2011%26volume%3D96%26spage%3DE1409%26epage%3D1417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Kogure, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiyamuta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kojima, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, S.</span><span> </span><span class="NLM_article-title">5-Hydroxy-eicosapentaenoic Acid Is an Endogenous GPR119 Agonist and Enhances Glucose-Dependent Insulin Secretion</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">416</span><span class="NLM_x">, </span> <span class="NLM_fpage">58</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=416&publication_year=2011&pages=58-63&author=R.+Kogureauthor=K.+Toyamaauthor=S.+Hiyamutaauthor=I.+Kojimaauthor=S.+Takeda&title=5-Hydroxy-eicosapentaenoic+Acid+Is+an+Endogenous+GPR119+Agonist+and+Enhances+Glucose-Dependent+Insulin+Secretion"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKogure%26aufirst%3DR.%26aulast%3DToyama%26aufirst%3DK.%26aulast%3DHiyamuta%26aufirst%3DS.%26aulast%3DKojima%26aufirst%3DI.%26aulast%3DTakeda%26aufirst%3DS.%26atitle%3D5-Hydroxy-eicosapentaenoic%2520Acid%2520Is%2520an%2520Endogenous%2520GPR119%2520Agonist%2520and%2520Enhances%2520Glucose-Dependent%2520Insulin%2520Secretion%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2011%26volume%3D416%26spage%3D58%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">McClure, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darout, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guimarães, C. R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeNinno, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mascitti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munchhof, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohrt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samp, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefker, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Futatsugi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonin, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornelius, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salter, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornby, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span> </span><span class="NLM_article-title">Activation of the G-Protein-Coupled Receptor 119: A Conformation-Based Hypothesis for Understanding Agonist Response</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1948</span><span class="NLM_x">–</span> <span class="NLM_lpage">1952</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200003p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1948-1952&author=K.+F.+McClureauthor=E.+Daroutauthor=C.+R.+W.+Guimar%C3%A3esauthor=M.+P.+DeNinnoauthor=V.+Mascittiauthor=M.+J.+Munchhofauthor=R.+P.+Robinsonauthor=J.+Kohrtauthor=A.+R.+Harrisauthor=D.+E.+Mooreauthor=B.+Liauthor=L.+Sampauthor=B.+A.+Lefkerauthor=K.+Futatsugiauthor=D.+Kungauthor=P.+D.+Boninauthor=P.+Corneliusauthor=R.+Wangauthor=E.+Salterauthor=S.+Hornbyauthor=A.+S.+Kalgutkarauthor=Y.+Chen&title=Activation+of+the+G-Protein-Coupled+Receptor+119%3A+A+Conformation-Based+Hypothesis+for+Understanding+Agonist+Response"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm200003p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200003p%26sid%3Dliteratum%253Aachs%26aulast%3DMcClure%26aufirst%3DK.%2BF.%26aulast%3DDarout%26aufirst%3DE.%26aulast%3DGuimar%25C3%25A3es%26aufirst%3DC.%2BR.%2BW.%26aulast%3DDeNinno%26aufirst%3DM.%2BP.%26aulast%3DMascitti%26aufirst%3DV.%26aulast%3DMunchhof%26aufirst%3DM.%2BJ.%26aulast%3DRobinson%26aufirst%3DR.%2BP.%26aulast%3DKohrt%26aufirst%3DJ.%26aulast%3DHarris%26aufirst%3DA.%2BR.%26aulast%3DMoore%26aufirst%3DD.%2BE.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DSamp%26aufirst%3DL.%26aulast%3DLefker%26aufirst%3DB.%2BA.%26aulast%3DFutatsugi%26aufirst%3DK.%26aulast%3DKung%26aufirst%3DD.%26aulast%3DBonin%26aufirst%3DP.%2BD.%26aulast%3DCornelius%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DSalter%26aufirst%3DE.%26aulast%3DHornby%26aufirst%3DS.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DChen%26aufirst%3DY.%26atitle%3DActivation%2520of%2520the%2520G-Protein-Coupled%2520Receptor%2520119%253A%2520A%2520Conformation-Based%2520Hypothesis%2520for%2520Understanding%2520Agonist%2520Response%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1948%26epage%3D1952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="note"><p class="first last">A moniker proposed by R. Robinson.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Banister, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoo, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chua, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassiou, M.</span><span> </span><span class="NLM_article-title"><i>N</i>-Arylalkyl-2-azaadamantanes as Cage-Expanded Polycarbocyclic sigma (σ) Receptor Ligands</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">5289</span><span class="NLM_x">–</span> <span class="NLM_lpage">5292</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=5289-5292&author=S.+D.+Banisterauthor=D.+T.+Yooauthor=S.+W.+Chuaauthor=J.+Cuiauthor=R.+H.+Machauthor=M.+Kassiou&title=N-Arylalkyl-2-azaadamantanes+as+Cage-Expanded+Polycarbocyclic+sigma+%28%CF%83%29+Receptor+Ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBanister%26aufirst%3DS.%2BD.%26aulast%3DYoo%26aufirst%3DD.%2BT.%26aulast%3DChua%26aufirst%3DS.%2BW.%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DKassiou%26aufirst%3DM.%26atitle%3DN-Arylalkyl-2-azaadamantanes%2520as%2520Cage-Expanded%2520Polycarbocyclic%2520sigma%2520%2528%25CF%2583%2529%2520Receptor%2520Ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D5289%26epage%3D5292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Yamauchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiwara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashiyama, K.</span><span> </span><span class="NLM_article-title">Concise Total Synthesis of (−)-Deoxocuscohygrine and (−)-Dihydrocuscohygrine</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">9784</span><span class="NLM_x">–</span> <span class="NLM_lpage">9787</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo801700f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=9784-9787&author=T.+Yamauchiauthor=S.+Hagiwaraauthor=K.+Higashiyama&title=Concise+Total+Synthesis+of+%28%E2%88%92%29-Deoxocuscohygrine+and+%28%E2%88%92%29-Dihydrocuscohygrine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjo801700f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo801700f%26sid%3Dliteratum%253Aachs%26aulast%3DYamauchi%26aufirst%3DT.%26aulast%3DHagiwara%26aufirst%3DS.%26aulast%3DHigashiyama%26aufirst%3DK.%26atitle%3DConcise%2520Total%2520Synthesis%2520of%2520%2528%25E2%2588%2592%2529-Deoxocuscohygrine%2520and%2520%2528%25E2%2588%2592%2529-Dihydrocuscohygrine%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2008%26volume%3D73%26spage%3D9784%26epage%3D9787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Momose, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toshima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koike, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyooka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirai, Y.</span><span> </span><span class="NLM_article-title">Bicyclo[3.3.1]nonanes as Synthetic Intermediates. Part 20.1 Asymmetric Synthesis of the Indolizidine Alkaloids Monomorine I and Indolizidine 223AB</span> <span class="citation_source-journal">J. Chem. Soc., Perkin Trans. 1</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_fpage">1315</span><span class="NLM_x">–</span> <span class="NLM_lpage">1322</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&pages=1315-1322&author=T.+Momoseauthor=M.+Toshimaauthor=S.+Sekiauthor=Y.+Koikeauthor=N.+Toyookaauthor=Y.+Hirai&title=Bicyclo%5B3.3.1%5Dnonanes+as+Synthetic+Intermediates.+Part+20.1+Asymmetric+Synthesis+of+the+Indolizidine+Alkaloids+Monomorine+I+and+Indolizidine+223AB"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMomose%26aufirst%3DT.%26aulast%3DToshima%26aufirst%3DM.%26aulast%3DSeki%26aufirst%3DS.%26aulast%3DKoike%26aufirst%3DY.%26aulast%3DToyooka%26aufirst%3DN.%26aulast%3DHirai%26aufirst%3DY.%26atitle%3DBicyclo%255B3.3.1%255Dnonanes%2520as%2520Synthetic%2520Intermediates.%2520Part%252020.1%2520Asymmetric%2520Synthesis%2520of%2520the%2520Indolizidine%2520Alkaloids%2520Monomorine%2520I%2520and%2520Indolizidine%2520223AB%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25201%26date%3D1997%26spage%3D1315%26epage%3D1322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Zaveri, N., T.; Jiang, F.; Toll, L.</span> Nicotinic Acetylcholine Receptor Modulators. WO11085389,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Zaveri%2C+N.%2C+T.%3B+Jiang%2C+F.%3B+Toll%2C+L.+Nicotinic+Acetylcholine+Receptor+Modulators.+WO11085389%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DZaveri%26aufirst%3DN.%252C%2BT.%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Berdini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cesta, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Anniballe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bello, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nano, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Topai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allegretti, M.</span><span> </span><span class="NLM_article-title">A Modified Palladium Catalysed Reductive Amination Procedure</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">5669</span><span class="NLM_x">–</span> <span class="NLM_lpage">5674</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm301626p&amp;key=10.1016%2FS0040-4020%2802%2900530-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm301626p&amp;key=1%3ACAS%3A528%3ADC%252BD38XltVahu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2002&pages=5669-5674&author=V.+Berdiniauthor=M.+C.+Cestaauthor=R.+Curtiauthor=G.+D%E2%80%99Anniballeauthor=N.+D.+Belloauthor=G.+Nanoauthor=L.+Nicoliniauthor=A.+Topaiauthor=M.+Allegretti&title=A+Modified+Palladium+Catalysed+Reductive+Amination+Procedure"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">A modified palladium-catalyzed reductive amination procedure</span></div><div class="casAuthors">Berdini, Valerio; Cesta, Maria C.; Curti, Roberto; D'Anniballe, Gaetano; Di Bello, Nicoletta; Nano, Giuseppe; Nicolini, Luca; Topai, Alessandra; Allegretti, Marcello</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">5669-5674</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">New, extended applications of a modified palladium catalyzed reductive amination procedure are described; a mechanistic hypothesis alternative to the common imine pathway is proposed.  This versatile method advances the usual reductive amination processes in terms of yield and shows high stereoselectivity whether applied to constrained carbonyl compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXGlgJ-iz6mbVg90H21EOLACvtfcHk0liwTNgcV5-eaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltVahu7g%253D&md5=ccb0c1cc49c1516756839f6372530780</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2802%2900530-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252802%252900530-6%26sid%3Dliteratum%253Aachs%26aulast%3DBerdini%26aufirst%3DV.%26aulast%3DCesta%26aufirst%3DM.%2BC.%26aulast%3DCurti%26aufirst%3DR.%26aulast%3DD%25E2%2580%2599Anniballe%26aufirst%3DG.%26aulast%3DBello%26aufirst%3DN.%2BD.%26aulast%3DNano%26aufirst%3DG.%26aulast%3DNicolini%26aufirst%3DL.%26aulast%3DTopai%26aufirst%3DA.%26aulast%3DAllegretti%26aufirst%3DM.%26atitle%3DA%2520Modified%2520Palladium%2520Catalysed%2520Reductive%2520Amination%2520Procedure%26jtitle%3DTetrahedron%26date%3D2002%26volume%3D58%26spage%3D5669%26epage%3D5674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Turconi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicola, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gil Quintero, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maiocchi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Micheletti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giraldo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donetti, A.</span><span> </span><span class="NLM_article-title">Synthesis of a New Class of 2,3-Dihydro-2-oxo-1<i>H</i>-benzimidazole-1-carboxylic Acid Derivatives as Highly Potent 5-HT3 Receptor Antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">2101</span><span class="NLM_x">–</span> <span class="NLM_lpage">2108</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00170a009" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1990&pages=2101-2108&author=M.+Turconiauthor=M.+Nicolaauthor=M.+Gil+Quinteroauthor=L.+Maiocchiauthor=R.+Michelettiauthor=E.+Giraldoauthor=A.+Donetti&title=Synthesis+of+a+New+Class+of+2%2C3-Dihydro-2-oxo-1H-benzimidazole-1-carboxylic+Acid+Derivatives+as+Highly+Potent+5-HT3+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm00170a009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00170a009%26sid%3Dliteratum%253Aachs%26aulast%3DTurconi%26aufirst%3DM.%26aulast%3DNicola%26aufirst%3DM.%26aulast%3DGil%2BQuintero%26aufirst%3DM.%26aulast%3DMaiocchi%26aufirst%3DL.%26aulast%3DMicheletti%26aufirst%3DR.%26aulast%3DGiraldo%26aufirst%3DE.%26aulast%3DDonetti%26aufirst%3DA.%26atitle%3DSynthesis%2520of%2520a%2520New%2520Class%2520of%25202%252C3-Dihydro-2-oxo-1H-benzimidazole-1-carboxylic%2520Acid%2520Derivatives%2520as%2520Highly%2520Potent%25205-HT3%2520Receptor%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1990%26volume%3D33%26spage%3D2101%26epage%3D2108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Vernekar, S. K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallaq, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarkson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silvestri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lummis, S. C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lochner, M.</span><span> </span><span class="NLM_article-title">Toward Biophysical Probes for the 5-HT3 Receptor: Structure–Activity Relationship Study of Granisetron Derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2324</span><span class="NLM_x">–</span> <span class="NLM_lpage">2328</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901827x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2324-2328&author=S.+K.+V.+Vernekarauthor=H.+Y.+Hallaqauthor=G.+Clarksonauthor=A.+J.+Thompsonauthor=L.+Silvestriauthor=S.+C.+R.+Lummisauthor=M.+Lochner&title=Toward+Biophysical+Probes+for+the+5-HT3+Receptor%3A+Structure%E2%80%93Activity+Relationship+Study+of+Granisetron+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm901827x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901827x%26sid%3Dliteratum%253Aachs%26aulast%3DVernekar%26aufirst%3DS.%2BK.%2BV.%26aulast%3DHallaq%26aufirst%3DH.%2BY.%26aulast%3DClarkson%26aufirst%3DG.%26aulast%3DThompson%26aufirst%3DA.%2BJ.%26aulast%3DSilvestri%26aufirst%3DL.%26aulast%3DLummis%26aufirst%3DS.%2BC.%2BR.%26aulast%3DLochner%26aufirst%3DM.%26atitle%3DToward%2520Biophysical%2520Probes%2520for%2520the%25205-HT3%2520Receptor%253A%2520Structure%25E2%2580%2593Activity%2520Relationship%2520Study%2520of%2520Granisetron%2520Derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2324%26epage%3D2328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Dupeyre, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rassat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronzaud, J.</span><span> </span><span class="NLM_article-title">Nitroxides. LII. Synthesis and Electron Spin Resonance Studies of <i>N</i>,<i>N</i>′-Dioxy-2,6-diazaadamantane, a Symmetrical Ground State Triplet</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1974</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">6559</span><span class="NLM_x">–</span> <span class="NLM_lpage">6568</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00828a004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1974&pages=6559-6568&author=R.+M.+Dupeyreauthor=A.+Rassatauthor=J.+Ronzaud&title=Nitroxides.+LII.+Synthesis+and+Electron+Spin+Resonance+Studies+of+N%2CN%E2%80%B2-Dioxy-2%2C6-diazaadamantane%2C+a+Symmetrical+Ground+State+Triplet"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fja00828a004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00828a004%26sid%3Dliteratum%253Aachs%26aulast%3DDupeyre%26aufirst%3DR.%2BM.%26aulast%3DRassat%26aufirst%3DA.%26aulast%3DRonzaud%26aufirst%3DJ.%26atitle%3DNitroxides.%2520LII.%2520Synthesis%2520and%2520Electron%2520Spin%2520Resonance%2520Studies%2520of%2520N%252CN%25E2%2580%25B2-Dioxy-2%252C6-diazaadamantane%252C%2520a%2520Symmetrical%2520Ground%2520State%2520Triplet%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1974%26volume%3D96%26spage%3D6559%26epage%3D6568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelsen, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalilov, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzei, I. A.</span><span> </span><span class="NLM_article-title"><i>O</i>-Capped Heteroadamantyl-Substituted Hydrazines and Their Oxidation Products</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">2445</span><span class="NLM_x">–</span> <span class="NLM_lpage">2452</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo100294u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm301626p&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtlajsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2010&pages=2445-2452&author=G.+Liauthor=S.+F.+Nelsenauthor=A.+S.+Jalilovauthor=I.+A.+Guzei&title=O-Capped+Heteroadamantyl-Substituted+Hydrazines+and+Their+Oxidation+Products"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">O-Capped Heteroadamantyl-Substituted Hydrazines and Their Oxidation Products</span></div><div class="casAuthors">Li, Gaoquan; Nelsen, Stephen F.; Jalilov, Almaz S.; Guzei, Ilia A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2445-2452</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">(Image Omited) The mixed valence bishydrazine radical cation 6+, obtained by oxidn. of 2,6-bi-(2'-oxa-6'-azaadamantane-6'-yl)-2,6-diazaadamantane-2,6-diyl (I;6) with silver or nitrosonium salts, has been prepd. and studied. 6 is obtained along with lesser amts. of the trishydrazine, some of the tetrahydrazine, and apparently traces of the pentahydrazine upon reaction of deprotonated 2-oxa-6-azaadamantane with 2,6-dichloro-2,6-diazaadamantane.  The EPR spectrum of 6+ shows that its charge is localized on one hydrazine unit on the EPR time scale.  It shows a Hush-type Robin-Day class II mixed valence band in its optical spectrum despite the fact that the nitrogen lone pairs are held in a perpendicular geometry that would lead to no electronic interaction between the nitrogen atoms that are sepd. by only four σ bonds if its nitrogens were planar.  The electron transfer distance that is estd. from the calcd. dipole moment of 6+ is the same as that obtained using the av. distance between the electrons of the triplet state of the dication 62+, calcd. from its dipolar EPR splitting, as a model for the electron transfer distance of 6+, 3.7 Å.  Using Hush's Gaussian approxn. for the optical spectrum with this electron transfer distance produces an est. of the electronic coupling Vab through the satd. bridge of about 400 cm-1, which is consistent with the obsd. EPR spectrum of 6+.  From the obsd. dipolar splitting, the trishydrazine diradical dication has its remote hydrazine units oxidized, although the monocation presumably forms at the central hydrazine unit, which lacks substitution by the more electron-withdrawing oxygen atoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJek_3-uI0wbVg90H21EOLACvtfcHk0lg5fi_UkX595w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtlajsLc%253D&md5=f3e44fb4e173cb69a841145b02121f55</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjo100294u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo100294u%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DG.%26aulast%3DNelsen%26aufirst%3DS.%2BF.%26aulast%3DJalilov%26aufirst%3DA.%2BS.%26aulast%3DGuzei%26aufirst%3DI.%2BA.%26atitle%3DO-Capped%2520Heteroadamantyl-Substituted%2520Hydrazines%2520and%2520Their%2520Oxidation%2520Products%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2010%26volume%3D75%26spage%3D2445%26epage%3D2452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Stella, L.</span><span> </span><span class="NLM_article-title">Homolytic Cyclizations of <i>N</i>-Chloroalkenylamines</span> <span class="citation_source-journal">Angew. Chem., Int. Ed. Engl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">422</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm301626p&amp;key=10.1002%2Fanie.198303373" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1983&pages=337-422&author=L.+Stella&title=Homolytic+Cyclizations+of+N-Chloroalkenylamines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fanie.198303373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.198303373%26sid%3Dliteratum%253Aachs%26aulast%3DStella%26aufirst%3DL.%26atitle%3DHomolytic%2520Cyclizations%2520of%2520N-Chloroalkenylamines%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%2520Engl.%26date%3D1983%26volume%3D22%26spage%3D337%26epage%3D422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Ban, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, M.</span><span> </span><span class="NLM_article-title">A Synthesis of 1,3-Diaza Heterocycles. A Hofmann–Löffler Type of Photocyclization in the Absence of Strong Acid</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm301626p&amp;key=1%3ACAS%3A528%3ADyaE28Xktlaqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1976&pages=201-202&author=Y.+Banauthor=M.+Kimura&title=A+Synthesis+of+1%2C3-Diaza+Heterocycles.+A+Hofmann%E2%80%93L%C3%B6ffler+Type+of+Photocyclization+in+the+Absence+of+Strong+Acid"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">A synthesis of 1,3-diaza heterocycles.  A Hofmann-Loeffler type of photocyclization in the absence of strong acid</span></div><div class="casAuthors">Kimura, Masayuki; Ban, Yoshio</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">201-2</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    </div><div class="casAbstract">Chloropiperidine (I, R = Cl), obtained from I (R = H) and N-chlorosuccinimide, or irradn. in situ in ether with a 300 W high pressure Hg lamp gave pyrimidine II in 50% yield; the yield was increased to almost 100% by carrying out the irradn. in the presence of Et3N.  Similarly III (R = H, Me; n = 2-4) were cyclized to IV and V was cyclized to VI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5H4zXQWtbqrVg90H21EOLACvtfcHk0lg5fi_UkX595w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28Xktlaqtrk%253D&md5=ce40357862d232612e256a57dcc7ae20</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBan%26aufirst%3DY.%26aulast%3DKimura%26aufirst%3DM.%26atitle%3DA%2520Synthesis%2520of%25201%252C3-Diaza%2520Heterocycles.%2520A%2520Hofmann%25E2%2580%2593L%25C3%25B6ffler%2520Type%2520of%2520Photocyclization%2520in%2520the%2520Absence%2520of%2520Strong%2520Acid%26jtitle%3DSynthesis%26date%3D1976%26spage%3D201%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Sommer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. M.</span><span> </span><span class="NLM_article-title">Synthetic Studies toward Paraherquamides E and F and Related <sup>13</sup>C-Labeled Putative Biosynthetic Intermediates: Stereocontrolled Synthesis of the α-Alkyl-β-methylproline Ring System</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">7106</span><span class="NLM_x">–</span> <span class="NLM_lpage">7111</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2008&pages=7106-7111&author=K.+Sommerauthor=R.+M.+Williams&title=Synthetic+Studies+toward+Paraherquamides+E+and+F+and+Related+13C-Labeled+Putative+Biosynthetic+Intermediates%3A+Stereocontrolled+Synthesis+of+the+%CE%B1-Alkyl-%CE%B2-methylproline+Ring+System"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSommer%26aufirst%3DK.%26aulast%3DWilliams%26aufirst%3DR.%2BM.%26atitle%3DSynthetic%2520Studies%2520toward%2520Paraherquamides%2520E%2520and%2520F%2520and%2520Related%252013C-Labeled%2520Putative%2520Biosynthetic%2520Intermediates%253A%2520Stereocontrolled%2520Synthesis%2520of%2520the%2520%25CE%25B1-Alkyl-%25CE%25B2-methylproline%2520Ring%2520System%26jtitle%3DTetrahedron%26date%3D2008%26volume%3D64%26spage%3D7106%26epage%3D7111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Olofson, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martz, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senet, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piteau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malfroot, T.</span><span> </span><span class="NLM_article-title">A New Reagent for the Selective, High-Yield N-Dealkylation of Tertiary Amines: Improved Syntheses of Naltrexone and Nalbuphine</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2081</span><span class="NLM_x">–</span> <span class="NLM_lpage">2082</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00185a072" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm301626p&amp;key=1%3ACAS%3A528%3ADyaL2cXktlyks7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1984&pages=2081-2082&author=R.+A.+Olofsonauthor=J.+T.+Martzauthor=J.+P.+Senetauthor=M.+Piteauauthor=T.+Malfroot&title=A+New+Reagent+for+the+Selective%2C+High-Yield+N-Dealkylation+of+Tertiary+Amines%3A+Improved+Syntheses+of+Naltrexone+and+Nalbuphine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">A new reagent for the selective, high-yield N-dealkylation of tertiary amines:  improved syntheses of naltrexone and nalbuphine</span></div><div class="casAuthors">Olofson, R. A.; Martz, Jonathan T.; Senet, Jean Pierre; Piteau, Marc; Malfroot, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2081-2</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">Reaction of tertiary amines with ClCO2CHClMe in ClCH2CH2Cl at reflux affords the intermediates, R2NCO2CHClMe (R = alkyl, R2 = cycloalkyl), which are converted to the desired salts, R2NH·HCl, just by heating in MeOH.  The N-dealkylation reagent is made in 96% yield by mixing MeCHO with COCl2 in the presence of an R4N+ Cl- catalyst.  The N-dealkylations are highly selective, mild, occur in high yield, and permit the presence of a variety of functionalities.  The process is exemplified by the conversion of glaucine (I) to the phenanthrene (II) in 89% yield and by the N-demethylations of arecoline, O-acetyltropine, and 6-acetylcodeine in yields of 95-97%.  The methodol. was used as part of a process for the transformation of oxycodone to the com. narcotic antagonist, naltrexone (58% overall yield) and to the prescription analgesic, nalbuphine (III) (69% overall yield).  Arom. tertiary amines also are N-dealkylated, although under more vigorous conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcSuAJiJApjLVg90H21EOLACvtfcHk0lg5fi_UkX595w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXktlyks7k%253D&md5=9402bfb15be7a0d057bfe7bf95bde7b6</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjo00185a072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00185a072%26sid%3Dliteratum%253Aachs%26aulast%3DOlofson%26aufirst%3DR.%2BA.%26aulast%3DMartz%26aufirst%3DJ.%2BT.%26aulast%3DSenet%26aufirst%3DJ.%2BP.%26aulast%3DPiteau%26aufirst%3DM.%26aulast%3DMalfroot%26aufirst%3DT.%26atitle%3DA%2520New%2520Reagent%2520for%2520the%2520Selective%252C%2520High-Yield%2520N-Dealkylation%2520of%2520Tertiary%2520Amines%253A%2520Improved%2520Syntheses%2520of%2520Naltrexone%2520and%2520Nalbuphine%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1984%26volume%3D49%26spage%3D2081%26epage%3D2082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Zhicai, Y.; Manning, D., D.</span> 2-Alkylbenzoxazole Carboxamides as 5HT<sub>3</sub> Modulators. WO2008019363,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Zhicai%2C+Y.%3B+Manning%2C+D.%2C+D.+2-Alkylbenzoxazole+Carboxamides+as+5HT3+Modulators.+WO2008019363%2C+2008."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DZhicai%26aufirst%3DY.%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Jones, R. M.; Semple, G.; Fioravanti, B.; Pereira, G.; Calderon, I.; Uy, J.; Duwuri, K.; Choi, J. S. K.; Xiong, Y.; Dave, V.</span><span> </span><span class="NLM_article-title">Preparation of 1,2,3-Trisubstituted Aryl and Heteroaryl Derivatives, in Particular Pyrimidines, as Modulators, in Particular Agonists and Inverse Agonists, of G-Coupled Protein Receptor and Their Use in the Prophylaxis and Treatment of Metabolic Disorder Such as Diabetes and Hyperglycemia</span>. WO2004065380,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=R.+M.+Jones&author=G.+Semple&author=B.+Fioravanti&author=G.+Pereira&author=I.+Calderon&author=J.+Uy&author=K.+Duwuri&author=J.+S.+K.+Choi&author=Y.+Xiong&author=V.+Dave&title=Preparation+of+1%2C2%2C3-Trisubstituted+Aryl+and+Heteroaryl+Derivatives%2C+in+Particular+Pyrimidines%2C+as+Modulators%2C+in+Particular+Agonists+and+Inverse+Agonists%2C+of+G-Coupled+Protein+Receptor+and+Their+Use+in+the+Prophylaxis+and+Treatment+of+Metabolic+Disorder+Such+as+Diabetes+and+Hyperglycemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DR.%2BM.%26atitle%3DPreparation%2520of%25201%252C2%252C3-Trisubstituted%2520Aryl%2520and%2520Heteroaryl%2520Derivatives%252C%2520in%2520Particular%2520Pyrimidines%252C%2520as%2520Modulators%252C%2520in%2520Particular%2520Agonists%2520and%2520Inverse%2520Agonists%252C%2520of%2520G-Coupled%2520Protein%2520Receptor%2520and%2520Their%2520Use%2520in%2520the%2520Prophylaxis%2520and%2520Treatment%2520of%2520Metabolic%2520Disorder%2520Such%2520as%2520Diabetes%2520and%2520Hyperglycemia%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shalaeva, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tupper, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, F.</span><span> </span><span class="NLM_article-title">ElogD<sub>oct</sub>: A Tool for Lipophilicity Determination in Drug Discovery. 2. Basic and Neutral Compounds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">2490</span><span class="NLM_x">–</span> <span class="NLM_lpage">2497</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0100990" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=2490-2497&author=F.+Lombardoauthor=M.+Y.+Shalaevaauthor=K.+A.+Tupperauthor=F.+Gao&title=ElogDoct%3A+A+Tool+for+Lipophilicity+Determination+in+Drug+Discovery.+2.+Basic+and+Neutral+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm0100990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0100990%26sid%3Dliteratum%253Aachs%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DShalaeva%26aufirst%3DM.%2BY.%26aulast%3DTupper%26aufirst%3DK.%2BA.%26aulast%3DGao%26aufirst%3DF.%26atitle%3DElogDoct%253A%2520A%2520Tool%2520for%2520Lipophilicity%2520Determination%2520in%2520Drug%2520Discovery.%25202.%2520Basic%2520and%2520Neutral%2520Compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D2490%26epage%3D2497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Scott, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birch, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brocklehurst, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butlin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidsson, Ö.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ertan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groombridge, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laber, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacFaul, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKerrecher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickup, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schofield, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sörme, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teague, J.</span><span> </span><span class="NLM_article-title">Use of Small-Molecule Crystal Structures To Address Solubility in a Novel Series of G Protein Coupled Receptor 119 Agonists: Optimization of a Lead and in Vivo Evaluation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">5361</span><span class="NLM_x">–</span> <span class="NLM_lpage">5379</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300310c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm301626p&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1Oqt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5361-5379&author=J.+S.+Scottauthor=A.+M.+Birchauthor=K.+J.+Brocklehurstauthor=A.+Brooauthor=H.+S.+Brownauthor=R.+J.+Butlinauthor=D.+S.+Clarkeauthor=%C3%96.+Davidssonauthor=A.+Ertanauthor=K.+Goldbergauthor=S.+D.+Groombridgeauthor=J.+A.+Hudsonauthor=D.+Laberauthor=A.+G.+Leachauthor=P.+A.+MacFaulauthor=D.+McKerrecherauthor=A.+Pickupauthor=P.+Schofieldauthor=P.+H.+Svenssonauthor=P.+S%C3%B6rmeauthor=J.+Teague&title=Use+of+Small-Molecule+Crystal+Structures+To+Address+Solubility+in+a+Novel+Series+of+G+Protein+Coupled+Receptor+119+Agonists%3A+Optimization+of+a+Lead+and+in+Vivo+Evaluation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Use of Small-Molecule Crystal Structures To Address Solubility in a Novel Series of G Protein Coupled Receptor 119 Agonists: Optimization of a Lead and in Vivo Evaluation</span></div><div class="casAuthors">Scott, James S.; Birch, Alan M.; Brocklehurst, Katy J.; Broo, Anders; Brown, Hayley S.; Butlin, Roger J.; Clarke, David S.; Davidsson, Ojvind; Ertan, Anne; Goldberg, Kristin; Groombridge, Sam D.; Hudson, Julian A.; Laber, David; Leach, Andrew G.; MacFaul, Philip A.; McKerrecher, Darren; Pickup, Adrian; Schofield, Paul; Svensson, Per H.; Sorme, Pernilla; Teague, Joanne</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5361-5379</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">G protein coupled receptor 119 (GPR119) is viewed as an attractive target for the treatment of type 2 diabetes and other elements of the metabolic syndrome.  During a program toward discovering agonists of GPR119, we herein describe optimization of an initial lead compd., 2, into a development candidate, 42.  A key challenge in this program of work was the insoly. of the lead compd.  Small-mol. crystallog. was utilized to understand the intermol. interactions in the solid state and resulted in a switch from an aryl sulfone to a 3-cyanopyridyl motif.  The compd. was shown to be effective in wild-type but not knockout animals, confirming that the biol. effects were due to GPR119 agonism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXZ_DoHJ0cfrVg90H21EOLACvtfcHk0lghvZmYnSWO7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1Oqt78%253D&md5=3cd34d57e05864ddcc87c51f034f9188</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm300310c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300310c%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DJ.%2BS.%26aulast%3DBirch%26aufirst%3DA.%2BM.%26aulast%3DBrocklehurst%26aufirst%3DK.%2BJ.%26aulast%3DBroo%26aufirst%3DA.%26aulast%3DBrown%26aufirst%3DH.%2BS.%26aulast%3DButlin%26aufirst%3DR.%2BJ.%26aulast%3DClarke%26aufirst%3DD.%2BS.%26aulast%3DDavidsson%26aufirst%3D%25C3%2596.%26aulast%3DErtan%26aufirst%3DA.%26aulast%3DGoldberg%26aufirst%3DK.%26aulast%3DGroombridge%26aufirst%3DS.%2BD.%26aulast%3DHudson%26aufirst%3DJ.%2BA.%26aulast%3DLaber%26aufirst%3DD.%26aulast%3DLeach%26aufirst%3DA.%2BG.%26aulast%3DMacFaul%26aufirst%3DP.%2BA.%26aulast%3DMcKerrecher%26aufirst%3DD.%26aulast%3DPickup%26aufirst%3DA.%26aulast%3DSchofield%26aufirst%3DP.%26aulast%3DSvensson%26aufirst%3DP.%2BH.%26aulast%3DS%25C3%25B6rme%26aufirst%3DP.%26aulast%3DTeague%26aufirst%3DJ.%26atitle%3DUse%2520of%2520Small-Molecule%2520Crystal%2520Structures%2520To%2520Address%2520Solubility%2520in%2520a%2520Novel%2520Series%2520of%2520G%2520Protein%2520Coupled%2520Receptor%2520119%2520Agonists%253A%2520Optimization%2520of%2520a%2520Lead%2520and%2520in%2520Vivo%2520Evaluation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5361%26epage%3D5379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springthorpe, B.</span><span> </span><span class="NLM_article-title">The Influence of Drug-like Concepts on Decision-Making in Medicinal Chemistry</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm301626p&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm301626p&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm301626p&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+Influence+of+Drug-like+Concepts+on+Decision-Making+in+Medicinal+Chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0lghvZmYnSWO7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520Influence%2520of%2520Drug-like%2520Concepts%2520on%2520Decision-Making%2520in%2520Medicinal%2520Chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Leach, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hann, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffen, E. J.</span><span> </span><span class="NLM_article-title">Fragment Screening: An Introduction</span> <span class="citation_source-journal">Mol BioSyst</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">446</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm301626p&amp;key=10.1039%2Fb610069b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm301626p&amp;key=17153140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm301626p&amp;key=1%3ACAS%3A280%3ADC%252BD28jhs1Gntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=430-446&author=A.+R.+Leachauthor=M.+M.+Hannauthor=J.+N.+Burrowsauthor=E.+J.+Griffen&title=Fragment+Screening%3A+An+Introduction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment screening: an introduction</span></div><div class="casAuthors">Leach Andrew R; Hann Michael M; Burrows Jeremy N; Griffen Ed J</div><div class="citationInfo"><span class="NLM_cas:title">Molecular bioSystems</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">430-46</span>
        ISSN:<span class="NLM_cas:issn">1742-206X</span>.
    </div><div class="casAbstract">There are clearly many different philosophies associated with adapting fragment screening into mainstream Drug Discovery Lead Generation strategies.  Scientists at Astex, for instance, focus entirely on strategies involving use of X-ray crystallography and NMR.  However, AstraZeneca uses a number of different fragment screening strategies.  One approach is to screen a 2000 compound fragment set (with close to "lead-like" complexity) at 100 microM in parallel with every HTS such that the data are obtained on the entire screening collection at 10 microM plus the extra samples at 100 microM; this provides valuable compound potency data in a concentration range that is usually unexplored.  The fragments are then screen-specific "privileged structures" that can be searched for in the rest of the HTS output and other databases as well as having synthesis follow-up.  A typical workflow for a fragment screen within AstraZeneca is shown below (Figure 24) and highlights the desirability (particularly when screening >100 microM) for NMR and X-ray information to validate weak hits and give information on how to optimise them.  In this chapter, we have provided an introduction to the theoretical and practical issues associated with the use of fragment methods and lead-likeness.  Fragment-based approaches are still in an early stage of development and are just one of many interrelated techniques that are now used to identify novel lead compounds for drug development.  Fragment based screening has some advantages, but like every other drug hunting strategy will not be universally applicable.  There are in particular some practical challenges associated with fragment screening that relate to the generally lower level of potency that such compounds initially possess.  Considerable synthetic effort has to be applied for post-fragment screening to build the sort of potency that would be expected to be found from a traditional HTS.  However, if there are no low-hanging fruit in a screening collection to be found by HTS then the use of fragment screening can help find novelty that may lead to a target not being discarded as intractable.  As such, the approach offers some significant advantages by providing less complex molecules, which may have better potential for novel drug optimisation and by enabling new chemical space to be more effectively explored.  Many literature examples that cover examples of fragment screening approaches are still at the "proof of concept" stage and although delivering inhibitors or ligands, may still prove to be unsuitable when further ADMET and toxicity profiling is done.  The next few years should see a maturing of the area, and as our understanding of how the concepts can be best applied, there are likely to be many more examples of attractive, small molecule hits, leads and candidate drugs derived from the approaches described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQlsCStQZNnJwaK-_ZudimnfW6udTcc2eYNbIS1OS9y1Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28jhs1Gntw%253D%253D&md5=775fb6b69a537ca76bc87dc309459fe4</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1039%2Fb610069b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb610069b%26sid%3Dliteratum%253Aachs%26aulast%3DLeach%26aufirst%3DA.%2BR.%26aulast%3DHann%26aufirst%3DM.%2BM.%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DGriffen%26aufirst%3DE.%2BJ.%26atitle%3DFragment%2520Screening%253A%2520An%2520Introduction%26jtitle%3DMol%2520BioSyst%26date%3D2006%26volume%3D2%26spage%3D430%26epage%3D446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">McClure, K. F.</span><span> </span><span class="NLM_article-title">GPR119: Expanding Your Lead Options by Changing the Constant</span>. Presented at the 7th Annual Meeting of Discovery on Target, GPCR-Based Drug Discovery, Boston, MA, October 2,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=K.+F.+McClure&title=GPR119%3A+Expanding+Your+Lead+Options+by+Changing+the+Constant"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DMcClure%26aufirst%3DK.%2BF.%26atitle%3DGPR119%253A%2520Expanding%2520Your%2520Lead%2520Options%2520by%2520Changing%2520the%2520Constant%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Kuntz, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kollman, P. A.</span><span> </span><span class="NLM_article-title">The Maximal Affinity of Ligands</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">9997</span><span class="NLM_x">–</span> <span class="NLM_lpage">10002</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm301626p&amp;key=10.1073%2Fpnas.96.18.9997" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm301626p&amp;key=10468550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm301626p&amp;key=1%3ACAS%3A528%3ADyaK1MXlvFehu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=9997-10002&author=I.+D.+Kuntzauthor=K.+Chenauthor=K.+A.+Sharpauthor=P.+A.+Kollman&title=The+Maximal+Affinity+of+Ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">The maximal affinity of ligands</span></div><div class="casAuthors">Kuntz, I. D.; Chen, K.; Sharp, K. A.; Kollman, P. A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">9997-10002</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">We explore the question of what are the best ligands for macromol. targets.  A survey of exptl. data on a large no. of the strongest-binding ligands indicates that the free energy of binding increases with the no. of nonhydrogen atoms with an initial slope of ≈-1.5 kcal/mol (1 cal = 4.18 J) per atom.  For ligands that contain more than 15 nonhydrogen atoms, the free energy of binding increases very little with relative mol. mass.  This nonlinearity is largely ascribed to nonthermodynamic factors.  An anal. of the dominant interactions suggests that van der Waals interactions and hydrophobic effects provide a reasonable basis for understanding binding affinities across the entire set of ligands.  Interesting outliers that bind unusually strongly on a per atom basis include metal ions, covalently attached ligands, and a few well known complexes such as biotin-avidin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0L6KZhR0TxbVg90H21EOLACvtfcHk0liZ2qNIpj9iNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvFehu7s%253D&md5=46fe894b016f3041831a2f0b71f812b1</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1073%2Fpnas.96.18.9997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.96.18.9997%26sid%3Dliteratum%253Aachs%26aulast%3DKuntz%26aufirst%3DI.%2BD.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DSharp%26aufirst%3DK.%2BA.%26aulast%3DKollman%26aufirst%3DP.%2BA.%26atitle%3DThe%2520Maximal%2520Affinity%2520of%2520Ligands%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1999%26volume%3D96%26spage%3D9997%26epage%3D10002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand Efficiency: A Useful Metric for Lead Selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm301626p&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm301626p&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm301626p&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+Efficiency%3A+A+Useful+Metric+for+Lead+Selection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2eYNbIS1OS9y1Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520Efficiency%253A%2520A%2520Useful%2520Metric%2520for%2520Lead%2520Selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Ryckmans, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correia, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tutt, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, T.</span><span> </span><span class="NLM_article-title">Rapid Assessment of a Novel Series of Selective CB(2) Agonists Using Parallel Synthesis Protocols: A Lipophilic Efficiency (LipE) Analysis</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4406</span><span class="NLM_x">–</span> <span class="NLM_lpage">4409</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm301626p&amp;key=10.1016%2Fj.bmcl.2009.05.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm301626p&amp;key=19500981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm301626p&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVGlsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4406-4409&author=T.+Ryckmansauthor=M.+P.+Edwardsauthor=V.+A.+Horneauthor=A.+M.+Correiaauthor=D.+R.+Owenauthor=L.+R.+Thompsonauthor=I.+Tranauthor=M.+F.+Tuttauthor=T.+Young&title=Rapid+Assessment+of+a+Novel+Series+of+Selective+CB%282%29+Agonists+Using+Parallel+Synthesis+Protocols%3A+A+Lipophilic+Efficiency+%28LipE%29+Analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid assessment of a novel series of selective CB2 agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis</span></div><div class="casAuthors">Ryckmans, Thomas; Edwards, Martin P.; Horne, Val A.; Correia, Ana Monica; Owen, Dafydd R.; Thompson, Lisa R.; Tran, Isabelle; Tutt, Michelle F.; Young, Tim</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4406-4409</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of libraries were designed using the 1-(cyclopropylmethyl)-2-alkyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-5-ium templates 2a-b, and Sulfonamide derivs. 11a-n proved to be potent agonists of the CB2 receptor.  Anal. of the Lipophilic Efficiency (LipE) of potent compds. provided new insight for the design of potent, metabolically stable CB2 agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1cihq9YHuO7Vg90H21EOLACvtfcHk0lhB6CF7B5iIgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVGlsrg%253D&md5=b62d97e5f52a594cfdd510f32d2e566f</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.05.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.05.062%26sid%3Dliteratum%253Aachs%26aulast%3DRyckmans%26aufirst%3DT.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26aulast%3DHorne%26aufirst%3DV.%2BA.%26aulast%3DCorreia%26aufirst%3DA.%2BM.%26aulast%3DOwen%26aufirst%3DD.%2BR.%26aulast%3DThompson%26aufirst%3DL.%2BR.%26aulast%3DTran%26aufirst%3DI.%26aulast%3DTutt%26aufirst%3DM.%2BF.%26aulast%3DYoung%26aufirst%3DT.%26atitle%3DRapid%2520Assessment%2520of%2520a%2520Novel%2520Series%2520of%2520Selective%2520CB%25282%2529%2520Agonists%2520Using%2520Parallel%2520Synthesis%2520Protocols%253A%2520A%2520Lipophilic%2520Efficiency%2520%2528LipE%2529%2520Analysis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4406%26epage%3D4409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Edwards, M. P.; Price, D. A.</span><span> </span><span class="NLM_article-title">Role of Physicochemical Properties and Ligand Lipophilicity Efficiency in Addressing Drug Safety Risks</span>. In  <span class="citation_source-book">Annual Reports in Medicinal Chemistry</span>; <span class="NLM_contrib-group">Macor, J. E.</span>, Ed.; <span class="NLM_publisher-name">Academic Press</span>: Boston, MA,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">45</span>, Chapter 23, pp  <span class="NLM_fpage">380</span><span class="NLM_x">–</span> <span class="NLM_lpage">391</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm301626p&amp;key=10.1016%2FS0065-7743%2810%2945023-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=380-391&author=M.+P.+Edwards&author=D.+A.+Priceauthor=J.+E.+Macor&title=Annual+Reports+in+Medicinal+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2FS0065-7743%2810%2945023-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FS0065-7743%252810%252945023-X%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26atitle%3DRole%2520of%2520Physicochemical%2520Properties%2520and%2520Ligand%2520Lipophilicity%2520Efficiency%2520in%2520Addressing%2520Drug%2520Safety%2520Risks%26btitle%3DAnnual%2520Reports%2520in%2520Medicinal%2520Chemistry%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26pub%3DAcademic%2520Press%26date%3D2010%26volume%3D45%26spage%3D380%26epage%3D391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Kenakin, T. P.</span> <span class="citation_source-book">A Pharmacology Primer: Theory, Applications, and Methods</span>, <span class="NLM_edition">3</span>rd ed.; <span class="NLM_publisher-name">Academic Press</span>: Boston, MA,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=T.+P.+Kenakin&title=A+Pharmacology+Primer%3A+Theory%2C+Applications%2C+and+Methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DKenakin%26aufirst%3DT.%2BP.%26btitle%3DA%2520Pharmacology%2520Primer%253A%2520Theory%252C%2520Applications%252C%2520and%2520Methods%26pub%3DAcademic%2520Press%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Overton, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babbs, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doel, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fyfe, M. C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Procter, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasamison, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang-Christensen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Widdowson, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynet, C.</span><span> </span><span class="NLM_article-title">Deorphanization of a G Protein-Coupled Receptor for Oleoylethanolamide and Its Use in the Discovery of Small-Molecule Hypophagic Agents</span> <span class="citation_source-journal">Cell Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">175</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm301626p&amp;key=10.1016%2Fj.cmet.2006.02.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm301626p&amp;key=16517404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm301626p&amp;key=1%3ACAS%3A528%3ADC%252BD28Xislyhtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=167-175&author=H.+A.+Overtonauthor=A.+J.+Babbsauthor=S.+M.+Doelauthor=M.+C.+T.+Fyfeauthor=L.+S.+Gardnerauthor=G.+Griffinauthor=H.+C.+Jacksonauthor=M.+J.+Procterauthor=C.+M.+Rasamisonauthor=M.+Tang-Christensenauthor=P.+S.+Widdowsonauthor=G.+M.+Williamsauthor=C.+Reynet&title=Deorphanization+of+a+G+Protein-Coupled+Receptor+for+Oleoylethanolamide+and+Its+Use+in+the+Discovery+of+Small-Molecule+Hypophagic+Agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents</span></div><div class="casAuthors">Overton, Hilary A.; Babbs, Adam J.; Doel, Sheila M.; Fyfe, Matthew C. T.; Gardner, Lisa S.; Griffin, Graeme; Jackson, Helen C.; Procter, Martin J.; Rasamison, Chrystelle M.; Tang-Christensen, Mads; Widdowson, Peter S.; Williams, Geoffery M.; Reynet, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">167-175</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The endogenous lipid signaling agent oleoylethanolamide (OEA) has recently been described as a peripherally acting agent that reduces food intake and body wt. gain in rat feeding models.  This paper presents evidence that OEA is an endogenous ligand of the orphan receptor GPR119, a G protein-coupled receptor (GPCR) expressed predominantly in the human and rodent pancreas and gastrointestinal tract and also in rodent brain, suggesting that the reported effects of OEA on food intake may be mediated, at least in part, via the GPR119 receptor.  Furthermore, we have used the recombinant receptor to discover novel selective small-mol. GPR119 agonists, typified by PSN632408, which suppress food intake in rats and reduce body wt. gain and white adipose tissue deposition upon subchronic oral administration to high-fat-fed rats.  GPR119 therefore represents a novel and attractive potential target for the therapy of obesity and related metabolic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr8xt3VqDV07Vg90H21EOLACvtfcHk0lhB6CF7B5iIgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xislyhtr8%253D&md5=85c2756aa0809be0069ea515e2a1574d</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2006.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2006.02.004%26sid%3Dliteratum%253Aachs%26aulast%3DOverton%26aufirst%3DH.%2BA.%26aulast%3DBabbs%26aufirst%3DA.%2BJ.%26aulast%3DDoel%26aufirst%3DS.%2BM.%26aulast%3DFyfe%26aufirst%3DM.%2BC.%2BT.%26aulast%3DGardner%26aufirst%3DL.%2BS.%26aulast%3DGriffin%26aufirst%3DG.%26aulast%3DJackson%26aufirst%3DH.%2BC.%26aulast%3DProcter%26aufirst%3DM.%2BJ.%26aulast%3DRasamison%26aufirst%3DC.%2BM.%26aulast%3DTang-Christensen%26aufirst%3DM.%26aulast%3DWiddowson%26aufirst%3DP.%2BS.%26aulast%3DWilliams%26aufirst%3DG.%2BM.%26aulast%3DReynet%26aufirst%3DC.%26atitle%3DDeorphanization%2520of%2520a%2520G%2520Protein-Coupled%2520Receptor%2520for%2520Oleoylethanolamide%2520and%2520Its%2520Use%2520in%2520the%2520Discovery%2520of%2520Small-Molecule%2520Hypophagic%2520Agents%26jtitle%3DCell%2520Metab.%26date%3D2006%26volume%3D3%26spage%3D167%26epage%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="note"><p class="first last">To include all the cage compounds, the AgLLE calculations used ClogP rather than the measured ElogD.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="note"><p class="first last">The rat in vitro GPR119 pharmacology for <b>32i</b> is as follows: rat cAMP EC<sub>50</sub> = 294 nM, 107% IA, <i>n</i> = 1; rat <i>K</i><sub>i</sub> = 71.8 ± 12.7 nM, <i>n</i> = 3; obtained as in ref <a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">21</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuntz, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauls, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ammala, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadepalli, S.</span><span> </span><span class="NLM_article-title">2,5-Disubstituted Pyridines as Potent GPR119 Agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2577</span><span class="NLM_x">–</span> <span class="NLM_lpage">2581</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2577-2581&author=Y.+Wuauthor=J.+D.+Kuntzauthor=A.+J.+Carpenterauthor=J.+Fangauthor=H.+R.+Saulsauthor=D.+J.+Gomezauthor=C.+Ammalaauthor=Y.+Xuauthor=S.+Hartauthor=S.+Tadepalli&title=2%2C5-Disubstituted+Pyridines+as+Potent+GPR119+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%26aulast%3DKuntz%26aufirst%3DJ.%2BD.%26aulast%3DCarpenter%26aufirst%3DA.%2BJ.%26aulast%3DFang%26aufirst%3DJ.%26aulast%3DSauls%26aufirst%3DH.%2BR.%26aulast%3DGomez%26aufirst%3DD.%2BJ.%26aulast%3DAmmala%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DHart%26aufirst%3DS.%26aulast%3DTadepalli%26aufirst%3DS.%26atitle%3D2%252C5-Disubstituted%2520Pyridines%2520as%2520Potent%2520GPR119%2520Agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2577%26epage%3D2581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitney-Pickett, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umland, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gebhard, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federico, J. J.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reyner, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varma, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kempshall, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kattan, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liston, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span> </span><span class="NLM_article-title">Development of a New Permeability Assay Using Low-Efflux MDCKII Cells</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">4974</span><span class="NLM_x">–</span> <span class="NLM_lpage">4985</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm301626p&amp;key=10.1002%2Fjps.22674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm301626p&amp;key=21766308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm301626p&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovFGltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2011&pages=4974-4985&author=L.+Diauthor=C.+Whitney-Pickettauthor=J.+P.+Umlandauthor=H.+Zhangauthor=X.+Zhangauthor=D.+F.+Gebhardauthor=Y.+Laiauthor=J.+J.+Federicoauthor=R.+E.+Davidsonauthor=R.+Smithauthor=E.+L.+Reynerauthor=C.+Leeauthor=B.+Fengauthor=C.+Rotterauthor=M.+V.+Varmaauthor=S.+Kempshallauthor=K.+Fennerauthor=A.+F.+El-Kattanauthor=T.+E.+Listonauthor=M.+D.+Troutman&title=Development+of+a+New+Permeability+Assay+Using+Low-Efflux+MDCKII+Cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a new permeability assay using low-efflux MDCKII cells</span></div><div class="casAuthors">Di, Li; Whitney-Pickett, Carrie; Umland, John P.; Zhang, Hui; Zhang, Xun; Gebhard, David F.; Lai, Yurong; Federico, James J.; Davidson, Ralph E.; Smith, Russ; Reyner, Eric L.; Lee, Caroline; Feng, Bo; Rotter, Charles; Varma, Manthena V.; Kempshall, Sarah; Fenner, Katherine; El-kattan, Ayman F.; Liston, Theodore E.; Troutman, Matthew D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4974-4985</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Permeability is an important property of drug candidates.  The Madin-Darby canine kidney cell line (MDCK) permeability assay is widely used and the primary concern of using MDCK cells is the presence of endogenous transporters of nonhuman origin.  The canine P-glycoprotein (Pgp) can interfere with permeability and transporter studies, leading to less reliable data.  A new cell line, MDCKII-LE (low efflux), has been developed by selecting a subpopulation of low-efflux cells from MDCKII-WT using an iterative fluorescence-activated cell sorting technique with calcein-AM as a Pgp and efflux substrate.  MDCKII-LE cells are a subpopulation of MDCKII cells with over 200-fold lower canine Pgp mRNA level and fivefold lower protein level than MDCKII-WT.  MDCKII-LE cells showed less functional efflux activity than MDCKII-WT based on efflux ratios.  Notably, MDCKII-MDR1 showed about 1.5-fold decreased expression of endogenous canine Pgp, suggesting that using the net flux ratio might not completely cancel out the background endogenous transporter activities.  MDCKII-LE cells offer clear advantages over the MDCKII-WT by providing less efflux transporter background signals and minimizing interference from canine Pgp.  The MDCKII-LE apparent permeability values well differentiates compds. from high to medium/low human intestinal absorption and can be used for Biopharmaceutical Classification System.  The MDCKII-LE permeability assay (4-in-1 cassette dosing) is high throughput with good precision, reproducibility, robustness, and cost-effective. © 2011 Wiley-Liss, Inc. and the American Pharmacists Assocn. J Pharm Sci.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTVtRmYnbF17Vg90H21EOLACvtfcHk0lguxrAIiBHHrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovFGltb8%253D&md5=97f647fc215ea6d04882351ffc912a1e</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1002%2Fjps.22674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.22674%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DWhitney-Pickett%26aufirst%3DC.%26aulast%3DUmland%26aufirst%3DJ.%2BP.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DGebhard%26aufirst%3DD.%2BF.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DFederico%26aufirst%3DJ.%2BJ.%26aulast%3DDavidson%26aufirst%3DR.%2BE.%26aulast%3DSmith%26aufirst%3DR.%26aulast%3DReyner%26aufirst%3DE.%2BL.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DRotter%26aufirst%3DC.%26aulast%3DVarma%26aufirst%3DM.%2BV.%26aulast%3DKempshall%26aufirst%3DS.%26aulast%3DFenner%26aufirst%3DK.%26aulast%3DEl-Kattan%26aufirst%3DA.%2BF.%26aulast%3DListon%26aufirst%3DT.%2BE.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26atitle%3DDevelopment%2520of%2520a%2520New%2520Permeability%2520Assay%2520Using%2520Low-Efflux%2520MDCKII%2520Cells%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2011%26volume%3D100%26spage%3D4974%26epage%3D4985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Curatolo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nightingale, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbig, S. M.</span><span> </span><span class="NLM_article-title">Utility of Hydroxypropylmethylcellulose Acetate Succinate (HPMCAS) for Initiation and Maintenance of Drug Supersaturation in the GI Milieu</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1419</span><span class="NLM_x">–</span> <span class="NLM_lpage">1431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm301626p&amp;key=10.1007%2Fs11095-009-9852-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm301626p&amp;key=19277850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm301626p&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivVKnt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2009&pages=1419-1431&author=W.+Curatoloauthor=J.+A.+Nightingaleauthor=S.+M.+Herbig&title=Utility+of+Hydroxypropylmethylcellulose+Acetate+Succinate+%28HPMCAS%29+for+Initiation+and+Maintenance+of+Drug+Supersaturation+in+the+GI+Milieu"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Utility of Hydroxypropylmethylcellulose Acetate Succinate (HPMCAS) for Initiation and Maintenance of Drug Supersaturation in the GI Milieu</span></div><div class="casAuthors">Curatolo, William; Nightingale, James A.; Herbig, Scott M.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1419-1431</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">To identify materials and processes which effect supersatn. of the GI milieu for low soly. drugs in order to increase oral bioavailability.  A variety of small and polymeric mols. were screened for their ability to inhibit drug pptn. in supersatd. solns.  The best polymeric materials were utilized to create spray-dried dispersions (SDDs) of drug and polymer, and these were tested for drug form and homogeneity.  Dispersions were tested in vitro for their ability to achieve and maintain drug supersatn., for a variety of drug structures.  Of the 41 materials tested, HPMCAS was the most effective at maintaining drug supersatn.  Drug/HPMCAS SDDs were consistently more effective at achieving and maintaining drug supersatn. in vitro than were SDDs prepd. with other polymers.  Drug/HPMCAS SDDs were effective in vitro for eight low soly. drugs of widely varying structure.  Drug/HPMCAS SDDs were more effective at achieving and maintaining supersatn. than were rotoevaporated Drug/HPMCAS dispersions or phys. mixts. of Drug and HPMCAS.  The degree of achievable drug supersatn. increased with increasing polymer content in the SDD.  The drug in drug /HPMCAS SDDs was amorphous, and the dispersions were demonstrated to have a single glass transition and were thus homogeneous.  HPMCAS has been identified as a uniquely effective polymer for use in SDDs of low soly. drugs, with broad applicability across a variety of drug structures and properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4s3z_VWbntrVg90H21EOLACvtfcHk0lguxrAIiBHHrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivVKnt7Y%253D&md5=ded648a652939b723e96ce6d1c1a5ad9</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1007%2Fs11095-009-9852-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-009-9852-z%26sid%3Dliteratum%253Aachs%26aulast%3DCuratolo%26aufirst%3DW.%26aulast%3DNightingale%26aufirst%3DJ.%2BA.%26aulast%3DHerbig%26aufirst%3DS.%2BM.%26atitle%3DUtility%2520of%2520Hydroxypropylmethylcellulose%2520Acetate%2520Succinate%2520%2528HPMCAS%2529%2520for%2520Initiation%2520and%2520Maintenance%2520of%2520Drug%2520Supersaturation%2520in%2520the%2520GI%2520Milieu%26jtitle%3DPharm.%2520Res.%26date%3D2009%26volume%3D26%26spage%3D1419%26epage%3D1431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':[],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':[],'ref50':[],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 27 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Zhimin Yang, Richard A. Stein, Thacien Ngendahimana, Maren Pink, Suchada Rajca, Gunnar Jeschke, Sandra S. Eaton, Gareth R. Eaton, Hassane S. Mchaourab, <span class="NLM_string-name hlFld-ContribAuthor">Andrzej Rajca</span>. </span><span class="cited-content_cbyCitation_article-title">Supramolecular Approach to Electron Paramagnetic Resonance Distance Measurement of Spin-Labeled Proteins. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Physical Chemistry B</span><span> <strong>2020,</strong> <em>124 </em>
                                    (16)
                                     , 3291-3299. <a href="https://doi.org/10.1021/acs.jpcb.0c00743" title="DOI URL">https://doi.org/10.1021/acs.jpcb.0c00743</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jpcb.0c00743&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jpcb.0c00743%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Physical%2520Chemistry%2520B%26atitle%3DSupramolecular%252BApproach%252Bto%252BElectron%252BParamagnetic%252BResonance%252BDistance%252BMeasurement%252Bof%252BSpin-Labeled%252BProteins%26aulast%3DYang%26aufirst%3DZhimin%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D27012020%26date%3D30032020%26date%3D13042020%26date%3D30032020%26volume%3D124%26issue%3D16%26spage%3D3291%26epage%3D3299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jianbo Wu, Derek A. Leas, Yuxiang Dong, Xiaofang Wang, Edward L. Ezell, Douglas E. Stack, <span class="NLM_string-name hlFld-ContribAuthor">Jonathan L. Vennerstrom</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 2-Azaadamantan-6-one: A Missing Isomer. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2018,</strong> <em>3 </em>
                                    (9)
                                     , 11362-11367. <a href="https://doi.org/10.1021/acsomega.8b01819" title="DOI URL">https://doi.org/10.1021/acsomega.8b01819</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.8b01819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.8b01819%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DSynthesis%252Bof%252B2-Azaadamantan-6-one%25253A%252BA%252BMissing%252BIsomer%26aulast%3DWu%26aufirst%3DJianbo%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D30072018%26date%3D10092018%26volume%3D3%26issue%3D9%26spage%3D11362%26epage%3D11367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kurt  Ritter</span>, <span class="hlFld-ContribAuthor ">Christian  Buning</span>, <span class="hlFld-ContribAuthor ">Nis  Halland</span>, <span class="hlFld-ContribAuthor ">Christoph  Pöverlein</span>, and <span class="hlFld-ContribAuthor ">Lothar  Schwink</span>  . </span><span class="cited-content_cbyCitation_article-title">G Protein-Coupled Receptor 119 (GPR119) Agonists for the Treatment of Diabetes: Recent Progress and Prevailing Challenges. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (8)
                                     , 3579-3592. <a href="https://doi.org/10.1021/acs.jmedchem.5b01198" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01198</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01198%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DG%252BProtein-Coupled%252BReceptor%252B119%252B%252528GPR119%252529%252BAgonists%252Bfor%252Bthe%252BTreatment%252Bof%252BDiabetes%25253A%252BRecent%252BProgress%252Band%252BPrevailing%252BChallenges%26aulast%3DRitter%26aufirst%3DKurt%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D30072015%26date%3D09112015%26date%3D28042016%26date%3D29102015%26volume%3D59%26issue%3D8%26spage%3D3579%26epage%3D3592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amarjit  Singh</span>, <span class="hlFld-ContribAuthor ">James  Falabella</span>, <span class="hlFld-ContribAuthor ">Thomas L  LaPorte</span>, and <span class="hlFld-ContribAuthor ">Animesh  Goswami</span>  . </span><span class="cited-content_cbyCitation_article-title">Enzymatic Process for N-Substituted (3S)- and (3R)-3-Hydroxypyrrolidin-2-ones. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2015,</strong> <em>19 </em>
                                    (7)
                                     , 819-830. <a href="https://doi.org/10.1021/acs.oprd.5b00084" title="DOI URL">https://doi.org/10.1021/acs.oprd.5b00084</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.5b00084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.5b00084%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DEnzymatic%252BProcess%252Bfor%252BN-Substituted%252B%2525283S%252529-%252Band%252B%2525283R%252529-3-Hydroxypyrrolidin-2-ones%26aulast%3DSingh%26aufirst%3DAmarjit%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D16032015%26date%3D07072015%26date%3D17072015%26date%3D24062015%26volume%3D19%26issue%3D7%26spage%3D819%26epage%3D830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James S.  Scott</span>, <span class="hlFld-ContribAuthor ">Suzanne S.  Bowker</span>, <span class="hlFld-ContribAuthor ">Katy J.  Brocklehurst</span>, <span class="hlFld-ContribAuthor ">Hayley S.  Brown</span>, <span class="hlFld-ContribAuthor ">David S.  Clarke</span>, <span class="hlFld-ContribAuthor ">Alison  Easter</span>, <span class="hlFld-ContribAuthor ">Anne  Ertan</span>, <span class="hlFld-ContribAuthor ">Kristin  Goldberg</span>, <span class="hlFld-ContribAuthor ">Julian A.  Hudson</span>, <span class="hlFld-ContribAuthor ">Stefan  Kavanagh</span>, <span class="hlFld-ContribAuthor ">David  Laber</span>, <span class="hlFld-ContribAuthor ">Andrew G.  Leach</span>, <span class="hlFld-ContribAuthor ">Philip A.  MacFaul</span>, <span class="hlFld-ContribAuthor ">Elizabeth A.  Martin</span>, <span class="hlFld-ContribAuthor ">Darren  McKerrecher</span>, <span class="hlFld-ContribAuthor ">Paul  Schofield</span>, <span class="hlFld-ContribAuthor ">Per H.  Svensson</span>, and <span class="hlFld-ContribAuthor ">Joanne  Teague</span>  . </span><span class="cited-content_cbyCitation_article-title">Circumventing Seizure Activity in a Series of G Protein Coupled Receptor 119 (GPR119) Agonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (21)
                                     , 8984-8998. <a href="https://doi.org/10.1021/jm5011012" title="DOI URL">https://doi.org/10.1021/jm5011012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5011012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5011012%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCircumventing%252BSeizure%252BActivity%252Bin%252Ba%252BSeries%252Bof%252BG%252BProtein%252BCoupled%252BReceptor%252B119%252B%252528GPR119%252529%252BAgonists%26aulast%3DScott%26aufirst%3DJames%2BS.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D21072014%26date%3D03112014%26date%3D13112014%26date%3D06102014%26volume%3D57%26issue%3D21%26spage%3D8984%26epage%3D8998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hye Yeon  Sagong</span>, <span class="hlFld-ContribAuthor ">Joseph D.  Bauman</span>, <span class="hlFld-ContribAuthor ">Disha  Patel</span>, <span class="hlFld-ContribAuthor ">Kalyan  Das</span>, <span class="hlFld-ContribAuthor ">Eddy  Arnold</span>, and <span class="hlFld-ContribAuthor ">Edmond J.  LaVoie</span>  . </span><span class="cited-content_cbyCitation_article-title">Phenyl Substituted 4-Hydroxypyridazin-3(2H)-ones and 5-Hydroxypyrimidin-4(3H)-ones: Inhibitors of Influenza A Endonuclease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (19)
                                     , 8086-8098. <a href="https://doi.org/10.1021/jm500958x" title="DOI URL">https://doi.org/10.1021/jm500958x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500958x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500958x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPhenyl%252BSubstituted%252B4-Hydroxypyridazin-3%2525282H%252529-ones%252Band%252B5-Hydroxypyrimidin-4%2525283H%252529-ones%25253A%252BInhibitors%252Bof%252BInfluenza%252BA%252BEndonuclease%26aulast%3DSagong%26aufirst%3DHye%2BYeon%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D11072014%26date%3D29092014%26date%3D09102014%26date%3D16092014%26volume%3D57%26issue%3D19%26spage%3D8086%26epage%3D8098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fiona I.  McGonagle</span>, <span class="hlFld-ContribAuthor ">Helen F.  Sneddon</span>, <span class="hlFld-ContribAuthor ">Craig  Jamieson</span>, and <span class="hlFld-ContribAuthor ">Allan J. B.  Watson</span>  . </span><span class="cited-content_cbyCitation_article-title">Molar Efficiency: A Useful Metric To Gauge Relative Reaction Efficiency in Discovery Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">ACS Sustainable Chemistry & Engineering</span><span> <strong>2014,</strong> <em>2 </em>
                                    (3)
                                     , 523-532. <a href="https://doi.org/10.1021/sc4004532" title="DOI URL">https://doi.org/10.1021/sc4004532</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/sc4004532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fsc4004532%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Sustainable%2520Chemistry%2520%2526%2520Engineering%26atitle%3DMolar%252BEfficiency%25253A%252BA%252BUseful%252BMetric%252BTo%252BGauge%252BRelative%252BReaction%252BEfficiency%252Bin%252BDiscovery%252BMedicinal%252BChemistry%26aulast%3DMcGonagle%26aufirst%3DFiona%2BI.%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D06112013%26date%3D28112013%26date%3D06122013%26date%3D03032014%26date%3D02122013%26volume%3D2%26issue%3D3%26spage%3D523%26epage%3D532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zeping  Zuo</span>, <span class="hlFld-ContribAuthor ">Miaomiao  Chen</span>, <span class="hlFld-ContribAuthor ">Xiaoni  Shao</span>, <span class="hlFld-ContribAuthor ">Xinying  Qian</span>, <span class="hlFld-ContribAuthor ">Xiaocong  Liu</span>, <span class="hlFld-ContribAuthor ">Xia  Zhou</span>, <span class="hlFld-ContribAuthor ">Jiawei  Xiang</span>, <span class="hlFld-ContribAuthor ">Pengchi  Deng</span>, <span class="hlFld-ContribAuthor ">Yan  Li</span>, <span class="hlFld-ContribAuthor ">Hui  Jie</span>, <span class="hlFld-ContribAuthor ">Chunqi  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaobo  Cen</span>, <span class="hlFld-ContribAuthor ">Yongmei  Xie</span>, <span class="hlFld-ContribAuthor ">Yinglan  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Design and biological evaluation of tetrahydropyridine derivatives as novel human GPR119 agonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (4)
                                     , 126855. <a href="https://doi.org/10.1016/j.bmcl.2019.126855" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126855</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126855&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126855%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252Bbiological%252Bevaluation%252Bof%252Btetrahydropyridine%252Bderivatives%252Bas%252Bnovel%252Bhuman%252BGPR119%252Bagonists%26aulast%3DZuo%26aufirst%3DZeping%26date%3D2020%26volume%3D30%26issue%3D4%26spage%3D126855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuanying  Fang</span>, <span class="hlFld-ContribAuthor ">Jun  Xu</span>, <span class="hlFld-ContribAuthor ">Zhifeng  Li</span>, <span class="hlFld-ContribAuthor ">Zunhua  Yang</span>, <span class="hlFld-ContribAuthor ">Lijuan  Xiong</span>, <span class="hlFld-ContribAuthor ">Yi  Jin</span>, <span class="hlFld-ContribAuthor ">Qi  Wang</span>, <span class="hlFld-ContribAuthor ">Saisai  Xie</span>, <span class="hlFld-ContribAuthor ">Wufu  Zhu</span>, <span class="hlFld-ContribAuthor ">Sheng  Chang</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of novel pyrimido[5,4-d]pyrimidine derivatives as GPR119 agonist for treatment of type 2 diabetes. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (14)
                                     , 4080-4087. <a href="https://doi.org/10.1016/j.bmc.2018.06.035" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.06.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.06.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.06.035%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bnovel%252Bpyrimido%25255B5%25252C4-d%25255Dpyrimidine%252Bderivatives%252Bas%252BGPR119%252Bagonist%252Bfor%252Btreatment%252Bof%252Btype%252B2%252Bdiabetes%26aulast%3DFang%26aufirst%3DYuanying%26date%3D2018%26volume%3D26%26issue%3D14%26spage%3D4080%26epage%3D4087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ainhoa  Nieto</span>, <span class="hlFld-ContribAuthor ">Virneliz  Fernández-Vega</span>, <span class="hlFld-ContribAuthor ">Timothy P.  Spicer</span>, <span class="hlFld-ContribAuthor ">Emmanuel  Sturchler</span>, <span class="hlFld-ContribAuthor ">Pramisha  Adhikari</span>, <span class="hlFld-ContribAuthor ">Nicole  Kennedy</span>, <span class="hlFld-ContribAuthor ">Sean  Mandat</span>, <span class="hlFld-ContribAuthor ">Peter  Chase</span>, <span class="hlFld-ContribAuthor ">Louis  Scampavia</span>, <span class="hlFld-ContribAuthor ">Thomas  Bannister</span>, <span class="hlFld-ContribAuthor ">Peter  Hodder</span>, <span class="hlFld-ContribAuthor ">Patricia H.  McDonald</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Novel, Structurally Diverse, Small Molecule Modulators of GPR119. </span><span class="cited-content_cbyCitation_journal-name">ASSAY and Drug Development Technologies</span><span> <strong>2018,</strong> <em>16 </em>
                                    (5)
                                     , 278-288. <a href="https://doi.org/10.1089/adt.2018.849" title="DOI URL">https://doi.org/10.1089/adt.2018.849</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1089/adt.2018.849&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1089%2Fadt.2018.849%26sid%3Dliteratum%253Aachs%26jtitle%3DASSAY%2520and%2520Drug%2520Development%2520Technologies%26atitle%3DIdentification%252Bof%252BNovel%25252C%252BStructurally%252BDiverse%25252C%252BSmall%252BMolecule%252BModulators%252Bof%252BGPR119%26aulast%3DNieto%26aufirst%3DAinhoa%26date%3D2018%26volume%3D16%26issue%3D5%26spage%3D278%26epage%3D288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tianjiao  Hou</span>, <span class="hlFld-ContribAuthor ">Hongwei  Ruan</span>, <span class="hlFld-ContribAuthor ">Guixiang  Wang</span>, <span class="hlFld-ContribAuthor ">Jun  Luo</span>. </span><span class="cited-content_cbyCitation_article-title">2,4,4,8,8-Pentanitro-2-Azaadamantane: A High-Density Energetic Compound. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>2017 </em>
                                    (46)
                                     , 6957-6960. <a href="https://doi.org/10.1002/ejoc.201701403" title="DOI URL">https://doi.org/10.1002/ejoc.201701403</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201701403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201701403%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3D2%25252C4%25252C4%25252C8%25252C8-Pentanitro-2-Azaadamantane%25253A%252BA%252BHigh-Density%252BEnergetic%252BCompound%26aulast%3DHou%26aufirst%3DTianjiao%26date%3D2017%26date%3D2017%26volume%3D2017%26issue%3D46%26spage%3D6957%26epage%3D6960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zunhua  Yang</span>, <span class="hlFld-ContribAuthor ">Yuanying  Fang</span>, <span class="hlFld-ContribAuthor ">Haeil  Park</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of pyrimidine derivatives with diverse azabicyclic ether/amine as novel GPR119 agonist. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (11)
                                     , 2515-2519. <a href="https://doi.org/10.1016/j.bmcl.2017.03.092" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.03.092</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.03.092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.03.092%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bpyrimidine%252Bderivatives%252Bwith%252Bdiverse%252Bazabicyclic%252Bether%25252Famine%252Bas%252Bnovel%252BGPR119%252Bagonist%26aulast%3DYang%26aufirst%3DZunhua%26date%3D2017%26volume%3D27%26issue%3D11%26spage%3D2515%26epage%3D2519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">László  Ürge</span>, <span class="hlFld-ContribAuthor ">Jesus  Alcazar</span>, <span class="hlFld-ContribAuthor ">Lena  Huck</span>, <span class="hlFld-ContribAuthor ">György  Dormán</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances of Microfluidics Technologies in the Field of Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 87-147. <a href="https://doi.org/10.1016/bs.armc.2017.09.001" title="DOI URL">https://doi.org/10.1016/bs.armc.2017.09.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.armc.2017.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.armc.2017.09.001%26sid%3Dliteratum%253Aachs%26atitle%3DRecent%252BAdvances%252Bof%252BMicrofluidics%252BTechnologies%252Bin%252Bthe%252BField%252Bof%252BMedicinal%252BChemistry%26aulast%3D%25C3%259Crge%26aufirst%3DL%25C3%25A1szl%25C3%25B3%26date%3D2017%26spage%3D87%26epage%3D147%26pub%3DElsevier%26atitle%3DPlatform%252BTechnologies%252Bin%252BDrug%252BDiscovery%252Band%252BValidation%26date%3D2017%26volume%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuanying  Fang</span>, <span class="hlFld-ContribAuthor ">Zunhua  Yang</span>, <span class="hlFld-ContribAuthor ">Shankariah  Gundeti</span>, <span class="hlFld-ContribAuthor ">Jongkook  Lee</span>, <span class="hlFld-ContribAuthor ">Haeil  Park</span>. </span><span class="cited-content_cbyCitation_article-title">Novel 5-nitropyrimidine derivatives bearing endo-azabicyclic alcohols/amines as potent GPR119 agonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (1)
                                     , 254-260. <a href="https://doi.org/10.1016/j.bmc.2016.10.030" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.10.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.10.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.10.030%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DNovel%252B5-nitropyrimidine%252Bderivatives%252Bbearing%252Bendo-azabicyclic%252Balcohols%25252Famines%252Bas%252Bpotent%252BGPR119%252Bagonists%26aulast%3DFang%26aufirst%3DYuanying%26date%3D2017%26volume%3D25%26issue%3D1%26spage%3D254%26epage%3D260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tianjiao  Hou</span>, <span class="hlFld-ContribAuthor ">Jian  Zhang</span>, <span class="hlFld-ContribAuthor ">Chenjiao  Wang</span>, <span class="hlFld-ContribAuthor ">Jun  Luo</span>. </span><span class="cited-content_cbyCitation_article-title">A facile method to construct a 2,4,9-triazaadamantane skeleton and synthesize nitramine derivatives. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2017,</strong> <em>4 </em>
                                    (9)
                                     , 1819-1823. <a href="https://doi.org/10.1039/C7QO00357A" title="DOI URL">https://doi.org/10.1039/C7QO00357A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7QO00357A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7QO00357A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DA%252Bfacile%252Bmethod%252Bto%252Bconstruct%252Ba%252B2%25252C4%25252C9-triazaadamantane%252Bskeleton%252Band%252Bsynthesize%252Bnitramine%252Bderivatives%26aulast%3DHou%26aufirst%3DTianjiao%26date%3D2017%26date%3D2017%26volume%3D4%26issue%3D9%26spage%3D1819%26epage%3D1823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Toma  Glasnov</span>. </span><span class="cited-content_cbyCitation_article-title">Organic Synthesis in Dedicated Continuous Flow Systems. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 49-67. <a href="https://doi.org/10.1007/978-3-319-32196-7_6" title="DOI URL">https://doi.org/10.1007/978-3-319-32196-7_6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-32196-7_6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-32196-7_6%26sid%3Dliteratum%253Aachs%26atitle%3DOrganic%252BSynthesis%252Bin%252BDedicated%252BContinuous%252BFlow%252BSystems%26aulast%3DGlasnov%26aufirst%3DToma%26date%3D2016%26date%3D2016%26spage%3D49%26epage%3D67%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DContinuous-Flow%252BChemistry%252Bin%252Bthe%252BResearch%252BLaboratory%26aulast%3DGlasnov%26aufirst%3DToma%26date%3D2016%26volume%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexandria P.  Taylor</span>, <span class="hlFld-ContribAuthor ">Ralph P.  Robinson</span>, <span class="hlFld-ContribAuthor ">Yvette M.  Fobian</span>, <span class="hlFld-ContribAuthor ">David C.  Blakemore</span>, <span class="hlFld-ContribAuthor ">Lyn H.  Jones</span>, <span class="hlFld-ContribAuthor ">Olugbeminiyi  Fadeyi</span>. </span><span class="cited-content_cbyCitation_article-title">Modern advances in heterocyclic chemistry in drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2016,</strong> <em>14 </em>
                                    (28)
                                     , 6611-6637. <a href="https://doi.org/10.1039/C6OB00936K" title="DOI URL">https://doi.org/10.1039/C6OB00936K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6OB00936K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6OB00936K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DModern%252Badvances%252Bin%252Bheterocyclic%252Bchemistry%252Bin%252Bdrug%252Bdiscovery%26aulast%3DTaylor%26aufirst%3DAlexandria%2BP.%26date%3D2016%26date%3D2016%26volume%3D14%26issue%3D28%26spage%3D6611%26epage%3D6637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xing  Dai</span>, <span class="hlFld-ContribAuthor ">Andrew  Stamford</span>, <span class="hlFld-ContribAuthor ">Hong  Liu</span>, <span class="hlFld-ContribAuthor ">Bernard  Neustadt</span>, <span class="hlFld-ContribAuthor ">Jingsong  Hao</span>, <span class="hlFld-ContribAuthor ">Tim  Kowalski</span>, <span class="hlFld-ContribAuthor ">Brian  Hawes</span>, <span class="hlFld-ContribAuthor ">Xiaoying  Xu</span>, <span class="hlFld-ContribAuthor ">Hana  Baker</span>, <span class="hlFld-ContribAuthor ">Kim  O’Neill</span>, <span class="hlFld-ContribAuthor ">Morgan  Woods</span>, <span class="hlFld-ContribAuthor ">Huadong  Tang</span>, <span class="hlFld-ContribAuthor ">William  Greenlee</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of the oxazabicyclo[3.3.1]nonane derivatives as potent and orally active GPR119 agonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (22)
                                     , 5291-5294. <a href="https://doi.org/10.1016/j.bmcl.2015.09.047" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.09.047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.09.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.09.047%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bthe%252Boxazabicyclo%25255B3.3.1%25255Dnonane%252Bderivatives%252Bas%252Bpotent%252Band%252Borally%252Bactive%252BGPR119%252Bagonists%26aulast%3DDai%26aufirst%3DXing%26date%3D2015%26volume%3D25%26issue%3D22%26spage%3D5291%26epage%3D5294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiang-Yang  Ye</span>, <span class="hlFld-ContribAuthor ">Christian L.  Morales</span>, <span class="hlFld-ContribAuthor ">Ying  Wang</span>, <span class="hlFld-ContribAuthor ">Karen A.  Rossi</span>, <span class="hlFld-ContribAuthor ">Sarah E.  Malmstrom</span>, <span class="hlFld-ContribAuthor ">Mojgan  Abousleiman</span>, <span class="hlFld-ContribAuthor ">Larisa  Sereda</span>, <span class="hlFld-ContribAuthor ">Atsu  Apedo</span>, <span class="hlFld-ContribAuthor ">Jeffrey A.  Robl</span>, <span class="hlFld-ContribAuthor ">Keith J.  Miller</span>, <span class="hlFld-ContribAuthor ">John  Krupinski</span>, <span class="hlFld-ContribAuthor ">Dean A.  Wacker</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and structure–activity relationship of dihydrobenzofuran derivatives as novel human GPR119 agonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (11)
                                     , 2539-2545. <a href="https://doi.org/10.1016/j.bmcl.2014.03.096" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.03.096</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.03.096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.03.096%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bstructure%2525E2%252580%252593activity%252Brelationship%252Bof%252Bdihydrobenzofuran%252Bderivatives%252Bas%252Bnovel%252Bhuman%252BGPR119%252Bagonists%26aulast%3DYe%26aufirst%3DXiang-Yang%26date%3D2014%26volume%3D24%26issue%3D11%26spage%3D2539%26epage%3D2545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul  Gillespie</span>, <span class="hlFld-ContribAuthor ">Robert A.  Goodnow</span>, <span class="hlFld-ContribAuthor ">Goutam  Saha</span>, <span class="hlFld-ContribAuthor ">Gopal  Bose</span>, <span class="hlFld-ContribAuthor ">Kakali  Moulik</span>, <span class="hlFld-ContribAuthor ">Catherine  Zwingelstein</span>, <span class="hlFld-ContribAuthor ">Michael  Myers</span>, <span class="hlFld-ContribAuthor ">Karin  Conde-Knape</span>, <span class="hlFld-ContribAuthor ">Sherrie  Pietranico-Cole</span>, <span class="hlFld-ContribAuthor ">Sung-Sau  So</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of pyrazolo[3,4-d]pyrimidine derivatives as GPR119 agonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (3)
                                     , 949-953. <a href="https://doi.org/10.1016/j.bmcl.2013.12.063" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.12.063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.12.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.12.063%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bpyrazolo%25255B3%25252C4-d%25255Dpyrimidine%252Bderivatives%252Bas%252BGPR119%252Bagonists%26aulast%3DGillespie%26aufirst%3DPaul%26date%3D2014%26volume%3D24%26issue%3D3%26spage%3D949%26epage%3D953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew L.  Hopkins</span>, <span class="hlFld-ContribAuthor ">György M.  Keserü</span>, <span class="hlFld-ContribAuthor ">Paul D.  Leeson</span>, <span class="hlFld-ContribAuthor ">David C.  Rees</span>, <span class="hlFld-ContribAuthor ">Charles H.  Reynolds</span>. </span><span class="cited-content_cbyCitation_article-title">The role of ligand efficiency metrics in drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2014,</strong> <em>13 </em>
                                    (2)
                                     , 105-121. <a href="https://doi.org/10.1038/nrd4163" title="DOI URL">https://doi.org/10.1038/nrd4163</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nrd4163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnrd4163%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DThe%252Brole%252Bof%252Bligand%252Befficiency%252Bmetrics%252Bin%252Bdrug%252Bdiscovery%26aulast%3DHopkins%26aufirst%3DAndrew%2BL.%26date%3D2014%26date%3D2014%26volume%3D13%26issue%3D2%26spage%3D105%26epage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiu-Lei  Mo</span>, <span class="hlFld-ContribAuthor ">Zhao  Yang</span>, <span class="hlFld-ContribAuthor ">Ya-Xiong  Tao</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting GPR119 for the Potential Treatment of Type 2 Diabetes Mellitus. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 95-131. <a href="https://doi.org/10.1016/B978-0-12-800101-1.00004-1" title="DOI URL">https://doi.org/10.1016/B978-0-12-800101-1.00004-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-800101-1.00004-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-800101-1.00004-1%26sid%3Dliteratum%253Aachs%26atitle%3DTargeting%252BGPR119%252Bfor%252Bthe%252BPotential%252BTreatment%252Bof%252BType%252B2%252BDiabetes%252BMellitus%26aulast%3DMo%26aufirst%3DXiu-Lei%26date%3D2014%26spage%3D95%26epage%3D131%26pub%3DElsevier%26atitle%3DGlucose%252BHomeostatis%252Band%252Bthe%252BPathogenesis%252Bof%252BDiabetes%252BMellitus%26date%3D2014%26volume%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kimiyuki  Shibuya</span>, <span class="hlFld-ContribAuthor ">Tomoaki  Koshizawa</span>, <span class="hlFld-ContribAuthor ">Hayato  Hosoi</span>, <span class="hlFld-ContribAuthor ">Gen  Watanabe</span>, <span class="hlFld-ContribAuthor ">Toshiharu  Morimoto</span>, <span class="hlFld-ContribAuthor ">Tadaaki  Ohgiya</span>. </span><span class="cited-content_cbyCitation_article-title">A Practical Synthesis of (4-(Spiro[chromane-2,4'-piperidin]-6-yl)phenyl)methanol as a Key Intermediate of Novel GPR119 Agonist. </span><span class="cited-content_cbyCitation_journal-name">HETEROCYCLES</span><span> <strong>2014,</strong> <em>89 </em>
                                    (7)
                                     , 1632. <a href="https://doi.org/10.3987/COM-14-13012" title="DOI URL">https://doi.org/10.3987/COM-14-13012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3987/COM-14-13012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3987%2FCOM-14-13012%26sid%3Dliteratum%253Aachs%26jtitle%3DHETEROCYCLES%26atitle%3DA%252BPractical%252BSynthesis%252Bof%252B%2525284-%252528Spiro%25255Bchromane-2%25252C4%252527-piperidin%25255D-6-yl%252529phenyl%252529methanol%252Bas%252Ba%252BKey%252BIntermediate%252Bof%252BNovel%252BGPR119%252BAgonist%26aulast%3DShibuya%26aufirst%3DKimiyuki%26date%3D2014%26volume%3D89%26issue%3D7%26spage%3D1632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sang-Uk  Kang</span>. </span><span class="cited-content_cbyCitation_article-title">GPR119 agonists: a promising approach for T2DM treatment? A SWOT analysis of GPR119. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2013,</strong> <em>18 </em>
                                    (23-24)
                                     , 1309-1315. <a href="https://doi.org/10.1016/j.drudis.2013.09.011" title="DOI URL">https://doi.org/10.1016/j.drudis.2013.09.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2013.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2013.09.011%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DGPR119%252Bagonists%25253A%252Ba%252Bpromising%252Bapproach%252Bfor%252BT2DM%252Btreatment%25253F%252BA%252BSWOT%252Banalysis%252Bof%252BGPR119%26aulast%3DKang%26aufirst%3DSang-Uk%26date%3D2013%26volume%3D18%26issue%3D23-24%26spage%3D1309%26epage%3D1315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Toma N.  Glasnov</span>. </span><span class="cited-content_cbyCitation_article-title">Highlights from the Flow Chemistry Literature 2013 (Part 1). </span><span class="cited-content_cbyCitation_journal-name">Journal of Flow Chemistry</span><span> <strong>2013,</strong> <em>3 </em>
                                    (2)
                                     , 59-63. <a href="https://doi.org/10.1556/JFC-D-13-00008" title="DOI URL">https://doi.org/10.1556/JFC-D-13-00008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1556/JFC-D-13-00008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1556%2FJFC-D-13-00008%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Flow%2520Chemistry%26atitle%3DHighlights%252Bfrom%252Bthe%252BFlow%252BChemistry%252BLiterature%252B2013%252B%252528Part%252B1%252529%26aulast%3DGlasnov%26aufirst%3DToma%2BN.%26date%3D2013%26volume%3D3%26issue%3D2%26spage%3D59%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James S.  Scott</span>, <span class="hlFld-ContribAuthor ">Katy J.  Brocklehurst</span>, <span class="hlFld-ContribAuthor ">Hayley S.  Brown</span>, <span class="hlFld-ContribAuthor ">David S.  Clarke</span>, <span class="hlFld-ContribAuthor ">Helen  Coe</span>, <span class="hlFld-ContribAuthor ">Sam D.  Groombridge</span>, <span class="hlFld-ContribAuthor ">David  Laber</span>, <span class="hlFld-ContribAuthor ">Philip A.  MacFaul</span>, <span class="hlFld-ContribAuthor ">Darren  McKerrecher</span>, <span class="hlFld-ContribAuthor ">Paul  Schofield</span>. </span><span class="cited-content_cbyCitation_article-title">Conformational restriction in a series of GPR119 agonists: Differences in pharmacology between mouse and human. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (11)
                                     , 3175-3179. <a href="https://doi.org/10.1016/j.bmcl.2013.04.006" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.04.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.04.006%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DConformational%252Brestriction%252Bin%252Ba%252Bseries%252Bof%252BGPR119%252Bagonists%25253A%252BDifferences%252Bin%252Bpharmacology%252Bbetween%252Bmouse%252Band%252Bhuman%26aulast%3DScott%26aufirst%3DJames%2BS.%26date%3D2013%26volume%3D23%26issue%3D11%26spage%3D3175%26epage%3D3179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yoshiharu  Iwabuchi</span>, <span class="hlFld-ContribAuthor ">Yusuke  Sasano</span>, <span class="hlFld-ContribAuthor ">Tomohiro  Nishiyama</span>, <span class="hlFld-ContribAuthor ">Masaki  Tomizawa</span>, <span class="hlFld-ContribAuthor ">Masatoshi  Shibuya</span>. </span><span class="cited-content_cbyCitation_article-title">C–H MODIFICATION OF 2-AZAADAMANTANE: SYNTHESIS OF C5-FUNCTIONALIZED AZADOS FOR ADVANCED USE. </span><span class="cited-content_cbyCitation_journal-name">HETEROCYCLES</span><span> <strong>2013,</strong> <em>87 </em>
                                    (10)
                                     , 2109. <a href="https://doi.org/10.3987/COM-13-12804" title="DOI URL">https://doi.org/10.3987/COM-13-12804</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3987/COM-13-12804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3987%2FCOM-13-12804%26sid%3Dliteratum%253Aachs%26jtitle%3DHETEROCYCLES%26atitle%3DC%2525E2%252580%252593H%252BMODIFICATION%252BOF%252B2-AZAADAMANTANE%25253A%252BSYNTHESIS%252BOF%252BC5-FUNCTIONALIZED%252BAZADOS%252BFOR%252BADVANCED%252BUSE%26aulast%3DIwabuchi%26aufirst%3DYoshiharu%26date%3D2013%26volume%3D87%26issue%3D10%26spage%3D2109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/medium/jm-2012-01626p_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301626p&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/medium/jm-2012-01626p_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Functional profile for bridged cyclic vs unbridged structures.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301626p&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/medium/jm-2012-01626p_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0006.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Retrosynthetic Analysis of the 2,6-Diazatricyclo[3.3.1.1∼3,7∼]decane Ring System</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301626p&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/medium/jm-2012-01626p_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0007.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Mannich/Reductive Amination Approach<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301626p&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 1,3-acetonedicarboxylic acid, BnNH<sub>2</sub>, conc HCl, H<sub>2</sub>O, 50 °C (35%); (b) H<sub>2</sub>, Pd(OH)<sub>2</sub>, Boc<sub>2</sub>O, MeOH, 23 °C (quant).</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/medium/jm-2012-01626p_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0008.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Rassat’s Route to 2,6-Diazaadamantane Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301626p&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Br<sub>2</sub>, cyclohexane, 0 °C; (b) 84% H<sub>2</sub>SO<sub>4</sub>, 65 °C, 30 min (<b>15</b>, 30%, <b>18</b>, 33%).</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/medium/jm-2012-01626p_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0009.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Initial Hofmann–Löffler–Freytag Reaction<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301626p&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NCS, Et<sub>2</sub>O, 0 °C, 5 min; then Et<sub>3</sub>N, hν, 0 °C, 45 min (<b>17</b>, 29%; <b>18</b>, 40%).</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/medium/jm-2012-01626p_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0010.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Optimization of the Hofmann–Löffler–Freytag Reaction<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301626p&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>t</i>-BuOCl, Et<sub>2</sub>O, 23 °C, 15 min; then hν, 35 °C, 60 min, (68%) of 3:1 mix <b>20</b>/<b>19</b>; (b) Boc<sub>2</sub>O, Et<sub>3</sub>N, MeOH, 23 °C, 30 min (54%, steps a and b); (c) 1-methylcyclopropyl 4-nitrophenylcarbonate, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 16 h, (44%, steps a and c); (d) KMnO<sub>4</sub>, NaOH (1.5 N), THF, 68 h (90%); (e) ACE-Cl, 1,2-DCE, 90 °C, 1.5 h; MeOH, 90 °C, 1.5 h (93%).</p></p></figure><figure data-id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/medium/jm-2012-01626p_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0011.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Addition of the 2,6-Diazatricyclo[3.3.1.1∼3,7∼]decane to Biaryl Chloropyrimidine via S<sub>N</sub>Ar<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301626p&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2-fluoro-4-(methylsulfonyl)phenol, Cs<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, microwave 120 °C, 1.5 h (57%); (b) 2-methyl-2,6-diazatricyclo[3.3.1.1∼3,7∼]decane, Cs<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, microwave 180 °C, 1 h (57%); (c) ACE-Cl, 1,2-DCE, 90 °C, 1.5 h; MeOH, 90 °C, 1.5 h; (d) Boc<sub>2</sub>O, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 23 °C, 30 min (17%, steps c and d); (e) isopropyl chloroformate, DIPEA, CH<sub>2</sub>Cl<sub>2</sub>, 23 °C, 18 h (74%); (f) 1-methylcyclopropyl 4-nitrophenylcarbonate, DIPEA, CH<sub>2</sub>Cl<sub>2</sub>, 16 h (57%).</p></p></figure><figure data-id="fig2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/medium/jm-2012-01626p_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0003.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Piperidinol comparator.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301626p&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/medium/jm-2012-01626p_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0004.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. ORTEP of <b>25b</b> with ellipsoids drawn at the 50% confidence level.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301626p&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/medium/jm-2012-01626p_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0012.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of 2,6-Diazatricyclo[3.3.1.1∼3,7∼]decane Pyridyloxypyrimidine Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301626p&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>tert</i>-butyl 2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate <b>5a</b>, Na<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, 1200 °C, 42 h (53%); (b) 4 N HCl/1,4-dioxane, MeOH, 20 °C, 16 h; (c) R<sub>1</sub>OC(O)X, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 23 °C, 12–16 h (31–94%, steps b and c).</p></p></figure><figure data-id="sch8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/medium/jm-2012-01626p_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0013.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthesis of C-5 Substituted Pyrimidine Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301626p&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2-methylpyridin-3-ol, KO-<i>t</i>-Bu, THF/DMF, 0–23 °C (81–90%); (b) <i>tert</i>-butyl 2,6-diazatricyclo[3.3.1.1∼3,7∼]decane-2-carboxylate <b>5a</b>, Na<sub>2</sub>CO<sub>3</sub> or NaHCO<sub>3</sub>, DMF or DMA, 80–120 °C, 1–16.5 h (51–87%); (c) 4 N HCl/1,4-dioxane, MeOH or TFA, CH<sub>2</sub>Cl<sub>2</sub>, 23 °C, 1.25–3 h; (d) R<sub>1</sub>OC(O)X, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 23 °C, 12–16 h (7–93%, steps c and d).</p></p></figure><figure data-id="sch9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/medium/jm-2012-01626p_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0014.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Synthesis of 2,6-Diazatricyclo[3.3.1.1–3,7∼]decane Analogues with Tail Variations<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301626p&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) R<sub>3</sub>OH, Cs<sub>2</sub>CO<sub>3</sub> or K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN or DMF, 23–120 °C, 1–24 h (43–90%); (b) <i>tert</i>-butyl 2,6-diazatricyclo[3.3.1.1–3,7∼]decane-2-carboxylate <b>5a</b>, NaHCO<sub>3</sub>, Cs<sub>2</sub>CO<sub>3</sub>, or DIPEA, DMF, DMSO, or CH<sub>3</sub>CN, 60–120 °C, 2–64 h, (13–72%); (c) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 23 °C, 3 h; (d) R<sub>1</sub>OC(O)Cl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 23 °C, 12–16 h (24–72%, steps c and d).</p></p></figure><figure data-id="fig4" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/medium/jm-2012-01626p_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0005.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Plot of pEC<sub>50</sub> vs ClogP sized by AgLLE with lines of constant LLE.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301626p/production/images/large/jm-2012-01626p_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301626p&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i95">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86535" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86535" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 53 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span>Diabetes Fact Sheet. <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva, Switzerland</span>, August<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Diabetes+Fact+Sheet.+World+Health+Organization%3A+Geneva%2C+Switzerland%2C+August+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26pub%3DWorld%2520Health%2520Organization%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span> </span><span class="NLM_article-title">International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes</span>.  <span class="citation_source-journal">Diabetes Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1327</span><span class="NLM_x">–</span> <span class="NLM_lpage">1334</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=International+Expert+Committee+Report+on+the+Role+of+the+A1C+Assay+in+the+Diagnosis+of+Diabetes.+Diabetes+Care+2009%2C+32%2C+1327%E2%80%931334."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26atitle%3DInternational%2520Expert%2520Committee%2520Report%2520on%2520the%2520Role%2520of%2520the%2520A1C%2520Assay%2520in%2520the%2520Diagnosis%2520of%2520Diabetes%26jtitle%3DDiabetes%2520Care%26date%3D2009%26volume%3D32%26spage%3D1327%26epage%3D1334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Krentz, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, C. J.</span><span> </span><span class="NLM_article-title">Oral Antidiabetic Agents: Current Role in Type 2 Diabetes Mellitus</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">411</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=385-411&author=A.+J.+Krentzauthor=C.+J.+Bailey&title=Oral+Antidiabetic+Agents%3A+Current+Role+in+Type+2+Diabetes+Mellitus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKrentz%26aufirst%3DA.%2BJ.%26aulast%3DBailey%26aufirst%3DC.%2BJ.%26atitle%3DOral%2520Antidiabetic%2520Agents%253A%2520Current%2520Role%2520in%2520Type%25202%2520Diabetes%2520Mellitus%26jtitle%3DDrugs%26date%3D2005%26volume%3D65%26spage%3D385%26epage%3D411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">DeFronzo, R. A.</span><span> </span><span class="NLM_article-title">From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">773</span><span class="NLM_x">–</span> <span class="NLM_lpage">795</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2009&pages=773-795&author=R.+A.+DeFronzo&title=From+the+Triumvirate+to+the+Ominous+Octet%3A+A+New+Paradigm+for+the+Treatment+of+Type+2+Diabetes+Mellitus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeFronzo%26aufirst%3DR.%2BA.%26atitle%3DFrom%2520the%2520Triumvirate%2520to%2520the%2520Ominous%2520Octet%253A%2520A%2520New%2520Paradigm%2520for%2520the%2520Treatment%2520of%2520Type%25202%2520Diabetes%2520Mellitus%26jtitle%3DDiabetes%26date%3D2009%26volume%3D58%26spage%3D773%26epage%3D795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Chao, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, R. R.</span><span> </span><span class="NLM_article-title">SGLT2 Inhibition—A Novel Strategy for Diabetes Treatment</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">551</span><span class="NLM_x">–</span> <span class="NLM_lpage">559</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=551-559&author=E.+C.+Chaoauthor=R.+R.+Henry&title=SGLT2+Inhibition%E2%80%94A+Novel+Strategy+for+Diabetes+Treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChao%26aufirst%3DE.%2BC.%26aulast%3DHenry%26aufirst%3DR.%2BR.%26atitle%3DSGLT2%2520Inhibition%25E2%2580%2594A%2520Novel%2520Strategy%2520for%2520Diabetes%2520Treatment%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D551%26epage%3D559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Briones, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajaj, M.</span><span> </span><span class="NLM_article-title">Exenatide: A GLP-1 Receptor Agonist As Novel Therapy for Type 2 Diabetes Mellitus</span> <span class="citation_source-journal">Expert Opin. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1055</span><span class="NLM_x">–</span> <span class="NLM_lpage">1064</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm301626p&amp;key=10.1517%2F14656566.7.8.1055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm301626p&amp;key=16722815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm301626p&amp;key=1%3ACAS%3A528%3ADC%252BD28XltVOgsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=1055-1064&author=M.+Brionesauthor=M.+Bajaj&title=Exenatide%3A+A+GLP-1+Receptor+Agonist+As+Novel+Therapy+for+Type+2+Diabetes+Mellitus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Exenatide: a GLP-1 receptor agonist as novel therapy for Type 2 diabetes mellitus</span></div><div class="casAuthors">Briones, Mariele; Bajaj, Mandeep</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1055-1064</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Exenatide is a glucagon-like peptide 1 receptor agonist, which has recently received FDA approval in the US for the treatment of Type 2 diabetes.  Exenatide is an incretin mimetic that improves glycemic control in patients with diabetes through acute mechanisms, such as glucose-dependent stimulation of insulin secretion, suppression of inappropriate glucagon secretion and slowing of gastric emptying, as well as chronic mechanisms that include enhancement of β-cell mass in rodent studies and wt. loss and inhibition of food intake in humans.  This article reviews the mechanisms of exenatide action, as well as its efficacy in the treatment of Type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB6R6S9GYNNbVg90H21EOLACvtfcHk0ljMOgTQ_J6gjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltVOgsrk%253D&md5=b37a4213cd24bd2219d1886b66d1307c</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1517%2F14656566.7.8.1055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.7.8.1055%26sid%3Dliteratum%253Aachs%26aulast%3DBriones%26aufirst%3DM.%26aulast%3DBajaj%26aufirst%3DM.%26atitle%3DExenatide%253A%2520A%2520GLP-1%2520Receptor%2520Agonist%2520As%2520Novel%2520Therapy%2520for%2520Type%25202%2520Diabetes%2520Mellitus%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2006%26volume%3D7%26spage%3D1055%26epage%3D1064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Derosa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maffioli, P.</span><span> </span><span class="NLM_article-title">Dipeptidyl Peptidase-4 Inhibitors: 3 Years of Experience</span> <span class="citation_source-journal">Diabetes Technol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">350</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm301626p&amp;key=10.1089%2Fdia.2011.0204" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm301626p&amp;key=22324384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm301626p&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvFSnsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=350-364&author=G.+Derosaauthor=P.+Maffioli&title=Dipeptidyl+Peptidase-4+Inhibitors%3A+3+Years+of+Experience"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl Peptidase-4 Inhibitors: 3 Years of Experience</span></div><div class="casAuthors">Derosa, Giuseppe; Maffioli, Pamela</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes Technology & Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">350-364</span>CODEN:
                <span class="NLM_cas:coden">DTTHFH</span>;
        ISSN:<span class="NLM_cas:issn">1520-9156</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">According to the latest American Diabetes Assocn. guidelines, lowering glycated Hb (HbA1c) to below or around 7% has been shown to reduce microvascular and neuropathic complications of diabetes and, if implemented soon after the diagnosis of diabetes, is assocd. with long-term redn. in macrovascular disease.  Recently a new class of antidiabetes drugs has been developed, dipeptidyl peptidase-4 (DPP-4) inhibitors, which act by inhibiting DPP-4, the enzyme that inactivates glucagon-like peptide-1 (GLP-1).  Through the inhibition of DPP-4, DPP-4 inhibitors enhance the effects of GLP-1 and glucose-dependent insulinotropic peptide, increasing glucose-mediated insulin secretion and suppressing glucagon secretion.  We conducted a review analyzing clin. efficacy and safety of DPP-4 inhibitors, both alone and in combination with other antidiabetes drugs, including randomized controlled trials about sitagliptin, vildagliptin, saxagliptin, and linagliptin conducted in the latest 15 years.  We concluded that, once metformin fails to maintain glycemic control, addn. of DPP-4 inhibitors should be the logical choice: they seems to lower HbA1c levels by 0.6-0.9 percentage points and to have a comparable effect on HbA1c vs. the addn. of a sulfonylurea or glitazone.  They also have pos. effects on β-cell function, and they have neutral effects on body wt.  Furthermore, DPP-4 inhibitors prevent the risk of hypoglycemia posed by sulfonylureas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWF2HG6yjq3bVg90H21EOLACvtfcHk0ljMOgTQ_J6gjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvFSnsrk%253D&md5=c17b5978ffa303d88b1ad76dca040199</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1089%2Fdia.2011.0204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fdia.2011.0204%26sid%3Dliteratum%253Aachs%26aulast%3DDerosa%26aufirst%3DG.%26aulast%3DMaffioli%26aufirst%3DP.%26atitle%3DDipeptidyl%2520Peptidase-4%2520Inhibitors%253A%25203%2520Years%2520of%2520Experience%26jtitle%3DDiabetes%2520Technol.%2520Ther.%26date%3D2012%26volume%3D14%26spage%3D350%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Ohishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, S.</span><span> </span><span class="NLM_article-title">The Therapeutic Potential of GPR119 Agonists for Type 2 Diabetes</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">321</span><span class="NLM_x">–</span> <span class="NLM_lpage">328</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=321-328&author=T.+Ohishiauthor=S.+Yoshida&title=The+Therapeutic+Potential+of+GPR119+Agonists+for+Type+2+Diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOhishi%26aufirst%3DT.%26aulast%3DYoshida%26aufirst%3DS.%26atitle%3DThe%2520Therapeutic%2520Potential%2520of%2520GPR119%2520Agonists%2520for%2520Type%25202%2520Diabetes%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2012%26volume%3D21%26spage%3D321%26epage%3D328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Dhayal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, N. G.</span><span> </span><span class="NLM_article-title">The Significance of GPR119 Agonists as a Future Treatment for Type 2 Diabetes</span> <span class="citation_source-journal">Drug News Perspect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">418</span><span class="NLM_x">–</span> <span class="NLM_lpage">424</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm301626p&amp;key=20862393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm301626p&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1Squ7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2010&pages=418-424&author=S.+Dhayalauthor=N.+G.+Morgan&title=The+Significance+of+GPR119+Agonists+as+a+Future+Treatment+for+Type+2+Diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The significance of GPR119 agonists as a future treatment for type 2 diabetes</span></div><div class="casAuthors">Morgan, Noel G.; Dhayal, Shalinee</div><div class="citationInfo"><span class="NLM_cas:title">Drug News & Perspectives</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">418-424</span>CODEN:
                <span class="NLM_cas:coden">DNPEED</span>;
        ISSN:<span class="NLM_cas:issn">0214-0934</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  GPR119 is a G protein-coupled receptor that is expressed on only a limited no. of tissues, including pancreatic β-cells and enteroendocrine cells in the small intestine, and that appears to be involved in the regulation of metabolic homeostasis.  The protein was originally defined as an orphan receptor, but it has subsequently been shown to bind a variety of lipid-derived ligands, as well as a range of small synthetic mols.  There is still debate as to the identity of its principal endogenous ligand, but certain lysophospholipids species, various fatty acyl-ethanolamides and N-oleoyldopamine have all been proposed as potential agonists.  GPR119 is coupled to the signal transducer Gαs and activation of the receptor leads to increased adenylate cyclase activity via Gαs and a rise in intracellular cAMP.  This then potentiates glucose-induced insulin secretion or promotes the release of intestinal incretin hormones, according to cell type.  Both mechanisms ultimately lead to a rise in insulin secretion (either directly or indirectly) and improved glucose control.  Thus, GPR119 may represent an important new therapeutic target for the design of insulin secretagogues able to promote improvements in blood glucose control in patients with type 2 diabetes.  Accordingly, a range of lead compds. are in development as potential therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCF8Hp9CJ0irVg90H21EOLACvtfcHk0ljfKSNEwdugLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1Squ7nN&md5=87b158bbda240cd2b595edb3b68dfefe</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDhayal%26aufirst%3DS.%26aulast%3DMorgan%26aufirst%3DN.%2BG.%26atitle%3DThe%2520Significance%2520of%2520GPR119%2520Agonists%2520as%2520a%2520Future%2520Treatment%2520for%2520Type%25202%2520Diabetes%26jtitle%3DDrug%2520News%2520Perspect.%26date%3D2010%26volume%3D23%26spage%3D418%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Gao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weng, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhagroo, N. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorenson, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Z.</span><span> </span><span class="NLM_article-title">Stimulating beta Cell Replication and Improving Islet Graft Function by GPR119 Agonists</span> <span class="citation_source-journal">Transplant Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1124</span><span class="NLM_x">–</span> <span class="NLM_lpage">1134</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm301626p&amp;key=10.1111%2Fj.1432-2277.2011.01332.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm301626p&amp;key=21902730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm301626p&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2rsbzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=1124-1134&author=J.+Gaoauthor=L.+Tianauthor=G.+Wengauthor=N.+V.+Bhagrooauthor=R.+L.+Sorensonauthor=T.+D.+O%E2%80%99Brienauthor=J.+Luoauthor=Z.+Guo&title=Stimulating+beta+Cell+Replication+and+Improving+Islet+Graft+Function+by+GPR119+Agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Stimulating beta cell replication and improving islet graft function GPR119 agonists</span></div><div class="casAuthors">Gao, Jie; Tian, Lei; Weng, Guobin; Bhagroo, Nicholas V.; Sorenson, Robert L.; O'Brien, Timothy D.; Luo, Jian; Guo, Zhiguang</div><div class="citationInfo"><span class="NLM_cas:title">Transplant International</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1124-1134</span>CODEN:
                <span class="NLM_cas:coden">TRINE5</span>;
        ISSN:<span class="NLM_cas:issn">0934-0874</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">G protein-coupled receptor 119 (GPR119) is predominantly expressed in β cells and intestinal L cells.  In this study, we investigated whether oleoylethanolamide (OEA), a GPR119 endogenous ligand, and PSN632408, a GPR119 synthetic agonist, can stimulate β-cell replication in vitro and in vivo and improve islet graft function in diabetic mice.  We found that OEA and PSN632408 significantly increased nos. of insulin+/5-bromo-2'-deoxyuridine (BrdU)+ β cells in cultured mouse islets in a dose-dependent manner.  All diabetic recipient mice, given marginal syngeneic islet transplants with OEA or PSN632408 or vehicle, achieved normoglycemia at 4 wk after transplantation.  However, normoglycemia was achieved significantly faster in OEA- or PSN632408-treated diabetic mice than in vehicle-treated diabetic mice (P < 0.05).  The percentage of insulin+/BrdU+ β cells in islet grafts in OEA- and PSN632408-treated mice was significantly higher than in vehicle-treated mice (P < 0.01).  Our data demonstrated that OEA and PSN632408 can stimulate β-cell replication in vitro and in vivo and improve islet graft function.  Targeting GPR119 is a novel therapeutic approach to increase β-cell mass and to improve islet graft function by stimulating β-cell replication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobMOzNy5VWoLVg90H21EOLACvtfcHk0ljfKSNEwdugLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2rsbzI&md5=0e70e491b52e5b734442ae0cf27c509d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-2277.2011.01332.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-2277.2011.01332.x%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DTian%26aufirst%3DL.%26aulast%3DWeng%26aufirst%3DG.%26aulast%3DBhagroo%26aufirst%3DN.%2BV.%26aulast%3DSorenson%26aufirst%3DR.%2BL.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DT.%2BD.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DZ.%26atitle%3DStimulating%2520beta%2520Cell%2520Replication%2520and%2520Improving%2520Islet%2520Graft%2520Function%2520by%2520GPR119%2520Agonists%26jtitle%3DTransplant%2520Int.%26date%3D2011%26volume%3D24%26spage%3D1124%26epage%3D1134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Katz, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gambale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothenberg, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanapalli, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaccaro, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polidori, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vets, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarich, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, P. P.</span><span> </span><span class="NLM_article-title">Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of JNJ-38431055, a Novel GPR119 Receptor Agonist and Potential Antidiabetes Agent, in Healthy Male Subjects</span> <span class="citation_source-journal">Clin. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">685</span><span class="NLM_x">–</span> <span class="NLM_lpage">692</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm301626p&amp;key=10.1038%2Fclpt.2011.169" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm301626p&amp;key=21975348" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm301626p&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlGlsLnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2011&pages=685-692&author=L.+B.+Katzauthor=J.+J.+Gambaleauthor=P.+L.+Rothenbergauthor=S.+R.+Vanapalliauthor=N.+Vaccaroauthor=L.+Xiauthor=D.+C.+Polidoriauthor=E.+Vetsauthor=T.+C.+Sarichauthor=P.+P.+Stein&title=Pharmacokinetics%2C+Pharmacodynamics%2C+Safety%2C+and+Tolerability+of+JNJ-38431055%2C+a+Novel+GPR119+Receptor+Agonist+and+Potential+Antidiabetes+Agent%2C+in+Healthy+Male+Subjects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of JNJ-38431055, a Novel GPR119 Receptor Agonist and Potential Antidiabetes Agent, in Healthy Male Subjects</span></div><div class="casAuthors">Katz, L. B.; Gambale, J. J.; Rothenberg, P. L.; Vanapalli, S. R.; Vaccaro, N.; Xi, L.; Polidori, D. C.; Vets, E.; Sarich, T. C.; Stein, P. P.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">685-692</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The incidence of type 2 diabetes mellitus is increasing worldwide.  Several G-protein-coupled receptor agonists are being studied for their efficacy as antidiabetes agents.  JNJ-38431055 is a novel, potent, and orally available selective agonist of the glucose-dependent insulinotropic (GPR119) receptor.  Double-blind, randomized, placebo-controlled studies were conducted to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of JNJ-38431055 (2.5-800 mg) in healthy male volunteers.  The systemic exposure of JNJ-38431055 in plasma increased in proportion to the dose and was not influenced by coadministration of food.  The terminal elimination half-life was ∼13 h when administered as an oral suspension formulation.  JNJ-38431055 was well tolerated and was not assocd. with hypoglycemia.  As compared with placebo, single-dose oral JNJ-38431055 increased postmeal plasma glucagon-like peptide 1 (GLP-1), glucose-dependent insulinotropic peptide (GIP), and peptide YY (PYY) concns. but did not significantly decrease glucose excursion or increase insulin secretion.  However, in a graded glucose infusion study, JNJ-38431055 was shown to induce a higher insulin secretion rate (ISR) relative to placebo at elevated plasma glucose levels.  These studies provide evidence for the potential efficacy of JNJ-38431055 as an antidiabetes agent in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu9J3wfDOF_LVg90H21EOLACvtfcHk0ljfKSNEwdugLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlGlsLnP&md5=a9345cd8b438a8568505c0ff327f522f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fclpt.2011.169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fclpt.2011.169%26sid%3Dliteratum%253Aachs%26aulast%3DKatz%26aufirst%3DL.%2BB.%26aulast%3DGambale%26aufirst%3DJ.%2BJ.%26aulast%3DRothenberg%26aufirst%3DP.%2BL.%26aulast%3DVanapalli%26aufirst%3DS.%2BR.%26aulast%3DVaccaro%26aufirst%3DN.%26aulast%3DXi%26aufirst%3DL.%26aulast%3DPolidori%26aufirst%3DD.%2BC.%26aulast%3DVets%26aufirst%3DE.%26aulast%3DSarich%26aufirst%3DT.%2BC.%26aulast%3DStein%26aufirst%3DP.%2BP.%26atitle%3DPharmacokinetics%252C%2520Pharmacodynamics%252C%2520Safety%252C%2520and%2520Tolerability%2520of%2520JNJ-38431055%252C%2520a%2520Novel%2520GPR119%2520Receptor%2520Agonist%2520and%2520Potential%2520Antidiabetes%2520Agent%252C%2520in%2520Healthy%2520Male%2520Subjects%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D2011%26volume%3D90%26spage%3D685%26epage%3D692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Katz, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gambale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothenberg, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanapalli, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaccaro, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarich, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, P. P.</span><span> </span><span class="NLM_article-title">Effects of JNJ-38431055, a Novel GPR119 Receptor Agonist, in Randomized, Double-Blind, Placebo-Controlled Studies in Subjects with Type 2 Diabetes</span> <span class="citation_source-journal">Diabetes Obes. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=1-8&author=L.+B.+Katzauthor=J.+J.+Gambaleauthor=P.+L.+Rothenbergauthor=S.+R.+Vanapalliauthor=N.+Vaccaroauthor=L.+Xiauthor=T.+C.+Sarichauthor=P.+P.+Stein&title=Effects+of+JNJ-38431055%2C+a+Novel+GPR119+Receptor+Agonist%2C+in+Randomized%2C+Double-Blind%2C+Placebo-Controlled+Studies+in+Subjects+with+Type+2+Diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKatz%26aufirst%3DL.%2BB.%26aulast%3DGambale%26aufirst%3DJ.%2BJ.%26aulast%3DRothenberg%26aufirst%3DP.%2BL.%26aulast%3DVanapalli%26aufirst%3DS.%2BR.%26aulast%3DVaccaro%26aufirst%3DN.%26aulast%3DXi%26aufirst%3DL.%26aulast%3DSarich%26aufirst%3DT.%2BC.%26aulast%3DStein%26aufirst%3DP.%2BP.%26atitle%3DEffects%2520of%2520JNJ-38431055%252C%2520a%2520Novel%2520GPR119%2520Receptor%2520Agonist%252C%2520in%2520Randomized%252C%2520Double-Blind%252C%2520Placebo-Controlled%2520Studies%2520in%2520Subjects%2520with%2520Type%25202%2520Diabetes%26jtitle%3DDiabetes%2520Obes.%2520Metab.%26date%3D2012%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Semple, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruce, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sage, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebring, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, Z. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Shamma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grottick, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demarest, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. M.</span><span> </span><span class="NLM_article-title">Discovery of a Second Generation Agonist of the Orphan G-Protein Coupled Receptor GPR119 with an Improved Profile</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1750</span><span class="NLM_x">–</span> <span class="NLM_lpage">1755</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1750-1755&author=G.+Sempleauthor=J.+Lehmannauthor=A.+Wongauthor=A.+Renauthor=M.+Bruceauthor=Y.+J.+Shinauthor=C.+R.+Sageauthor=M.+Morganauthor=W.+C.+Chenauthor=K.+Sebringauthor=Z.+L.+Chuauthor=J.+N.+Leonardauthor=H.+Al-Shammaauthor=A.+J.+Grottickauthor=F.+Duauthor=Y.+Liangauthor=K.+Demarestauthor=R.+M.+Jones&title=Discovery+of+a+Second+Generation+Agonist+of+the+Orphan+G-Protein+Coupled+Receptor+GPR119+with+an+Improved+Profile"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSemple%26aufirst%3DG.%26aulast%3DLehmann%26aufirst%3DJ.%26aulast%3DWong%26aufirst%3DA.%26aulast%3DRen%26aufirst%3DA.%26aulast%3DBruce%26aufirst%3DM.%26aulast%3DShin%26aufirst%3DY.%2BJ.%26aulast%3DSage%26aufirst%3DC.%2BR.%26aulast%3DMorgan%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DW.%2BC.%26aulast%3DSebring%26aufirst%3DK.%26aulast%3DChu%26aufirst%3DZ.%2BL.%26aulast%3DLeonard%26aufirst%3DJ.%2BN.%26aulast%3DAl-Shamma%26aufirst%3DH.%26aulast%3DGrottick%26aufirst%3DA.%2BJ.%26aulast%3DDu%26aufirst%3DF.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DDemarest%26aufirst%3DK.%26aulast%3DJones%26aufirst%3DR.%2BM.%26atitle%3DDiscovery%2520of%2520a%2520Second%2520Generation%2520Agonist%2520of%2520the%2520Orphan%2520G-Protein%2520Coupled%2520Receptor%2520GPR119%2520with%2520an%2520Improved%2520Profile%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D1750%26epage%3D1755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Mascitti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClure, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guimarães, C. R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farley, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munchhof, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Futatsugi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavergne, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefker, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornelius, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonin, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span> </span><span class="NLM_article-title">Design and Evaluation of a 2-(2,3,6-Trifluorophenyl)acetamide Derivative as an Agonist of the GPR119 Receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1306</span><span class="NLM_x">–</span> <span class="NLM_lpage">1309</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=1306-1309&author=V.+Mascittiauthor=B.+D.+Stevensauthor=C.+Choiauthor=K.+F.+McClureauthor=C.+R.+W.+Guimar%C3%A3esauthor=K.+A.+Farleyauthor=M.+J.+Munchhofauthor=R.+P.+Robinsonauthor=K.+Futatsugiauthor=S.+Y.+Lavergneauthor=B.+A.+Lefkerauthor=P.+Corneliusauthor=P.+D.+Boninauthor=A.+S.+Kalgutkarauthor=R.+Sharmaauthor=Y.+Chen&title=Design+and+Evaluation+of+a+2-%282%2C3%2C6-Trifluorophenyl%29acetamide+Derivative+as+an+Agonist+of+the+GPR119+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMascitti%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DB.%2BD.%26aulast%3DChoi%26aufirst%3DC.%26aulast%3DMcClure%26aufirst%3DK.%2BF.%26aulast%3DGuimar%25C3%25A3es%26aufirst%3DC.%2BR.%2BW.%26aulast%3DFarley%26aufirst%3DK.%2BA.%26aulast%3DMunchhof%26aufirst%3DM.%2BJ.%26aulast%3DRobinson%26aufirst%3DR.%2BP.%26aulast%3DFutatsugi%26aufirst%3DK.%26aulast%3DLavergne%26aufirst%3DS.%2BY.%26aulast%3DLefker%26aufirst%3DB.%2BA.%26aulast%3DCornelius%26aufirst%3DP.%26aulast%3DBonin%26aufirst%3DP.%2BD.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DY.%26atitle%3DDesign%2520and%2520Evaluation%2520of%2520a%25202-%25282%252C3%252C6-Trifluorophenyl%2529acetamide%2520Derivative%2520as%2520an%2520Agonist%2520of%2520the%2520GPR119%2520Receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D1306%26epage%3D1309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Brocklehurst, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butlin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidsson, Ö.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groombridge, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKerrecher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poucher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schofield, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teague, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westgate, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M. J. M.</span><span> </span><span class="NLM_article-title">Discovery, Optimisation and in Vivo Evaluation of Novel GPR119 Agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">7310</span><span class="NLM_x">–</span> <span class="NLM_lpage">7316</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=7310-7316&author=K.+J.+Brocklehurstauthor=A.+Brooauthor=R.+J.+Butlinauthor=H.+S.+Brownauthor=D.+S.+Clarkeauthor=%C3%96.+Davidssonauthor=K.+Goldbergauthor=S.+D.+Groombridgeauthor=E.+E.+Kellyauthor=A.+Leachauthor=D.+McKerrecherauthor=C.+O%E2%80%99Donnellauthor=S.+Poucherauthor=P.+Schofieldauthor=J.+S.+Scottauthor=J.+Teagueauthor=L.+Westgateauthor=M.+J.+M.+Wood&title=Discovery%2C+Optimisation+and+in+Vivo+Evaluation+of+Novel+GPR119+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrocklehurst%26aufirst%3DK.%2BJ.%26aulast%3DBroo%26aufirst%3DA.%26aulast%3DButlin%26aufirst%3DR.%2BJ.%26aulast%3DBrown%26aufirst%3DH.%2BS.%26aulast%3DClarke%26aufirst%3DD.%2BS.%26aulast%3DDavidsson%26aufirst%3D%25C3%2596.%26aulast%3DGoldberg%26aufirst%3DK.%26aulast%3DGroombridge%26aufirst%3DS.%2BD.%26aulast%3DKelly%26aufirst%3DE.%2BE.%26aulast%3DLeach%26aufirst%3DA.%26aulast%3DMcKerrecher%26aufirst%3DD.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%26aulast%3DPoucher%26aufirst%3DS.%26aulast%3DSchofield%26aufirst%3DP.%26aulast%3DScott%26aufirst%3DJ.%2BS.%26aulast%3DTeague%26aufirst%3DJ.%26aulast%3DWestgate%26aufirst%3DL.%26aulast%3DWood%26aufirst%3DM.%2BJ.%2BM.%26atitle%3DDiscovery%252C%2520Optimisation%2520and%2520in%2520Vivo%2520Evaluation%2520of%2520Novel%2520GPR119%2520Agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D7310%26epage%3D7316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Negoro, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yonetoku, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, M.</span><span> </span><span class="NLM_article-title">Synthesis and Structure–Activity Relationship of 4-Amino-2-phenylpyrimidine Derivatives as a Series of Novel GPR119 Agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2369</span><span class="NLM_x">–</span> <span class="NLM_lpage">2375</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=2369-2375&author=K.+Negoroauthor=Y.+Yonetokuauthor=T.+Maruyamaauthor=S.+Yoshidaauthor=M.+Takeuchiauthor=M.+Ohta&title=Synthesis+and+Structure%E2%80%93Activity+Relationship+of+4-Amino-2-phenylpyrimidine+Derivatives+as+a+Series+of+Novel+GPR119+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNegoro%26aufirst%3DK.%26aulast%3DYonetoku%26aufirst%3DY.%26aulast%3DMaruyama%26aufirst%3DT.%26aulast%3DYoshida%26aufirst%3DS.%26aulast%3DTakeuchi%26aufirst%3DM.%26aulast%3DOhta%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520Structure%25E2%2580%2593Activity%2520Relationship%2520of%25204-Amino-2-phenylpyrimidine%2520Derivatives%2520as%2520a%2520Series%2520of%2520Novel%2520GPR119%2520Agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D2369%26epage%3D2375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Negoro, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yonetoku, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misawa-Mukai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamaguchi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, M.</span><span> </span><span class="NLM_article-title">Discovery and Biological Evaluation of Novel 4-Amino-2-phenylpyrimidine Derivatives as Potent and Orally Active GPR119 Agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">5235</span><span class="NLM_x">–</span> <span class="NLM_lpage">5246</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=5235-5246&author=K.+Negoroauthor=Y.+Yonetokuauthor=H.+Misawa-Mukaiauthor=W.+Hamaguchiauthor=T.+Maruyamaauthor=S.+Yoshidaauthor=M.+Takeuchiauthor=M.+Ohta&title=Discovery+and+Biological+Evaluation+of+Novel+4-Amino-2-phenylpyrimidine+Derivatives+as+Potent+and+Orally+Active+GPR119+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNegoro%26aufirst%3DK.%26aulast%3DYonetoku%26aufirst%3DY.%26aulast%3DMisawa-Mukai%26aufirst%3DH.%26aulast%3DHamaguchi%26aufirst%3DW.%26aulast%3DMaruyama%26aufirst%3DT.%26aulast%3DYoshida%26aufirst%3DS.%26aulast%3DTakeuchi%26aufirst%3DM.%26aulast%3DOhta%26aufirst%3DM.%26atitle%3DDiscovery%2520and%2520Biological%2520Evaluation%2520of%2520Novel%25204-Amino-2-phenylpyrimidine%2520Derivatives%2520as%2520Potent%2520and%2520Orally%2520Active%2520GPR119%2520Agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D5235%26epage%3D5246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Negoro, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yonetoku, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moritomo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayakawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iikubo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, M.</span><span> </span><span class="NLM_article-title">Synthesis and Structure–Activity Relationship of Fused-Pyrimidine Derivatives as a Series of Novel GPR119 Agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">6442</span><span class="NLM_x">–</span> <span class="NLM_lpage">6451</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=6442-6451&author=K.+Negoroauthor=Y.+Yonetokuauthor=A.+Moritomoauthor=M.+Hayakawaauthor=K.+Iikuboauthor=S.+Yoshidaauthor=M.+Takeuchiauthor=M.+Ohta&title=Synthesis+and+Structure%E2%80%93Activity+Relationship+of+Fused-Pyrimidine+Derivatives+as+a+Series+of+Novel+GPR119+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNegoro%26aufirst%3DK.%26aulast%3DYonetoku%26aufirst%3DY.%26aulast%3DMoritomo%26aufirst%3DA.%26aulast%3DHayakawa%26aufirst%3DM.%26aulast%3DIikubo%26aufirst%3DK.%26aulast%3DYoshida%26aufirst%3DS.%26aulast%3DTakeuchi%26aufirst%3DM.%26aulast%3DOhta%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520Structure%25E2%2580%2593Activity%2520Relationship%2520of%2520Fused-Pyrimidine%2520Derivatives%2520as%2520a%2520Series%2520of%2520Novel%2520GPR119%2520Agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D6442%26epage%3D6451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Hansen, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenkilde, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knop, F. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wellner, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diep, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rehfeld, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, U. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holst, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, H. S.</span><span> </span><span class="NLM_article-title">2-Oleoyl Glycerol Is a GPR119 Agonist and Signals GLP-1 Release in Humans</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">E1409</span><span class="NLM_x">–</span> <span class="NLM_lpage">1417</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2011&pages=E1409-1417&author=K.+B.+Hansenauthor=M.+M.+Rosenkildeauthor=F.+K.+Knopauthor=N.+Wellnerauthor=T.+A.+Diepauthor=J.+F.+Rehfeldauthor=U.+B.+Andersenauthor=J.+J.+Holstauthor=H.+S.+Hansen&title=2-Oleoyl+Glycerol+Is+a+GPR119+Agonist+and+Signals+GLP-1+Release+in+Humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DRosenkilde%26aufirst%3DM.%2BM.%26aulast%3DKnop%26aufirst%3DF.%2BK.%26aulast%3DWellner%26aufirst%3DN.%26aulast%3DDiep%26aufirst%3DT.%2BA.%26aulast%3DRehfeld%26aufirst%3DJ.%2BF.%26aulast%3DAndersen%26aufirst%3DU.%2BB.%26aulast%3DHolst%26aufirst%3DJ.%2BJ.%26aulast%3DHansen%26aufirst%3DH.%2BS.%26atitle%3D2-Oleoyl%2520Glycerol%2520Is%2520a%2520GPR119%2520Agonist%2520and%2520Signals%2520GLP-1%2520Release%2520in%2520Humans%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2011%26volume%3D96%26spage%3DE1409%26epage%3D1417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Kogure, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiyamuta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kojima, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, S.</span><span> </span><span class="NLM_article-title">5-Hydroxy-eicosapentaenoic Acid Is an Endogenous GPR119 Agonist and Enhances Glucose-Dependent Insulin Secretion</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">416</span><span class="NLM_x">, </span> <span class="NLM_fpage">58</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=416&publication_year=2011&pages=58-63&author=R.+Kogureauthor=K.+Toyamaauthor=S.+Hiyamutaauthor=I.+Kojimaauthor=S.+Takeda&title=5-Hydroxy-eicosapentaenoic+Acid+Is+an+Endogenous+GPR119+Agonist+and+Enhances+Glucose-Dependent+Insulin+Secretion"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKogure%26aufirst%3DR.%26aulast%3DToyama%26aufirst%3DK.%26aulast%3DHiyamuta%26aufirst%3DS.%26aulast%3DKojima%26aufirst%3DI.%26aulast%3DTakeda%26aufirst%3DS.%26atitle%3D5-Hydroxy-eicosapentaenoic%2520Acid%2520Is%2520an%2520Endogenous%2520GPR119%2520Agonist%2520and%2520Enhances%2520Glucose-Dependent%2520Insulin%2520Secretion%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2011%26volume%3D416%26spage%3D58%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">McClure, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darout, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guimarães, C. R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeNinno, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mascitti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munchhof, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohrt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samp, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefker, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Futatsugi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonin, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornelius, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salter, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornby, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span> </span><span class="NLM_article-title">Activation of the G-Protein-Coupled Receptor 119: A Conformation-Based Hypothesis for Understanding Agonist Response</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1948</span><span class="NLM_x">–</span> <span class="NLM_lpage">1952</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200003p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1948-1952&author=K.+F.+McClureauthor=E.+Daroutauthor=C.+R.+W.+Guimar%C3%A3esauthor=M.+P.+DeNinnoauthor=V.+Mascittiauthor=M.+J.+Munchhofauthor=R.+P.+Robinsonauthor=J.+Kohrtauthor=A.+R.+Harrisauthor=D.+E.+Mooreauthor=B.+Liauthor=L.+Sampauthor=B.+A.+Lefkerauthor=K.+Futatsugiauthor=D.+Kungauthor=P.+D.+Boninauthor=P.+Corneliusauthor=R.+Wangauthor=E.+Salterauthor=S.+Hornbyauthor=A.+S.+Kalgutkarauthor=Y.+Chen&title=Activation+of+the+G-Protein-Coupled+Receptor+119%3A+A+Conformation-Based+Hypothesis+for+Understanding+Agonist+Response"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm200003p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200003p%26sid%3Dliteratum%253Aachs%26aulast%3DMcClure%26aufirst%3DK.%2BF.%26aulast%3DDarout%26aufirst%3DE.%26aulast%3DGuimar%25C3%25A3es%26aufirst%3DC.%2BR.%2BW.%26aulast%3DDeNinno%26aufirst%3DM.%2BP.%26aulast%3DMascitti%26aufirst%3DV.%26aulast%3DMunchhof%26aufirst%3DM.%2BJ.%26aulast%3DRobinson%26aufirst%3DR.%2BP.%26aulast%3DKohrt%26aufirst%3DJ.%26aulast%3DHarris%26aufirst%3DA.%2BR.%26aulast%3DMoore%26aufirst%3DD.%2BE.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DSamp%26aufirst%3DL.%26aulast%3DLefker%26aufirst%3DB.%2BA.%26aulast%3DFutatsugi%26aufirst%3DK.%26aulast%3DKung%26aufirst%3DD.%26aulast%3DBonin%26aufirst%3DP.%2BD.%26aulast%3DCornelius%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DSalter%26aufirst%3DE.%26aulast%3DHornby%26aufirst%3DS.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DChen%26aufirst%3DY.%26atitle%3DActivation%2520of%2520the%2520G-Protein-Coupled%2520Receptor%2520119%253A%2520A%2520Conformation-Based%2520Hypothesis%2520for%2520Understanding%2520Agonist%2520Response%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1948%26epage%3D1952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="note"><p class="first last">A moniker proposed by R. Robinson.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Banister, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoo, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chua, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassiou, M.</span><span> </span><span class="NLM_article-title"><i>N</i>-Arylalkyl-2-azaadamantanes as Cage-Expanded Polycarbocyclic sigma (σ) Receptor Ligands</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">5289</span><span class="NLM_x">–</span> <span class="NLM_lpage">5292</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=5289-5292&author=S.+D.+Banisterauthor=D.+T.+Yooauthor=S.+W.+Chuaauthor=J.+Cuiauthor=R.+H.+Machauthor=M.+Kassiou&title=N-Arylalkyl-2-azaadamantanes+as+Cage-Expanded+Polycarbocyclic+sigma+%28%CF%83%29+Receptor+Ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBanister%26aufirst%3DS.%2BD.%26aulast%3DYoo%26aufirst%3DD.%2BT.%26aulast%3DChua%26aufirst%3DS.%2BW.%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DKassiou%26aufirst%3DM.%26atitle%3DN-Arylalkyl-2-azaadamantanes%2520as%2520Cage-Expanded%2520Polycarbocyclic%2520sigma%2520%2528%25CF%2583%2529%2520Receptor%2520Ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D5289%26epage%3D5292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Yamauchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiwara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashiyama, K.</span><span> </span><span class="NLM_article-title">Concise Total Synthesis of (−)-Deoxocuscohygrine and (−)-Dihydrocuscohygrine</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">9784</span><span class="NLM_x">–</span> <span class="NLM_lpage">9787</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo801700f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=9784-9787&author=T.+Yamauchiauthor=S.+Hagiwaraauthor=K.+Higashiyama&title=Concise+Total+Synthesis+of+%28%E2%88%92%29-Deoxocuscohygrine+and+%28%E2%88%92%29-Dihydrocuscohygrine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjo801700f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo801700f%26sid%3Dliteratum%253Aachs%26aulast%3DYamauchi%26aufirst%3DT.%26aulast%3DHagiwara%26aufirst%3DS.%26aulast%3DHigashiyama%26aufirst%3DK.%26atitle%3DConcise%2520Total%2520Synthesis%2520of%2520%2528%25E2%2588%2592%2529-Deoxocuscohygrine%2520and%2520%2528%25E2%2588%2592%2529-Dihydrocuscohygrine%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2008%26volume%3D73%26spage%3D9784%26epage%3D9787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Momose, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toshima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koike, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyooka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirai, Y.</span><span> </span><span class="NLM_article-title">Bicyclo[3.3.1]nonanes as Synthetic Intermediates. Part 20.1 Asymmetric Synthesis of the Indolizidine Alkaloids Monomorine I and Indolizidine 223AB</span> <span class="citation_source-journal">J. Chem. Soc., Perkin Trans. 1</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_fpage">1315</span><span class="NLM_x">–</span> <span class="NLM_lpage">1322</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&pages=1315-1322&author=T.+Momoseauthor=M.+Toshimaauthor=S.+Sekiauthor=Y.+Koikeauthor=N.+Toyookaauthor=Y.+Hirai&title=Bicyclo%5B3.3.1%5Dnonanes+as+Synthetic+Intermediates.+Part+20.1+Asymmetric+Synthesis+of+the+Indolizidine+Alkaloids+Monomorine+I+and+Indolizidine+223AB"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMomose%26aufirst%3DT.%26aulast%3DToshima%26aufirst%3DM.%26aulast%3DSeki%26aufirst%3DS.%26aulast%3DKoike%26aufirst%3DY.%26aulast%3DToyooka%26aufirst%3DN.%26aulast%3DHirai%26aufirst%3DY.%26atitle%3DBicyclo%255B3.3.1%255Dnonanes%2520as%2520Synthetic%2520Intermediates.%2520Part%252020.1%2520Asymmetric%2520Synthesis%2520of%2520the%2520Indolizidine%2520Alkaloids%2520Monomorine%2520I%2520and%2520Indolizidine%2520223AB%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25201%26date%3D1997%26spage%3D1315%26epage%3D1322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Zaveri, N., T.; Jiang, F.; Toll, L.</span> Nicotinic Acetylcholine Receptor Modulators. WO11085389,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Zaveri%2C+N.%2C+T.%3B+Jiang%2C+F.%3B+Toll%2C+L.+Nicotinic+Acetylcholine+Receptor+Modulators.+WO11085389%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DZaveri%26aufirst%3DN.%252C%2BT.%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Berdini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cesta, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Anniballe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bello, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nano, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Topai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allegretti, M.</span><span> </span><span class="NLM_article-title">A Modified Palladium Catalysed Reductive Amination Procedure</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">5669</span><span class="NLM_x">–</span> <span class="NLM_lpage">5674</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm301626p&amp;key=10.1016%2FS0040-4020%2802%2900530-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm301626p&amp;key=1%3ACAS%3A528%3ADC%252BD38XltVahu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2002&pages=5669-5674&author=V.+Berdiniauthor=M.+C.+Cestaauthor=R.+Curtiauthor=G.+D%E2%80%99Anniballeauthor=N.+D.+Belloauthor=G.+Nanoauthor=L.+Nicoliniauthor=A.+Topaiauthor=M.+Allegretti&title=A+Modified+Palladium+Catalysed+Reductive+Amination+Procedure"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">A modified palladium-catalyzed reductive amination procedure</span></div><div class="casAuthors">Berdini, Valerio; Cesta, Maria C.; Curti, Roberto; D'Anniballe, Gaetano; Di Bello, Nicoletta; Nano, Giuseppe; Nicolini, Luca; Topai, Alessandra; Allegretti, Marcello</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">5669-5674</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">New, extended applications of a modified palladium catalyzed reductive amination procedure are described; a mechanistic hypothesis alternative to the common imine pathway is proposed.  This versatile method advances the usual reductive amination processes in terms of yield and shows high stereoselectivity whether applied to constrained carbonyl compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXGlgJ-iz6mbVg90H21EOLACvtfcHk0lj7LE8AjQIinw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltVahu7g%253D&md5=ccb0c1cc49c1516756839f6372530780</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2802%2900530-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252802%252900530-6%26sid%3Dliteratum%253Aachs%26aulast%3DBerdini%26aufirst%3DV.%26aulast%3DCesta%26aufirst%3DM.%2BC.%26aulast%3DCurti%26aufirst%3DR.%26aulast%3DD%25E2%2580%2599Anniballe%26aufirst%3DG.%26aulast%3DBello%26aufirst%3DN.%2BD.%26aulast%3DNano%26aufirst%3DG.%26aulast%3DNicolini%26aufirst%3DL.%26aulast%3DTopai%26aufirst%3DA.%26aulast%3DAllegretti%26aufirst%3DM.%26atitle%3DA%2520Modified%2520Palladium%2520Catalysed%2520Reductive%2520Amination%2520Procedure%26jtitle%3DTetrahedron%26date%3D2002%26volume%3D58%26spage%3D5669%26epage%3D5674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Turconi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicola, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gil Quintero, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maiocchi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Micheletti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giraldo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donetti, A.</span><span> </span><span class="NLM_article-title">Synthesis of a New Class of 2,3-Dihydro-2-oxo-1<i>H</i>-benzimidazole-1-carboxylic Acid Derivatives as Highly Potent 5-HT3 Receptor Antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">2101</span><span class="NLM_x">–</span> <span class="NLM_lpage">2108</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00170a009" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1990&pages=2101-2108&author=M.+Turconiauthor=M.+Nicolaauthor=M.+Gil+Quinteroauthor=L.+Maiocchiauthor=R.+Michelettiauthor=E.+Giraldoauthor=A.+Donetti&title=Synthesis+of+a+New+Class+of+2%2C3-Dihydro-2-oxo-1H-benzimidazole-1-carboxylic+Acid+Derivatives+as+Highly+Potent+5-HT3+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm00170a009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00170a009%26sid%3Dliteratum%253Aachs%26aulast%3DTurconi%26aufirst%3DM.%26aulast%3DNicola%26aufirst%3DM.%26aulast%3DGil%2BQuintero%26aufirst%3DM.%26aulast%3DMaiocchi%26aufirst%3DL.%26aulast%3DMicheletti%26aufirst%3DR.%26aulast%3DGiraldo%26aufirst%3DE.%26aulast%3DDonetti%26aufirst%3DA.%26atitle%3DSynthesis%2520of%2520a%2520New%2520Class%2520of%25202%252C3-Dihydro-2-oxo-1H-benzimidazole-1-carboxylic%2520Acid%2520Derivatives%2520as%2520Highly%2520Potent%25205-HT3%2520Receptor%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1990%26volume%3D33%26spage%3D2101%26epage%3D2108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Vernekar, S. K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallaq, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarkson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silvestri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lummis, S. C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lochner, M.</span><span> </span><span class="NLM_article-title">Toward Biophysical Probes for the 5-HT3 Receptor: Structure–Activity Relationship Study of Granisetron Derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2324</span><span class="NLM_x">–</span> <span class="NLM_lpage">2328</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901827x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2324-2328&author=S.+K.+V.+Vernekarauthor=H.+Y.+Hallaqauthor=G.+Clarksonauthor=A.+J.+Thompsonauthor=L.+Silvestriauthor=S.+C.+R.+Lummisauthor=M.+Lochner&title=Toward+Biophysical+Probes+for+the+5-HT3+Receptor%3A+Structure%E2%80%93Activity+Relationship+Study+of+Granisetron+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm901827x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901827x%26sid%3Dliteratum%253Aachs%26aulast%3DVernekar%26aufirst%3DS.%2BK.%2BV.%26aulast%3DHallaq%26aufirst%3DH.%2BY.%26aulast%3DClarkson%26aufirst%3DG.%26aulast%3DThompson%26aufirst%3DA.%2BJ.%26aulast%3DSilvestri%26aufirst%3DL.%26aulast%3DLummis%26aufirst%3DS.%2BC.%2BR.%26aulast%3DLochner%26aufirst%3DM.%26atitle%3DToward%2520Biophysical%2520Probes%2520for%2520the%25205-HT3%2520Receptor%253A%2520Structure%25E2%2580%2593Activity%2520Relationship%2520Study%2520of%2520Granisetron%2520Derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2324%26epage%3D2328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Dupeyre, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rassat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronzaud, J.</span><span> </span><span class="NLM_article-title">Nitroxides. LII. Synthesis and Electron Spin Resonance Studies of <i>N</i>,<i>N</i>′-Dioxy-2,6-diazaadamantane, a Symmetrical Ground State Triplet</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1974</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">6559</span><span class="NLM_x">–</span> <span class="NLM_lpage">6568</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00828a004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1974&pages=6559-6568&author=R.+M.+Dupeyreauthor=A.+Rassatauthor=J.+Ronzaud&title=Nitroxides.+LII.+Synthesis+and+Electron+Spin+Resonance+Studies+of+N%2CN%E2%80%B2-Dioxy-2%2C6-diazaadamantane%2C+a+Symmetrical+Ground+State+Triplet"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fja00828a004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00828a004%26sid%3Dliteratum%253Aachs%26aulast%3DDupeyre%26aufirst%3DR.%2BM.%26aulast%3DRassat%26aufirst%3DA.%26aulast%3DRonzaud%26aufirst%3DJ.%26atitle%3DNitroxides.%2520LII.%2520Synthesis%2520and%2520Electron%2520Spin%2520Resonance%2520Studies%2520of%2520N%252CN%25E2%2580%25B2-Dioxy-2%252C6-diazaadamantane%252C%2520a%2520Symmetrical%2520Ground%2520State%2520Triplet%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1974%26volume%3D96%26spage%3D6559%26epage%3D6568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelsen, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalilov, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzei, I. A.</span><span> </span><span class="NLM_article-title"><i>O</i>-Capped Heteroadamantyl-Substituted Hydrazines and Their Oxidation Products</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">2445</span><span class="NLM_x">–</span> <span class="NLM_lpage">2452</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo100294u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm301626p&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtlajsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2010&pages=2445-2452&author=G.+Liauthor=S.+F.+Nelsenauthor=A.+S.+Jalilovauthor=I.+A.+Guzei&title=O-Capped+Heteroadamantyl-Substituted+Hydrazines+and+Their+Oxidation+Products"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">O-Capped Heteroadamantyl-Substituted Hydrazines and Their Oxidation Products</span></div><div class="casAuthors">Li, Gaoquan; Nelsen, Stephen F.; Jalilov, Almaz S.; Guzei, Ilia A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2445-2452</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">(Image Omited) The mixed valence bishydrazine radical cation 6+, obtained by oxidn. of 2,6-bi-(2'-oxa-6'-azaadamantane-6'-yl)-2,6-diazaadamantane-2,6-diyl (I;6) with silver or nitrosonium salts, has been prepd. and studied. 6 is obtained along with lesser amts. of the trishydrazine, some of the tetrahydrazine, and apparently traces of the pentahydrazine upon reaction of deprotonated 2-oxa-6-azaadamantane with 2,6-dichloro-2,6-diazaadamantane.  The EPR spectrum of 6+ shows that its charge is localized on one hydrazine unit on the EPR time scale.  It shows a Hush-type Robin-Day class II mixed valence band in its optical spectrum despite the fact that the nitrogen lone pairs are held in a perpendicular geometry that would lead to no electronic interaction between the nitrogen atoms that are sepd. by only four σ bonds if its nitrogens were planar.  The electron transfer distance that is estd. from the calcd. dipole moment of 6+ is the same as that obtained using the av. distance between the electrons of the triplet state of the dication 62+, calcd. from its dipolar EPR splitting, as a model for the electron transfer distance of 6+, 3.7 Å.  Using Hush's Gaussian approxn. for the optical spectrum with this electron transfer distance produces an est. of the electronic coupling Vab through the satd. bridge of about 400 cm-1, which is consistent with the obsd. EPR spectrum of 6+.  From the obsd. dipolar splitting, the trishydrazine diradical dication has its remote hydrazine units oxidized, although the monocation presumably forms at the central hydrazine unit, which lacks substitution by the more electron-withdrawing oxygen atoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJek_3-uI0wbVg90H21EOLACvtfcHk0liBs69SlVUaWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtlajsLc%253D&md5=f3e44fb4e173cb69a841145b02121f55</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjo100294u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo100294u%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DG.%26aulast%3DNelsen%26aufirst%3DS.%2BF.%26aulast%3DJalilov%26aufirst%3DA.%2BS.%26aulast%3DGuzei%26aufirst%3DI.%2BA.%26atitle%3DO-Capped%2520Heteroadamantyl-Substituted%2520Hydrazines%2520and%2520Their%2520Oxidation%2520Products%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2010%26volume%3D75%26spage%3D2445%26epage%3D2452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Stella, L.</span><span> </span><span class="NLM_article-title">Homolytic Cyclizations of <i>N</i>-Chloroalkenylamines</span> <span class="citation_source-journal">Angew. Chem., Int. Ed. Engl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">422</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm301626p&amp;key=10.1002%2Fanie.198303373" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1983&pages=337-422&author=L.+Stella&title=Homolytic+Cyclizations+of+N-Chloroalkenylamines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fanie.198303373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.198303373%26sid%3Dliteratum%253Aachs%26aulast%3DStella%26aufirst%3DL.%26atitle%3DHomolytic%2520Cyclizations%2520of%2520N-Chloroalkenylamines%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%2520Engl.%26date%3D1983%26volume%3D22%26spage%3D337%26epage%3D422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Ban, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, M.</span><span> </span><span class="NLM_article-title">A Synthesis of 1,3-Diaza Heterocycles. A Hofmann–Löffler Type of Photocyclization in the Absence of Strong Acid</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm301626p&amp;key=1%3ACAS%3A528%3ADyaE28Xktlaqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1976&pages=201-202&author=Y.+Banauthor=M.+Kimura&title=A+Synthesis+of+1%2C3-Diaza+Heterocycles.+A+Hofmann%E2%80%93L%C3%B6ffler+Type+of+Photocyclization+in+the+Absence+of+Strong+Acid"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">A synthesis of 1,3-diaza heterocycles.  A Hofmann-Loeffler type of photocyclization in the absence of strong acid</span></div><div class="casAuthors">Kimura, Masayuki; Ban, Yoshio</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">201-2</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    </div><div class="casAbstract">Chloropiperidine (I, R = Cl), obtained from I (R = H) and N-chlorosuccinimide, or irradn. in situ in ether with a 300 W high pressure Hg lamp gave pyrimidine II in 50% yield; the yield was increased to almost 100% by carrying out the irradn. in the presence of Et3N.  Similarly III (R = H, Me; n = 2-4) were cyclized to IV and V was cyclized to VI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5H4zXQWtbqrVg90H21EOLACvtfcHk0liBs69SlVUaWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28Xktlaqtrk%253D&md5=ce40357862d232612e256a57dcc7ae20</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBan%26aufirst%3DY.%26aulast%3DKimura%26aufirst%3DM.%26atitle%3DA%2520Synthesis%2520of%25201%252C3-Diaza%2520Heterocycles.%2520A%2520Hofmann%25E2%2580%2593L%25C3%25B6ffler%2520Type%2520of%2520Photocyclization%2520in%2520the%2520Absence%2520of%2520Strong%2520Acid%26jtitle%3DSynthesis%26date%3D1976%26spage%3D201%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Sommer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. M.</span><span> </span><span class="NLM_article-title">Synthetic Studies toward Paraherquamides E and F and Related <sup>13</sup>C-Labeled Putative Biosynthetic Intermediates: Stereocontrolled Synthesis of the α-Alkyl-β-methylproline Ring System</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">7106</span><span class="NLM_x">–</span> <span class="NLM_lpage">7111</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2008&pages=7106-7111&author=K.+Sommerauthor=R.+M.+Williams&title=Synthetic+Studies+toward+Paraherquamides+E+and+F+and+Related+13C-Labeled+Putative+Biosynthetic+Intermediates%3A+Stereocontrolled+Synthesis+of+the+%CE%B1-Alkyl-%CE%B2-methylproline+Ring+System"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSommer%26aufirst%3DK.%26aulast%3DWilliams%26aufirst%3DR.%2BM.%26atitle%3DSynthetic%2520Studies%2520toward%2520Paraherquamides%2520E%2520and%2520F%2520and%2520Related%252013C-Labeled%2520Putative%2520Biosynthetic%2520Intermediates%253A%2520Stereocontrolled%2520Synthesis%2520of%2520the%2520%25CE%25B1-Alkyl-%25CE%25B2-methylproline%2520Ring%2520System%26jtitle%3DTetrahedron%26date%3D2008%26volume%3D64%26spage%3D7106%26epage%3D7111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Olofson, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martz, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senet, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piteau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malfroot, T.</span><span> </span><span class="NLM_article-title">A New Reagent for the Selective, High-Yield N-Dealkylation of Tertiary Amines: Improved Syntheses of Naltrexone and Nalbuphine</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2081</span><span class="NLM_x">–</span> <span class="NLM_lpage">2082</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00185a072" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm301626p&amp;key=1%3ACAS%3A528%3ADyaL2cXktlyks7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1984&pages=2081-2082&author=R.+A.+Olofsonauthor=J.+T.+Martzauthor=J.+P.+Senetauthor=M.+Piteauauthor=T.+Malfroot&title=A+New+Reagent+for+the+Selective%2C+High-Yield+N-Dealkylation+of+Tertiary+Amines%3A+Improved+Syntheses+of+Naltrexone+and+Nalbuphine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">A new reagent for the selective, high-yield N-dealkylation of tertiary amines:  improved syntheses of naltrexone and nalbuphine</span></div><div class="casAuthors">Olofson, R. A.; Martz, Jonathan T.; Senet, Jean Pierre; Piteau, Marc; Malfroot, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2081-2</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">Reaction of tertiary amines with ClCO2CHClMe in ClCH2CH2Cl at reflux affords the intermediates, R2NCO2CHClMe (R = alkyl, R2 = cycloalkyl), which are converted to the desired salts, R2NH·HCl, just by heating in MeOH.  The N-dealkylation reagent is made in 96% yield by mixing MeCHO with COCl2 in the presence of an R4N+ Cl- catalyst.  The N-dealkylations are highly selective, mild, occur in high yield, and permit the presence of a variety of functionalities.  The process is exemplified by the conversion of glaucine (I) to the phenanthrene (II) in 89% yield and by the N-demethylations of arecoline, O-acetyltropine, and 6-acetylcodeine in yields of 95-97%.  The methodol. was used as part of a process for the transformation of oxycodone to the com. narcotic antagonist, naltrexone (58% overall yield) and to the prescription analgesic, nalbuphine (III) (69% overall yield).  Arom. tertiary amines also are N-dealkylated, although under more vigorous conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcSuAJiJApjLVg90H21EOLACvtfcHk0liBAKuo0PgFQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXktlyks7k%253D&md5=9402bfb15be7a0d057bfe7bf95bde7b6</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjo00185a072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00185a072%26sid%3Dliteratum%253Aachs%26aulast%3DOlofson%26aufirst%3DR.%2BA.%26aulast%3DMartz%26aufirst%3DJ.%2BT.%26aulast%3DSenet%26aufirst%3DJ.%2BP.%26aulast%3DPiteau%26aufirst%3DM.%26aulast%3DMalfroot%26aufirst%3DT.%26atitle%3DA%2520New%2520Reagent%2520for%2520the%2520Selective%252C%2520High-Yield%2520N-Dealkylation%2520of%2520Tertiary%2520Amines%253A%2520Improved%2520Syntheses%2520of%2520Naltrexone%2520and%2520Nalbuphine%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1984%26volume%3D49%26spage%3D2081%26epage%3D2082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Zhicai, Y.; Manning, D., D.</span> 2-Alkylbenzoxazole Carboxamides as 5HT<sub>3</sub> Modulators. WO2008019363,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Zhicai%2C+Y.%3B+Manning%2C+D.%2C+D.+2-Alkylbenzoxazole+Carboxamides+as+5HT3+Modulators.+WO2008019363%2C+2008."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DZhicai%26aufirst%3DY.%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Jones, R. M.; Semple, G.; Fioravanti, B.; Pereira, G.; Calderon, I.; Uy, J.; Duwuri, K.; Choi, J. S. K.; Xiong, Y.; Dave, V.</span><span> </span><span class="NLM_article-title">Preparation of 1,2,3-Trisubstituted Aryl and Heteroaryl Derivatives, in Particular Pyrimidines, as Modulators, in Particular Agonists and Inverse Agonists, of G-Coupled Protein Receptor and Their Use in the Prophylaxis and Treatment of Metabolic Disorder Such as Diabetes and Hyperglycemia</span>. WO2004065380,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=R.+M.+Jones&author=G.+Semple&author=B.+Fioravanti&author=G.+Pereira&author=I.+Calderon&author=J.+Uy&author=K.+Duwuri&author=J.+S.+K.+Choi&author=Y.+Xiong&author=V.+Dave&title=Preparation+of+1%2C2%2C3-Trisubstituted+Aryl+and+Heteroaryl+Derivatives%2C+in+Particular+Pyrimidines%2C+as+Modulators%2C+in+Particular+Agonists+and+Inverse+Agonists%2C+of+G-Coupled+Protein+Receptor+and+Their+Use+in+the+Prophylaxis+and+Treatment+of+Metabolic+Disorder+Such+as+Diabetes+and+Hyperglycemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DR.%2BM.%26atitle%3DPreparation%2520of%25201%252C2%252C3-Trisubstituted%2520Aryl%2520and%2520Heteroaryl%2520Derivatives%252C%2520in%2520Particular%2520Pyrimidines%252C%2520as%2520Modulators%252C%2520in%2520Particular%2520Agonists%2520and%2520Inverse%2520Agonists%252C%2520of%2520G-Coupled%2520Protein%2520Receptor%2520and%2520Their%2520Use%2520in%2520the%2520Prophylaxis%2520and%2520Treatment%2520of%2520Metabolic%2520Disorder%2520Such%2520as%2520Diabetes%2520and%2520Hyperglycemia%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shalaeva, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tupper, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, F.</span><span> </span><span class="NLM_article-title">ElogD<sub>oct</sub>: A Tool for Lipophilicity Determination in Drug Discovery. 2. Basic and Neutral Compounds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">2490</span><span class="NLM_x">–</span> <span class="NLM_lpage">2497</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0100990" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=2490-2497&author=F.+Lombardoauthor=M.+Y.+Shalaevaauthor=K.+A.+Tupperauthor=F.+Gao&title=ElogDoct%3A+A+Tool+for+Lipophilicity+Determination+in+Drug+Discovery.+2.+Basic+and+Neutral+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm0100990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0100990%26sid%3Dliteratum%253Aachs%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DShalaeva%26aufirst%3DM.%2BY.%26aulast%3DTupper%26aufirst%3DK.%2BA.%26aulast%3DGao%26aufirst%3DF.%26atitle%3DElogDoct%253A%2520A%2520Tool%2520for%2520Lipophilicity%2520Determination%2520in%2520Drug%2520Discovery.%25202.%2520Basic%2520and%2520Neutral%2520Compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D2490%26epage%3D2497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Scott, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birch, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brocklehurst, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butlin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidsson, Ö.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ertan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groombridge, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laber, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacFaul, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKerrecher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickup, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schofield, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sörme, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teague, J.</span><span> </span><span class="NLM_article-title">Use of Small-Molecule Crystal Structures To Address Solubility in a Novel Series of G Protein Coupled Receptor 119 Agonists: Optimization of a Lead and in Vivo Evaluation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">5361</span><span class="NLM_x">–</span> <span class="NLM_lpage">5379</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300310c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm301626p&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1Oqt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5361-5379&author=J.+S.+Scottauthor=A.+M.+Birchauthor=K.+J.+Brocklehurstauthor=A.+Brooauthor=H.+S.+Brownauthor=R.+J.+Butlinauthor=D.+S.+Clarkeauthor=%C3%96.+Davidssonauthor=A.+Ertanauthor=K.+Goldbergauthor=S.+D.+Groombridgeauthor=J.+A.+Hudsonauthor=D.+Laberauthor=A.+G.+Leachauthor=P.+A.+MacFaulauthor=D.+McKerrecherauthor=A.+Pickupauthor=P.+Schofieldauthor=P.+H.+Svenssonauthor=P.+S%C3%B6rmeauthor=J.+Teague&title=Use+of+Small-Molecule+Crystal+Structures+To+Address+Solubility+in+a+Novel+Series+of+G+Protein+Coupled+Receptor+119+Agonists%3A+Optimization+of+a+Lead+and+in+Vivo+Evaluation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Use of Small-Molecule Crystal Structures To Address Solubility in a Novel Series of G Protein Coupled Receptor 119 Agonists: Optimization of a Lead and in Vivo Evaluation</span></div><div class="casAuthors">Scott, James S.; Birch, Alan M.; Brocklehurst, Katy J.; Broo, Anders; Brown, Hayley S.; Butlin, Roger J.; Clarke, David S.; Davidsson, Ojvind; Ertan, Anne; Goldberg, Kristin; Groombridge, Sam D.; Hudson, Julian A.; Laber, David; Leach, Andrew G.; MacFaul, Philip A.; McKerrecher, Darren; Pickup, Adrian; Schofield, Paul; Svensson, Per H.; Sorme, Pernilla; Teague, Joanne</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5361-5379</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">G protein coupled receptor 119 (GPR119) is viewed as an attractive target for the treatment of type 2 diabetes and other elements of the metabolic syndrome.  During a program toward discovering agonists of GPR119, we herein describe optimization of an initial lead compd., 2, into a development candidate, 42.  A key challenge in this program of work was the insoly. of the lead compd.  Small-mol. crystallog. was utilized to understand the intermol. interactions in the solid state and resulted in a switch from an aryl sulfone to a 3-cyanopyridyl motif.  The compd. was shown to be effective in wild-type but not knockout animals, confirming that the biol. effects were due to GPR119 agonism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXZ_DoHJ0cfrVg90H21EOLACvtfcHk0lg2TEASWe2zZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1Oqt78%253D&md5=3cd34d57e05864ddcc87c51f034f9188</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm300310c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300310c%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DJ.%2BS.%26aulast%3DBirch%26aufirst%3DA.%2BM.%26aulast%3DBrocklehurst%26aufirst%3DK.%2BJ.%26aulast%3DBroo%26aufirst%3DA.%26aulast%3DBrown%26aufirst%3DH.%2BS.%26aulast%3DButlin%26aufirst%3DR.%2BJ.%26aulast%3DClarke%26aufirst%3DD.%2BS.%26aulast%3DDavidsson%26aufirst%3D%25C3%2596.%26aulast%3DErtan%26aufirst%3DA.%26aulast%3DGoldberg%26aufirst%3DK.%26aulast%3DGroombridge%26aufirst%3DS.%2BD.%26aulast%3DHudson%26aufirst%3DJ.%2BA.%26aulast%3DLaber%26aufirst%3DD.%26aulast%3DLeach%26aufirst%3DA.%2BG.%26aulast%3DMacFaul%26aufirst%3DP.%2BA.%26aulast%3DMcKerrecher%26aufirst%3DD.%26aulast%3DPickup%26aufirst%3DA.%26aulast%3DSchofield%26aufirst%3DP.%26aulast%3DSvensson%26aufirst%3DP.%2BH.%26aulast%3DS%25C3%25B6rme%26aufirst%3DP.%26aulast%3DTeague%26aufirst%3DJ.%26atitle%3DUse%2520of%2520Small-Molecule%2520Crystal%2520Structures%2520To%2520Address%2520Solubility%2520in%2520a%2520Novel%2520Series%2520of%2520G%2520Protein%2520Coupled%2520Receptor%2520119%2520Agonists%253A%2520Optimization%2520of%2520a%2520Lead%2520and%2520in%2520Vivo%2520Evaluation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5361%26epage%3D5379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springthorpe, B.</span><span> </span><span class="NLM_article-title">The Influence of Drug-like Concepts on Decision-Making in Medicinal Chemistry</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm301626p&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm301626p&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm301626p&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+Influence+of+Drug-like+Concepts+on+Decision-Making+in+Medicinal+Chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0lg2TEASWe2zZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520Influence%2520of%2520Drug-like%2520Concepts%2520on%2520Decision-Making%2520in%2520Medicinal%2520Chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Leach, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hann, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffen, E. J.</span><span> </span><span class="NLM_article-title">Fragment Screening: An Introduction</span> <span class="citation_source-journal">Mol BioSyst</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">446</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm301626p&amp;key=10.1039%2Fb610069b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm301626p&amp;key=17153140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm301626p&amp;key=1%3ACAS%3A280%3ADC%252BD28jhs1Gntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=430-446&author=A.+R.+Leachauthor=M.+M.+Hannauthor=J.+N.+Burrowsauthor=E.+J.+Griffen&title=Fragment+Screening%3A+An+Introduction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment screening: an introduction</span></div><div class="casAuthors">Leach Andrew R; Hann Michael M; Burrows Jeremy N; Griffen Ed J</div><div class="citationInfo"><span class="NLM_cas:title">Molecular bioSystems</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">430-46</span>
        ISSN:<span class="NLM_cas:issn">1742-206X</span>.
    </div><div class="casAbstract">There are clearly many different philosophies associated with adapting fragment screening into mainstream Drug Discovery Lead Generation strategies.  Scientists at Astex, for instance, focus entirely on strategies involving use of X-ray crystallography and NMR.  However, AstraZeneca uses a number of different fragment screening strategies.  One approach is to screen a 2000 compound fragment set (with close to "lead-like" complexity) at 100 microM in parallel with every HTS such that the data are obtained on the entire screening collection at 10 microM plus the extra samples at 100 microM; this provides valuable compound potency data in a concentration range that is usually unexplored.  The fragments are then screen-specific "privileged structures" that can be searched for in the rest of the HTS output and other databases as well as having synthesis follow-up.  A typical workflow for a fragment screen within AstraZeneca is shown below (Figure 24) and highlights the desirability (particularly when screening >100 microM) for NMR and X-ray information to validate weak hits and give information on how to optimise them.  In this chapter, we have provided an introduction to the theoretical and practical issues associated with the use of fragment methods and lead-likeness.  Fragment-based approaches are still in an early stage of development and are just one of many interrelated techniques that are now used to identify novel lead compounds for drug development.  Fragment based screening has some advantages, but like every other drug hunting strategy will not be universally applicable.  There are in particular some practical challenges associated with fragment screening that relate to the generally lower level of potency that such compounds initially possess.  Considerable synthetic effort has to be applied for post-fragment screening to build the sort of potency that would be expected to be found from a traditional HTS.  However, if there are no low-hanging fruit in a screening collection to be found by HTS then the use of fragment screening can help find novelty that may lead to a target not being discarded as intractable.  As such, the approach offers some significant advantages by providing less complex molecules, which may have better potential for novel drug optimisation and by enabling new chemical space to be more effectively explored.  Many literature examples that cover examples of fragment screening approaches are still at the "proof of concept" stage and although delivering inhibitors or ligands, may still prove to be unsuitable when further ADMET and toxicity profiling is done.  The next few years should see a maturing of the area, and as our understanding of how the concepts can be best applied, there are likely to be many more examples of attractive, small molecule hits, leads and candidate drugs derived from the approaches described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQlsCStQZNnJwaK-_ZudimnfW6udTcc2eYfrsTDp_qNUbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28jhs1Gntw%253D%253D&md5=775fb6b69a537ca76bc87dc309459fe4</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1039%2Fb610069b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb610069b%26sid%3Dliteratum%253Aachs%26aulast%3DLeach%26aufirst%3DA.%2BR.%26aulast%3DHann%26aufirst%3DM.%2BM.%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DGriffen%26aufirst%3DE.%2BJ.%26atitle%3DFragment%2520Screening%253A%2520An%2520Introduction%26jtitle%3DMol%2520BioSyst%26date%3D2006%26volume%3D2%26spage%3D430%26epage%3D446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">McClure, K. F.</span><span> </span><span class="NLM_article-title">GPR119: Expanding Your Lead Options by Changing the Constant</span>. Presented at the 7th Annual Meeting of Discovery on Target, GPCR-Based Drug Discovery, Boston, MA, October 2,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=K.+F.+McClure&title=GPR119%3A+Expanding+Your+Lead+Options+by+Changing+the+Constant"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DMcClure%26aufirst%3DK.%2BF.%26atitle%3DGPR119%253A%2520Expanding%2520Your%2520Lead%2520Options%2520by%2520Changing%2520the%2520Constant%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Kuntz, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kollman, P. A.</span><span> </span><span class="NLM_article-title">The Maximal Affinity of Ligands</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">9997</span><span class="NLM_x">–</span> <span class="NLM_lpage">10002</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm301626p&amp;key=10.1073%2Fpnas.96.18.9997" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm301626p&amp;key=10468550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm301626p&amp;key=1%3ACAS%3A528%3ADyaK1MXlvFehu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=9997-10002&author=I.+D.+Kuntzauthor=K.+Chenauthor=K.+A.+Sharpauthor=P.+A.+Kollman&title=The+Maximal+Affinity+of+Ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">The maximal affinity of ligands</span></div><div class="casAuthors">Kuntz, I. D.; Chen, K.; Sharp, K. A.; Kollman, P. A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">9997-10002</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">We explore the question of what are the best ligands for macromol. targets.  A survey of exptl. data on a large no. of the strongest-binding ligands indicates that the free energy of binding increases with the no. of nonhydrogen atoms with an initial slope of ≈-1.5 kcal/mol (1 cal = 4.18 J) per atom.  For ligands that contain more than 15 nonhydrogen atoms, the free energy of binding increases very little with relative mol. mass.  This nonlinearity is largely ascribed to nonthermodynamic factors.  An anal. of the dominant interactions suggests that van der Waals interactions and hydrophobic effects provide a reasonable basis for understanding binding affinities across the entire set of ligands.  Interesting outliers that bind unusually strongly on a per atom basis include metal ions, covalently attached ligands, and a few well known complexes such as biotin-avidin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0L6KZhR0TxbVg90H21EOLACvtfcHk0lg2TEASWe2zZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvFehu7s%253D&md5=46fe894b016f3041831a2f0b71f812b1</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1073%2Fpnas.96.18.9997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.96.18.9997%26sid%3Dliteratum%253Aachs%26aulast%3DKuntz%26aufirst%3DI.%2BD.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DSharp%26aufirst%3DK.%2BA.%26aulast%3DKollman%26aufirst%3DP.%2BA.%26atitle%3DThe%2520Maximal%2520Affinity%2520of%2520Ligands%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1999%26volume%3D96%26spage%3D9997%26epage%3D10002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand Efficiency: A Useful Metric for Lead Selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm301626p&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm301626p&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm301626p&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+Efficiency%3A+A+Useful+Metric+for+Lead+Selection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2eZAkEISwqNRx7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520Efficiency%253A%2520A%2520Useful%2520Metric%2520for%2520Lead%2520Selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Ryckmans, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correia, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tutt, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, T.</span><span> </span><span class="NLM_article-title">Rapid Assessment of a Novel Series of Selective CB(2) Agonists Using Parallel Synthesis Protocols: A Lipophilic Efficiency (LipE) Analysis</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4406</span><span class="NLM_x">–</span> <span class="NLM_lpage">4409</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm301626p&amp;key=10.1016%2Fj.bmcl.2009.05.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm301626p&amp;key=19500981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm301626p&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVGlsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4406-4409&author=T.+Ryckmansauthor=M.+P.+Edwardsauthor=V.+A.+Horneauthor=A.+M.+Correiaauthor=D.+R.+Owenauthor=L.+R.+Thompsonauthor=I.+Tranauthor=M.+F.+Tuttauthor=T.+Young&title=Rapid+Assessment+of+a+Novel+Series+of+Selective+CB%282%29+Agonists+Using+Parallel+Synthesis+Protocols%3A+A+Lipophilic+Efficiency+%28LipE%29+Analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid assessment of a novel series of selective CB2 agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis</span></div><div class="casAuthors">Ryckmans, Thomas; Edwards, Martin P.; Horne, Val A.; Correia, Ana Monica; Owen, Dafydd R.; Thompson, Lisa R.; Tran, Isabelle; Tutt, Michelle F.; Young, Tim</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4406-4409</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of libraries were designed using the 1-(cyclopropylmethyl)-2-alkyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-5-ium templates 2a-b, and Sulfonamide derivs. 11a-n proved to be potent agonists of the CB2 receptor.  Anal. of the Lipophilic Efficiency (LipE) of potent compds. provided new insight for the design of potent, metabolically stable CB2 agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1cihq9YHuO7Vg90H21EOLACvtfcHk0lhIJJ83lvBbTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVGlsrg%253D&md5=b62d97e5f52a594cfdd510f32d2e566f</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.05.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.05.062%26sid%3Dliteratum%253Aachs%26aulast%3DRyckmans%26aufirst%3DT.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26aulast%3DHorne%26aufirst%3DV.%2BA.%26aulast%3DCorreia%26aufirst%3DA.%2BM.%26aulast%3DOwen%26aufirst%3DD.%2BR.%26aulast%3DThompson%26aufirst%3DL.%2BR.%26aulast%3DTran%26aufirst%3DI.%26aulast%3DTutt%26aufirst%3DM.%2BF.%26aulast%3DYoung%26aufirst%3DT.%26atitle%3DRapid%2520Assessment%2520of%2520a%2520Novel%2520Series%2520of%2520Selective%2520CB%25282%2529%2520Agonists%2520Using%2520Parallel%2520Synthesis%2520Protocols%253A%2520A%2520Lipophilic%2520Efficiency%2520%2528LipE%2529%2520Analysis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4406%26epage%3D4409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Edwards, M. P.; Price, D. A.</span><span> </span><span class="NLM_article-title">Role of Physicochemical Properties and Ligand Lipophilicity Efficiency in Addressing Drug Safety Risks</span>. In  <span class="citation_source-book">Annual Reports in Medicinal Chemistry</span>; <span class="NLM_contrib-group">Macor, J. E.</span>, Ed.; <span class="NLM_publisher-name">Academic Press</span>: Boston, MA,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">45</span>, Chapter 23, pp  <span class="NLM_fpage">380</span><span class="NLM_x">–</span> <span class="NLM_lpage">391</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm301626p&amp;key=10.1016%2FS0065-7743%2810%2945023-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=380-391&author=M.+P.+Edwards&author=D.+A.+Priceauthor=J.+E.+Macor&title=Annual+Reports+in+Medicinal+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2FS0065-7743%2810%2945023-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FS0065-7743%252810%252945023-X%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26atitle%3DRole%2520of%2520Physicochemical%2520Properties%2520and%2520Ligand%2520Lipophilicity%2520Efficiency%2520in%2520Addressing%2520Drug%2520Safety%2520Risks%26btitle%3DAnnual%2520Reports%2520in%2520Medicinal%2520Chemistry%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26pub%3DAcademic%2520Press%26date%3D2010%26volume%3D45%26spage%3D380%26epage%3D391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Kenakin, T. P.</span> <span class="citation_source-book">A Pharmacology Primer: Theory, Applications, and Methods</span>, <span class="NLM_edition">3</span>rd ed.; <span class="NLM_publisher-name">Academic Press</span>: Boston, MA,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=T.+P.+Kenakin&title=A+Pharmacology+Primer%3A+Theory%2C+Applications%2C+and+Methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DKenakin%26aufirst%3DT.%2BP.%26btitle%3DA%2520Pharmacology%2520Primer%253A%2520Theory%252C%2520Applications%252C%2520and%2520Methods%26pub%3DAcademic%2520Press%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Overton, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babbs, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doel, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fyfe, M. C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Procter, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasamison, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang-Christensen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Widdowson, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynet, C.</span><span> </span><span class="NLM_article-title">Deorphanization of a G Protein-Coupled Receptor for Oleoylethanolamide and Its Use in the Discovery of Small-Molecule Hypophagic Agents</span> <span class="citation_source-journal">Cell Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">175</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm301626p&amp;key=10.1016%2Fj.cmet.2006.02.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm301626p&amp;key=16517404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm301626p&amp;key=1%3ACAS%3A528%3ADC%252BD28Xislyhtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=167-175&author=H.+A.+Overtonauthor=A.+J.+Babbsauthor=S.+M.+Doelauthor=M.+C.+T.+Fyfeauthor=L.+S.+Gardnerauthor=G.+Griffinauthor=H.+C.+Jacksonauthor=M.+J.+Procterauthor=C.+M.+Rasamisonauthor=M.+Tang-Christensenauthor=P.+S.+Widdowsonauthor=G.+M.+Williamsauthor=C.+Reynet&title=Deorphanization+of+a+G+Protein-Coupled+Receptor+for+Oleoylethanolamide+and+Its+Use+in+the+Discovery+of+Small-Molecule+Hypophagic+Agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents</span></div><div class="casAuthors">Overton, Hilary A.; Babbs, Adam J.; Doel, Sheila M.; Fyfe, Matthew C. T.; Gardner, Lisa S.; Griffin, Graeme; Jackson, Helen C.; Procter, Martin J.; Rasamison, Chrystelle M.; Tang-Christensen, Mads; Widdowson, Peter S.; Williams, Geoffery M.; Reynet, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">167-175</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The endogenous lipid signaling agent oleoylethanolamide (OEA) has recently been described as a peripherally acting agent that reduces food intake and body wt. gain in rat feeding models.  This paper presents evidence that OEA is an endogenous ligand of the orphan receptor GPR119, a G protein-coupled receptor (GPCR) expressed predominantly in the human and rodent pancreas and gastrointestinal tract and also in rodent brain, suggesting that the reported effects of OEA on food intake may be mediated, at least in part, via the GPR119 receptor.  Furthermore, we have used the recombinant receptor to discover novel selective small-mol. GPR119 agonists, typified by PSN632408, which suppress food intake in rats and reduce body wt. gain and white adipose tissue deposition upon subchronic oral administration to high-fat-fed rats.  GPR119 therefore represents a novel and attractive potential target for the therapy of obesity and related metabolic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr8xt3VqDV07Vg90H21EOLACvtfcHk0liNatmpA6qLmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xislyhtr8%253D&md5=85c2756aa0809be0069ea515e2a1574d</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2006.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2006.02.004%26sid%3Dliteratum%253Aachs%26aulast%3DOverton%26aufirst%3DH.%2BA.%26aulast%3DBabbs%26aufirst%3DA.%2BJ.%26aulast%3DDoel%26aufirst%3DS.%2BM.%26aulast%3DFyfe%26aufirst%3DM.%2BC.%2BT.%26aulast%3DGardner%26aufirst%3DL.%2BS.%26aulast%3DGriffin%26aufirst%3DG.%26aulast%3DJackson%26aufirst%3DH.%2BC.%26aulast%3DProcter%26aufirst%3DM.%2BJ.%26aulast%3DRasamison%26aufirst%3DC.%2BM.%26aulast%3DTang-Christensen%26aufirst%3DM.%26aulast%3DWiddowson%26aufirst%3DP.%2BS.%26aulast%3DWilliams%26aufirst%3DG.%2BM.%26aulast%3DReynet%26aufirst%3DC.%26atitle%3DDeorphanization%2520of%2520a%2520G%2520Protein-Coupled%2520Receptor%2520for%2520Oleoylethanolamide%2520and%2520Its%2520Use%2520in%2520the%2520Discovery%2520of%2520Small-Molecule%2520Hypophagic%2520Agents%26jtitle%3DCell%2520Metab.%26date%3D2006%26volume%3D3%26spage%3D167%26epage%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="note"><p class="first last">To include all the cage compounds, the AgLLE calculations used ClogP rather than the measured ElogD.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="note"><p class="first last">The rat in vitro GPR119 pharmacology for <b>32i</b> is as follows: rat cAMP EC<sub>50</sub> = 294 nM, 107% IA, <i>n</i> = 1; rat <i>K</i><sub>i</sub> = 71.8 ± 12.7 nM, <i>n</i> = 3; obtained as in ref <a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">21</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuntz, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauls, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ammala, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadepalli, S.</span><span> </span><span class="NLM_article-title">2,5-Disubstituted Pyridines as Potent GPR119 Agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2577</span><span class="NLM_x">–</span> <span class="NLM_lpage">2581</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2577-2581&author=Y.+Wuauthor=J.+D.+Kuntzauthor=A.+J.+Carpenterauthor=J.+Fangauthor=H.+R.+Saulsauthor=D.+J.+Gomezauthor=C.+Ammalaauthor=Y.+Xuauthor=S.+Hartauthor=S.+Tadepalli&title=2%2C5-Disubstituted+Pyridines+as+Potent+GPR119+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%26aulast%3DKuntz%26aufirst%3DJ.%2BD.%26aulast%3DCarpenter%26aufirst%3DA.%2BJ.%26aulast%3DFang%26aufirst%3DJ.%26aulast%3DSauls%26aufirst%3DH.%2BR.%26aulast%3DGomez%26aufirst%3DD.%2BJ.%26aulast%3DAmmala%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DHart%26aufirst%3DS.%26aulast%3DTadepalli%26aufirst%3DS.%26atitle%3D2%252C5-Disubstituted%2520Pyridines%2520as%2520Potent%2520GPR119%2520Agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2577%26epage%3D2581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitney-Pickett, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umland, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gebhard, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federico, J. J.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reyner, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varma, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kempshall, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kattan, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liston, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span> </span><span class="NLM_article-title">Development of a New Permeability Assay Using Low-Efflux MDCKII Cells</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">4974</span><span class="NLM_x">–</span> <span class="NLM_lpage">4985</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm301626p&amp;key=10.1002%2Fjps.22674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm301626p&amp;key=21766308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm301626p&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovFGltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2011&pages=4974-4985&author=L.+Diauthor=C.+Whitney-Pickettauthor=J.+P.+Umlandauthor=H.+Zhangauthor=X.+Zhangauthor=D.+F.+Gebhardauthor=Y.+Laiauthor=J.+J.+Federicoauthor=R.+E.+Davidsonauthor=R.+Smithauthor=E.+L.+Reynerauthor=C.+Leeauthor=B.+Fengauthor=C.+Rotterauthor=M.+V.+Varmaauthor=S.+Kempshallauthor=K.+Fennerauthor=A.+F.+El-Kattanauthor=T.+E.+Listonauthor=M.+D.+Troutman&title=Development+of+a+New+Permeability+Assay+Using+Low-Efflux+MDCKII+Cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a new permeability assay using low-efflux MDCKII cells</span></div><div class="casAuthors">Di, Li; Whitney-Pickett, Carrie; Umland, John P.; Zhang, Hui; Zhang, Xun; Gebhard, David F.; Lai, Yurong; Federico, James J.; Davidson, Ralph E.; Smith, Russ; Reyner, Eric L.; Lee, Caroline; Feng, Bo; Rotter, Charles; Varma, Manthena V.; Kempshall, Sarah; Fenner, Katherine; El-kattan, Ayman F.; Liston, Theodore E.; Troutman, Matthew D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4974-4985</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Permeability is an important property of drug candidates.  The Madin-Darby canine kidney cell line (MDCK) permeability assay is widely used and the primary concern of using MDCK cells is the presence of endogenous transporters of nonhuman origin.  The canine P-glycoprotein (Pgp) can interfere with permeability and transporter studies, leading to less reliable data.  A new cell line, MDCKII-LE (low efflux), has been developed by selecting a subpopulation of low-efflux cells from MDCKII-WT using an iterative fluorescence-activated cell sorting technique with calcein-AM as a Pgp and efflux substrate.  MDCKII-LE cells are a subpopulation of MDCKII cells with over 200-fold lower canine Pgp mRNA level and fivefold lower protein level than MDCKII-WT.  MDCKII-LE cells showed less functional efflux activity than MDCKII-WT based on efflux ratios.  Notably, MDCKII-MDR1 showed about 1.5-fold decreased expression of endogenous canine Pgp, suggesting that using the net flux ratio might not completely cancel out the background endogenous transporter activities.  MDCKII-LE cells offer clear advantages over the MDCKII-WT by providing less efflux transporter background signals and minimizing interference from canine Pgp.  The MDCKII-LE apparent permeability values well differentiates compds. from high to medium/low human intestinal absorption and can be used for Biopharmaceutical Classification System.  The MDCKII-LE permeability assay (4-in-1 cassette dosing) is high throughput with good precision, reproducibility, robustness, and cost-effective. © 2011 Wiley-Liss, Inc. and the American Pharmacists Assocn. J Pharm Sci.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTVtRmYnbF17Vg90H21EOLACvtfcHk0liNatmpA6qLmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovFGltb8%253D&md5=97f647fc215ea6d04882351ffc912a1e</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1002%2Fjps.22674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.22674%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DWhitney-Pickett%26aufirst%3DC.%26aulast%3DUmland%26aufirst%3DJ.%2BP.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DGebhard%26aufirst%3DD.%2BF.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DFederico%26aufirst%3DJ.%2BJ.%26aulast%3DDavidson%26aufirst%3DR.%2BE.%26aulast%3DSmith%26aufirst%3DR.%26aulast%3DReyner%26aufirst%3DE.%2BL.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DRotter%26aufirst%3DC.%26aulast%3DVarma%26aufirst%3DM.%2BV.%26aulast%3DKempshall%26aufirst%3DS.%26aulast%3DFenner%26aufirst%3DK.%26aulast%3DEl-Kattan%26aufirst%3DA.%2BF.%26aulast%3DListon%26aufirst%3DT.%2BE.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26atitle%3DDevelopment%2520of%2520a%2520New%2520Permeability%2520Assay%2520Using%2520Low-Efflux%2520MDCKII%2520Cells%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2011%26volume%3D100%26spage%3D4974%26epage%3D4985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Curatolo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nightingale, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbig, S. M.</span><span> </span><span class="NLM_article-title">Utility of Hydroxypropylmethylcellulose Acetate Succinate (HPMCAS) for Initiation and Maintenance of Drug Supersaturation in the GI Milieu</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1419</span><span class="NLM_x">–</span> <span class="NLM_lpage">1431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm301626p&amp;key=10.1007%2Fs11095-009-9852-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm301626p&amp;key=19277850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm301626p&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivVKnt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2009&pages=1419-1431&author=W.+Curatoloauthor=J.+A.+Nightingaleauthor=S.+M.+Herbig&title=Utility+of+Hydroxypropylmethylcellulose+Acetate+Succinate+%28HPMCAS%29+for+Initiation+and+Maintenance+of+Drug+Supersaturation+in+the+GI+Milieu"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Utility of Hydroxypropylmethylcellulose Acetate Succinate (HPMCAS) for Initiation and Maintenance of Drug Supersaturation in the GI Milieu</span></div><div class="casAuthors">Curatolo, William; Nightingale, James A.; Herbig, Scott M.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1419-1431</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">To identify materials and processes which effect supersatn. of the GI milieu for low soly. drugs in order to increase oral bioavailability.  A variety of small and polymeric mols. were screened for their ability to inhibit drug pptn. in supersatd. solns.  The best polymeric materials were utilized to create spray-dried dispersions (SDDs) of drug and polymer, and these were tested for drug form and homogeneity.  Dispersions were tested in vitro for their ability to achieve and maintain drug supersatn., for a variety of drug structures.  Of the 41 materials tested, HPMCAS was the most effective at maintaining drug supersatn.  Drug/HPMCAS SDDs were consistently more effective at achieving and maintaining drug supersatn. in vitro than were SDDs prepd. with other polymers.  Drug/HPMCAS SDDs were effective in vitro for eight low soly. drugs of widely varying structure.  Drug/HPMCAS SDDs were more effective at achieving and maintaining supersatn. than were rotoevaporated Drug/HPMCAS dispersions or phys. mixts. of Drug and HPMCAS.  The degree of achievable drug supersatn. increased with increasing polymer content in the SDD.  The drug in drug /HPMCAS SDDs was amorphous, and the dispersions were demonstrated to have a single glass transition and were thus homogeneous.  HPMCAS has been identified as a uniquely effective polymer for use in SDDs of low soly. drugs, with broad applicability across a variety of drug structures and properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4s3z_VWbntrVg90H21EOLACvtfcHk0liNatmpA6qLmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivVKnt7Y%253D&md5=ded648a652939b723e96ce6d1c1a5ad9</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1007%2Fs11095-009-9852-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-009-9852-z%26sid%3Dliteratum%253Aachs%26aulast%3DCuratolo%26aufirst%3DW.%26aulast%3DNightingale%26aufirst%3DJ.%2BA.%26aulast%3DHerbig%26aufirst%3DS.%2BM.%26atitle%3DUtility%2520of%2520Hydroxypropylmethylcellulose%2520Acetate%2520Succinate%2520%2528HPMCAS%2529%2520for%2520Initiation%2520and%2520Maintenance%2520of%2520Drug%2520Supersaturation%2520in%2520the%2520GI%2520Milieu%26jtitle%3DPharm.%2520Res.%26date%3D2009%26volume%3D26%26spage%3D1419%26epage%3D1431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i91"><a href="/doi/suppl/10.1021/jm301626p">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_71188"></div></div></div></div></div><hr /></hr><p class="last">X-ray experimental conditions for the structure determination of <b>25b</b> and the results. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm301626p/suppl_file/jm301626p_si_001.pdf">jm301626p_si_001.pdf (177.12 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm301626p&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm301626p%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2013.56.issue-1%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm301626p" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                975KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67998553aa3d24bb","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
